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Critical Review of the Literature 
 
Objectives: Non-suicidal self-injury (NSSI) is associated with several physical and social 
harmful consequences and has been found to be comorbid with other clinical 
presentations, including eating disorders. Models have been developed to understand the 
functions and risk factors of NSSI only, but it is unknown whether they apply to NSSI in 
the context of people with eating disorders.  
 
Methods: To investigate the risk factors and functions of NSSI in eating disorders, a 
systematic search was conducted leading to the identification of two longitudinal papers 
related to risk and six papers related to function, across 666 unique participants. 
  
Results: Affective lability and variation in affective activation were identified as risk 
factors. NSSI primarily served the functions of emotion regulation, self-punishment, 
identity formation and self-criticism arising from perceived parental criticism and the 
failure to meet high standards based on perfectionist traits.  
 
Conclusions: These risk factors and functions fit well with the intrapersonal and 
interpersonal vulnerability factors identified for NSSI and highlighted other factors, 
including perfectionism and identity confusion. These may interact with the reinforcing 








Service Improvement Project 
 
Objectives: Dialectical behavioural therapy (DBT) is an effective treatment for people 
with borderline personality disorder (BPD) to help with difficulties they may experience 
in affect, behaviour and interpersonal relationships. This study aimed to expand upon 
previous literature by exploring both client and staff perspectives of DBT, of a dual 
diagnosis DBT service that takes an integrated approach to concurrently treat both the 
symptoms of BPD and comorbid substance misuse.  
 
Methods: Questionnaires and individual interviews were completed by four clients. 
Questionnaires were completed by six team members and five of those also completed 
individual interviews.  
 
Results: For clients, results showed that they rated having a high level of satisfaction with 
the service and thematic analysis identified three main themes: ‘Building a life worth 
living’, ‘Challenging aspects of DBT’ and ‘The therapeutic environment’. Team members 
rated their delivery of DBT to be of good quality and felt that clients appeared to be 
satisfied. Thematic analysis identified two superordinate themes: ‘Not a dedicated DBT 
service’ and ‘Provision of DBT’.  
 
Conclusions: Recommendations made to the service included improving phone support 
and the presentation of skills to clients. Additional recommendations made included 








Main Research Project 
 
Objective: Negative subjective interpretations about the cause and consequences of 
physical symptoms is linked to psychological distress amongst cancer survivors. The 
present study aimed to extend upon previous literature by examining the role of mental 
defeat, fear of cancer recurrence (FCR) and health-related beliefs on psychological 
distress and quality of life, in cancer survivors who experience cancer pain and/or cancer-
related fatigue (CRF). 
 
Method: The first stage involved 117 cancer survivors completing a brief screening tool 
evaluating fatigue, pain, depression and anxiety. The second stage comprised 33 
participants who had completed the screening tool. Group comparisons were conducted 
between those experiencing higher levels of cancer pain and/or CRF interference and 
those with lower levels of cancer pain and CRF, on levels of distress, quality of life, FCR, 
mental defeat and health-related beliefs. 
 
Results: The screening tool was effective at identifying physical and psychological 
symptoms known to be present amongst many cancer survivors and was useful in 
prospectively predicting quality of life and FCR. In the second stage, participants 
experiencing higher levels of cancer pain and/or CRF interference had significantly 
higher levels of psychological distress and poorer quality of life, in comparison to those 
with lower levels of cancer pain and CRF interference. There were no significant group 
differences on any of the other measures. Mental defeat was a significant predictor of 
psychological distress and quality of life. 
 
Conclusions: These results highlight the detrimental impact that the experience of 
physical symptoms can have on cancer survivors. Findings suggest that the brief 
screening tool could be used clinically to provide earlier detection of cancer survivors 
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Non-suicidal self-injury (NSSI) is the direct and deliberate destruction of one’s bodily 
tissue without suicidal intent (Washburn, Potthoff, Juzwin, & Styer, 2015). Such 
behaviours include cutting, burning, biting, scratching and hitting oneself but exclude 
socially sanctioned bodily modifications such as tattooing and piercing (Franklin & Nock, 
2016).  
 
Lifetime prevalence for NSSI has been estimated at 5.9%, with an average onset of 16 
years (Klonsky, 2011). Research has shown comparable prevalence rates for NSSI in 
adolescent samples across numerous countries and cultures (Muehlenkamp, Claes, 
Havertape, & Plener, 2012). With regards to gender differences, prevalence rates of NSSI 
for men and women are similar, although women have been found to have an earlier age 
of onset (Andover, Primack, Gibb, & Pepper, 2010). Females report more cutting and 
scratching behaviours in comparison to males who report engaging in hitting and burning 
methods (Sornberger, Heath, Toste, & McLouth, 2012).  
 
There has been discussion and disagreement in the literature regarding the distinction of 
NSSI from suicidal behaviour, with regards to the extent of suicidal intention involved in 
a self-injurious act. Some authors have contested that NSSI should be a distinct diagnosis 
(Kapur, Cooper, Connor, & Hawton, 2013) whilst others have suggested that NSSI and 
suicidal self-injury (SSI) exist on a continuum (Orlando, Broman-Fulks, Whitlock, 
Curtin, & Michael, 2015). Terminology used has also reflected the lack of consensus 
within the field, with phrases such as ‘parasuicide’ and ‘deliberate self-harm’ being used 
to describe both acts of self-injury with suicidal intent and those without (Muehlenkamp 
et al., 2012; Nock, 2012).  
 
In the fifth edition of the Diagnostic Statistical Manual (DSM-V), NSSI has been 
recognised as a distinct condition but is defined as requiring further research before it can 
be considered as an official diagnosis (APA, 2013). It was previously captured only as a 
symptom of borderline personality disorder (BPD; APA, 2000) but it has been argued 
that this does not reflect the nature of NSSI accurately. To give a diagnosis of BPD to a 
young adolescent engaging in NSSI may be deemed inappropriate and even unethical, as 
it is a period when personality may still be developing (Wilkinson, 2013). The occurrence 
of NSSI has been recognised in other clinical presentations including depression, 
generalized anxiety disorder and substance misuse, (Nock, Joiner, Gordon, Lloyd-
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Richardson, & Prinstein, 2006) and within non clinical populations  (Lloyd-Richardson, 
Perrine, Dierker, & Kelley, 2007). 
 
An integrated theoretical model of the development and maintenance of NSSI (Nock, 
2009) 
NSSI is a clinically important behaviour that can have several harmful consequences for 
individuals engaging in it, including the experience of powerful emotions such as guilt 
and shame and negative reactions from others (Wilkinson, 2013). It poses a physical risk 
as habituation to self-injuring behaviours may lead to increased severity of injuries and 
an underestimation of the lethality of these acts (Muehlenkamp & Kerr, 2010).  
 
A growing body of literature has attempted to understand the characteristics, risk factors 
and functions of NSSI to improve clinical assessment, treatment and prevention. The 
identification of psychosocial characteristics of NSSI, including higher ratings of 
impulsivity, depression and suicidal thoughts, has helped to classify people who may be 
at a higher risk for self-injuring, yet fails to increase understanding of why people engage 
in these behaviours (Bentley, Nock, & Barlow, 2014; Nock & Prinstein, 2004).  
 
A four-function model (FFM; Nock & Prinstein, 2004) proposed a functional approach, 
whereby behaviours are believed to be a consequence of events that have preceded and 
followed them. In this model, NSSI is maintained by four reinforcement processes: (1) 
Intrapersonal-negative (automatic) reinforcement, in which behaviour is followed by an 
immediate decrease in internal aversive thoughts or feelings; (2) Intrapersonal-positive 
(automatic) reinforcement, in which behaviour generates internal positive thoughts or 
feelings; (3) Interpersonal-negative (social) reinforcement, whereby NSSI serves to 
facilitate escape from undesired social situations; (4) Interpersonal-positive (social) 
reinforcement, in which NSSI is followed by an increase in a desired social situation (e.g. 
attention). This model advanced upon previous theories with its wider consideration for 
the social function of engaging in NSSI, in addition to the function of affect regulation 
(Bentley et al., 2014). Each of the four functions has been found to have moderate to high 
internal consistency, with over half of the sample (52.9%) in Nock and Prinstein’s study 
(2004) endorsing intrapersonal-negative reinforcement (‘to stop bad feelings’) as a 




The FFM was incorporated into the Integrated Theoretical Model of the Development 
and Maintenance of NSSI (ITM; Nock, 2009), which includes general and specific 
vulnerability factors that increase the risk of individuals engaging in self-injury. General 
factors include an individual’s environment and neurobiology, such as experiencing 
abuse or neglect in childhood or having an increased stress response. These factors are 
not exclusive to self-injury but are thought to lead to emotion dysregulation, poor 
behavioural/cognitive control and impulsivity, which in turn increase the likelihood of an 
individual using self-injury to regulate these difficulties.  
 
Specific vulnerability factors include self-punishment, social learning (influence of 
peers), pragmatism (viewing self-injury as a rapid, effective act), implicit identification 
(identifying oneself as a self-injurer), social signalling (a way to elicit help) and pain 
analgesia (experiencing little or no pain during self-injury). These factors serve the 
primary function of regulation and can explain the maintenance of NSSI and an 
individual’s decision to engage in this behaviour over an alternative. Only one study has 
examined the model in its entirety, using a mixed-methods design, finding support for all 
of the intrapersonal and interpersonal vulnerability factors and specific vulnerability 





Figure 1.1 Nock’s Integrated Theoretical Model of the Development and Maintenance of NSSI
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NSSI and eating disorders 
NSSI has been found to occur within several different clinical presentations, including 
eating disorders (ED). A review on the nature of this association (Svirko & Hawton, 
2007) included 25 out of 62 studies which included self-injurious behaviours within 
ED. They reported the co-occurrence of these disorders found within two studies was 
54-61%, which is indicative of a strong association. Potential factors found to 
contribute to this association included affect regulation, dissociation and impulsivity 
and the authors suggested early trauma and abuse may lead to the development of such 
factors. However, it should be noted that the majority of studies in this review were 
literature reviews or did not actually include the co-occurrence of ED and NSSI.  
 
Eating-disordered behaviours and methods of weight control, such as purging and 
laxative abuse, are classed as indirect ways of mistreating or abusing one’s body, due 
to their potential to cause marked and lasting physical change (Hooley & Germain, 
2014). Discussions have focused on whether indirect self-injurious behaviours should 
be conceptualised as being on a continuum with NSSI, rather than as a separate 
condition. An investigation into this found many similarities (e.g. depressive 
symptoms, impulsivity) between individuals who engaged in NSSI and those who 
engaged in indirect self-injury only (Germain & Hooley, 2012). However, those who 
engaged in NSSI were found to have higher levels of self-criticism and were at a 
greater risk of attempting suicide. On the basis of these results, it was concluded that 
NSSI should remain a distinct condition rather than being viewed as interchangeable 
with indirect self-injury, for fear that individuals at high-risk of harm and suicide may 
not be identified.  
 
A recent review explored the association of suicide and self-injury in eating disorders, 
including anorexia nervosa (AN), bulimia nervosa (BN) and binge eating disorder 
(BED; Kostro, Lerman, & Attia, 2014). Studies in this review included both clinical 
and community samples and ranged from sample sizes of less than one hundred up to 
tens of thousands. The authors reported higher rates of suicidal behaviour were more 
often associated with AN, whilst NSSI co-occurred frequently with eating disorders 
that included bingeing or purging behaviours, particularly within adolescents who 




Aims of the current review 
There has been increased research and clinical attention towards NSSI in a bid to 
understand its aetiology, development and maintenance. NSSI is highly prevalent in 
ED and has been found to be associated with attempted suicide within this population, 
reflecting its clinical importance (Cucchi et al., 2016). 
 
A number of reviews have explored the prevalence and correlates of NSSI, suicidality 
and different ED presentations (Cucchi et al., 2016; Kostro et al., 2014; Svirko & 
Hawton, 2007). However, there has not been a review conducted which has examined 
the risk factors and functions of NSSI within ED, suggesting that such a review could 
be timely. 
 
The current review sought to provide a critical evaluation, using Nock’s (2009) ITM 
to synthesise findings and to explore whether the risk factors and functions outlined in 
this model could translate across different ED presentations.  
 
Research questions 
The following research questions were considered: 
1. What risk factors for NSSI have been identified in studies of people with ED? 
2. What are the functions of NSSI that have been identified in studies of people 
with ED? 
3. How do the risk factors and functions identified for NSSI in studies of people 




Electronic literature databases PsychINFO, PubMed and Web of Science were 
searched systematically to identify all papers that were on the topic of both NSSI and 
ED. The lead author conducted the searches in July 2016. Each search used the 
following combination of key words: “Non-suicidal self-injury”/ self-injur*/self-
cut*/self-harm*/self-mut*/self-destr* AND Eating disorder*/“disordered 
eating”/eating patholog*/anorexi*/bulimi*/purg*/bing*. Reference sections of 
included studies and literature reviews were examined to detect any further relevant 
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The process of searching for and selecting studies is shown in Figure 1.2. The initial 
search of three databases identified 346 records, of which 244 were duplicates. 
Screening of the titles and abstracts identified a further 29 records which met the 
exclusion criteria and these were also removed. To conduct as comprehensive a search 
as possible of these remaining titles and abstracts, they were subject to a key word 
search to identify records which specifically assessed risk factors and/or functions 
(Table 1.1). Previous literature related to risk factors in NSSI only (Fox et al., 2015) 
and functions of problematic behaviour, including NSSI (Gratz, 2003; Hanley, Iwata, 
& McCord, 2003), was consulted to develop a wide range of search terms. 46 records 
were excluded from the search of risk factor key words and 44 records were excluded 
from the search of function key words. The remaining full-text articles were screened 




 Inclusion criteria. 
These criteria were developed in accordance with previous relevant literature in the 
field and were used to increase rigour and provide a comprehensive review of the 
literature. For all articles: (1) primary studies explicitly measuring risk factors and/or 
functions of NSSI in people with ED, using methods of measurement that directly 
investigate these factors; (2) participants with an ED diagnosis confirmed either 
clinically or by the research team in accordance with DSM and/or International 
Classification of Diseases (ICD); (3) NSSI clearly defined as deliberate physical injury 
Table 1.1 
Risk factor and function key word search terms 
Risk Factors Function 
Risk, longitudinal*, predict*, prospective*, 
future 
Function, functional analysis, analysis, 
behavioural assessment (English UK and 
US spelling), antecedent, consequence, 
purpose, trigger, motivat*, reinforc*, 
automatic*, preced*, intent 
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to the self only, without suicidal intent. Additionally, for articles related to risk factors; 
(4) studies investigating causal risk factors using a longitudinal design. Studies could 
include either clinical or community samples, in accordance with meeting the above 
criteria of participants meeting a DSM/ICD classification of ED diagnosis.  There were 




As stated above, articles were first excluded if they were written in a language other 
than English and were not published in peer-reviewed journals. Reviews, book 
chapters and dissertations were excluded. Papers identified from the risk 
factor/function key word search were examined and excluded if the word identified 
had been used in a different context. Remaining studies were excluded if NSSI was 
conceptualised as being interchangeable with behaviours that had suicidal intent and 
if it was classified only as a symptom of another psychiatric disorder (e.g. BPD).  
 
Data extraction. 
A table was created to record data extracted from identified studies. Data extracted 
captured general information about the study (e.g. author, year of publication), sample 
and study characteristics (e.g. gender, age, methodology), specific ED and NSSI 
characteristics (e.g. measurement) and results. 
 
Quality appraisal 
Instruments used to appraise the quality of non-randomised studies were subject to a 
systematic review (Deeks et al., 2003) and it was suggested that only 6 out of 182 tools 
could potentially be useful. One of the tools assessed to be most useful included the 
Newcastle Ottawa Scale (NOS; Wells et al., 2008). The NOS was originally devised 
to assess the quality of case-control and cohort studies, although both Deeks et al. 
(2003) and the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 
& Green, 2011) advise that it should be adapted accordingly for each review 
conducted. As this review comprised cohort and cross-sectional designs, the NOS 




The following criteria was used to appraise the quality of studies: (1) Selection 
(representativeness of the sample, use of a control group, valid measures for assessing 
outcome of interest); (2) Confounding factors (whether these were controlled for); (3) 
Outcome (how outcomes of interest were assessed e.g. repeated measurements, self-
report, blind assessment; description and appropriateness of statistical tests used). For 
criterion fulfilled, the study was awarded a point of one and for those not fulfilled there 
were zero points awarded. The only exception to this was related to outcome 
measurements, where an additional point was awarded to studies employing 
methodology that increased reliability and validity (e.g. blind assessment, Ecological 
Momentary Assessment (EMA)). The total quality score that studies could be awarded 



























Figure 1.2 Flow chart of study selection 
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Records excluded 
Key word used in different 
context (n=3) 
Not longitudinal design 
(n=17) 
ED not confirmed diagnosis 
in line with DSM/ICD (n=4) 
 
 Records excluded 
Key word used in different 
context (n=13) 
Does not directly measure 
function (n=5) 
ED not confirmed diagnosis 
in line with DSM/ICD 
(n=4) 
 
   
     
 Studies related to risk factors 
included in review (n=2) 
 Studies related to function included 





Two papers were identified as measuring risk factors for NSSI in people with ED and 
six papers identified as investigating the function of NSSI in people with ED. None of 
the studies were relevant for both risk factors and function. However, two of the 
identified studies used the same community sample; one study assessing risk and one 
assessing function. They are both included as their research questions and 
methodologies are distinctly adapted to measure risk factors and function separately. 
Four of the studies investigating function have the same lead author, however all are 
included as they use different samples. 
 
Across the eight papers identified, there were 666 unique participants, ranging in age 
from 12-55 years (of those reported). All participants had an ED diagnosis, with the 
majority having a diagnosed subtype of BN (47%) or AN (41%). The approximate 
prevalence of reported NSSI across participants was 38%. Further details of the 
sample, methodology and results of each paper that met with inclusion criteria are 
outlined in Tables 1.2 and 1.3.  
 
Question 1: What risk factors for NSSI have been identified in studies of people 
with ED? 
Quality appraisal and limitations within literature. 
Both studies identified were deemed to be of good quality with Anestis et al. (2012) 
scoring 9/12 and Vansteelandt et al. (2013) scoring 7/12. The strengths of both studies 
were the representativeness of samples, use of EMA and controlling for confounding 
factors (e.g. ED diagnosis and other psychiatric disorders). The findings of Anestis et 
al. (2012) were slightly weakened due to the fact it does not report how many 
participants engaged in NSSI and how many did not. The slightly lower score awarded 
to Vansteelandt et al. (2013) resulted from the use of a non-validated questionnaire to 
measure the risk factor being assessed and from capturing the presence/absence of 
NSSI from medical records only, without additional self-report during the study 
period. A disadvantage of using retrospective data is the limited control over data 







The two studies had a combined total of 185 participants. Participants in Anestis et al. 
(2012) were drawn from a community sample, with 51.1% identified as full-time 
students and 96.9% as Caucasian. Participants in Vansteelandt et al. (2013) were 
drawn from a clinical sample of inpatients admitted to a specialist ED unit. 
 
 Eating disorder characteristics and measures. 
Anestis et al. (2012) aimed to recruit participants with a diagnosis of BN and reporting 
kappa ratings of inter-rater reliability in diagnosis as 1.00. Vansteelandt et al. (2013) 
recruited participants with confirmed diagnoses of AN (of both restricting and binge-
purging subtypes) and BN. 
 
NSSI characteristics and measures. 
Neither study used a validated tool to measure NSSI. Anestis et al. (2012) created a 
NSSI variable by summing the number of times a participant endorsed self-injurious 
behaviours of cutting, burning, head banging and repeated hitting. However, the study 
does not report how many participants in the sample reported engaging in NSSI. In 
Vansteelandt et al. (2013), only 16 participants were recorded as having ever engaged 
in NSSI. No other NSSI characteristics were recorded.   
 
 Design. 
Both studies employed a longitudinal design using EMA to capture participants’ 
behaviour and emotional experiences in current time. The studies were both conducted 
over a discrete period of between one and two weeks, with data collection at several 
time-points each day. Vansteelandt et al. (2013) programmed signals according to a 
stratified random interval time-series, ensuring that participants could not anticipate 
them. Anestis et al. (2012) directed readers to another of their published papers for a 
description of the procedure used (Anestis et al., 2010). From this, it appeared 
participants provided data in response to six semi-random signals per day, after 
engaging in self-destructive behaviours (e.g. NSSI/bingeing/purging) and at the end of 






Risk factor study characteristics 
Study  Method Sample ED measure and 
diagnosis 























Gender: All female 
Measure: SCID 












hitting, head banging   
No. of NSSI 
participants: not 
reported 















• Higher levels of self-
reported affective lability 
and number of lifetime 
suicide attempts interact to 
predict greater number of 
NSSI episodes during study 





















Gender: All female 
Measure: SCID 
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17.8; BN 





lifetime NSSI noted in 
medical records 
(dichotomous yes/no) 
Behaviour: not known 
No. of NSSI 
participants: 16 with 








• Participants with NSSI 
have higher mean for 
variability in activation, but 
not for valence, than those 
without NSSI (mean=2.82, 
SD=0.78, F(1,56)=7.46, 
p=0.008) 
• Variability in activation is a 
significant predictor of 
lifetime NSSI (odds 
ratio=5.71, p=0.01) 
Note: ED=eating disorder; NSSI=non-suicidal self-injury; EMA=Ecological Momentary Assessment; SD=standard deviation; SCID=structured clinical interview; DSM-




Risk factors assessed and results found.  
Both studies investigated the role of affect as a potential risk factor for NSSI. Anestis 
et al. (2012) examined whether an individual’s previous suicidal behaviours interacted 
with self-reported affective lability to predict the number of times they engaged in 
NSSI behaviours during the study follow-up period. At baseline, the authors assessed 
the number of lifetime suicidal gestures or attempts each participant had made by way 
of a diagnostic semi-structured interview for BPD symptoms. Affective lability is a 
term used to describe rapid shifts in the intensity and valence (e.g. positive or negative 
affect) of one’s emotional expression and this was also measured at baseline using the 
affective lability subscale of the dimensional assessment of personality pathology-
basic questionnaire (DAPP-BQ). The authors commented on the reliability and 
internal consistency of both of these measures. In this study, EMA recorded numbers 
of dysfunctional behaviours participants engaged in (e.g. NSSI) and intensity of 
negative affect during the day. Results supported their hypothesis that higher levels of 
affective lability and the presence of previous suicidal behaviour would interact to 
predict higher rates of NSSI behaviours.  
 
Vansteelandt et al. (2013) investigated whether affective variability (valence and 
activation e.g. level of arousal) predicted the number of lifetime NSSI episodes that an 
individual had engaged in. EMA measured affective variability using an unvalidated 
questionnaire developed specifically for the study. These scores were predictor 
variables and a logistic regression model analysed their effect on the presence/absence 
of lifetime NSSI. They found that individuals with an ED diagnosis and NSSI showed 
higher levels of variability in affective activation than those without NSSI, but that 
variability in valence and mean levels of both activation and valence did not vary 
significantly between the two groups. For those who engaged in NSSI, results also 
showed that variability in affective activation predicted lifetime NSSI whilst variation 
in affective valence did not.    
 
Question 2. What are the functions of NSSI that have been identified in studies of 
people with ED? 
Quality appraisal and limitations within literature. 
Four of the six studies were deemed as being of good quality with scores of eight or 
higher, out of twelve. The other two studies also scored fairly well with one study just 
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below 50% (Claes, Klonsky, Muehlenkamp, Kuppens, & Vandereycken, 2010) and 
the other at 50% (Itzhaky, Shahar, Stein, & Fennig, 2016). The studies scoring highly 
demonstrated representativeness in their samples, controlled for several confounding 
factors (e.g. age, gender, ED diagnosis), used self-reported outcomes and reported the 
results of appropriate statistical analyses. Muehlenkamp et al. (2009) was awarded an 
additional point for the use of EMA in addition to self-reported outcomes. All studies 
used validated measures to assess functions of NSSI.  
 
A control group would not have been necessary for analysing research questions 
related to the functions of NSSI only. However, a point was awarded to studies that 
included a control group when investigating other primary research questions, as this 
strengthened their findings.  
 
The primary reason for two studies scoring slightly less in the quality appraisal was 
caused by not controlling for as many confounding factors as others did. 
 
Sample characteristics. 
The sample size of all six papers ranged from 51 to 177 participants. Four studies 
appeared to include adult samples, although only one of these studies (Muehlenkamp 
et al., 2009) stated exclusion criteria for any participant under the age of 18 years. One 
study explicitly used an adolescent population (Itzhaky et al., 2016) and another used 
a mixed population of adolescents and adults (Claes, Soenens, Vansteenkiste, & 
Vandereycken, 2012). Five of the six studies were made up of an entirely female 
sample although the sixth only had four males (Itzhaky et al., 2016). One study used a 
community sample (Muehlenkamp et al., 2009) whilst the other studies used clinical 
samples; both inpatient and outpatient.  
 
 Eating disorder characteristics and measures. 
Muehlenkamp et al. (2009) recruited participants from the community with a BN 
diagnosis only. All of the other studies recruited participants with a range of diagnoses, 
including two subtypes of AN (restrictive and binge-purge), two subtypes of BN 
(purge and non-purge), binge-eating disorder (BED) and eating disorder not otherwise 
stated (EDNOS). Two studies reported mean BMI levels (Claes, Norré, Van Assche, 
& Bijttebier, 2014; Muehlenkamp et al., 2009). 
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 NSSI characteristics and measures.  
Four of the studies measured NSSI using the Self-Injury Questionnaire – Treatment 
Related (SIQ-TR; (Claes & Vandereycken, 2007) which was developed and validated 
by the lead author in each of these studies. The SIQ-TR primarily gathers data for five 
self-injurious behaviours (scratching until bleeding, bruising, cutting, biting and 
burning) but also allows individuals to answer according to other NSSI acts they may 
engage in. It assesses when the individual last engaged in NSSI behaviour, frequency, 
pain felt, affect before and after, premeditation and function/motivation. One study 
used the Functional Assessment of Self-Mutilation (FASM; Lloyd, Kelley, & Hope, 
1997) which assesses methods used, frequency and functions of self-injury. The sixth 
study (Muehlenkamp et al., 2009) brought together items from several scales to create 
a checklist of self-injurious behaviours for participants to indicate those they had 
engaged in. This checklist did not capture frequency or function of behaviours.  
 
Design. 
Five studies employed a cross-sectional study design using questionnaire and 
quantitative data from interviews. One study was longitudinal (Muehlenkamp et al., 
2009), using EMA to capture real-time emotional states before and after acts of NSSI 







Function study characteristics 
Study  Method Sample  ED measure and 
diagnosis 


















Measure: SCID for DSM-
IV Axis I Disorders, 
Patient 
Edition – Eating Disorder 
Module 
Diagnosis: All BN 
BMI: mean=23.8; SD=5.25 
Measure: A self-injurious 
behaviour checklist 
No. of NSSI participants: 
14.5% (n=19) NSSI 
Behaviours: Cutting, 
scratching, burning, hitting, 
head banging 
 
• Prior to acts of NSSI, negative affect 
significantly increased (t(212)=2.94, p< 
0.01), whilst positive affect significantly 
decreased (t(212)=-3.20, p< 0.01) 
• After acts of NSSI, positive affect 
significantly increased, whilst levels of 
negative affect remained unchanged.  


















Diagnosis: 48 AN-RT, 34 
AN-BP, 17 BN-NP, 55 
BN-P, 19 EDNOS, 4 N/A 
Measure: SIQ-TR 
No. of NSSI participants: 
43.5% (n=77) NSSI in past 
year; 27.7% (n=49) in past 
month or week 
NSSI behaviours: in past 
week or month, 18.1% 
(n=32) severe scratching, 
• 49 participants who had engaged in NSSI 
in past week or month were focus of 
analysis 
• Functions endorsed for NSSI: ‘to avoid or 
suppress negative feelings’ burning 
(100%), cutting (76.9%), severe scratching 
(68.8%); ‘to punish oneself’ bruising 
(93.8%). ‘To get attention from others’ and 
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14.7% (n=26) cutting; 9% 
(n=16) bruising, 2.8% 
(n=5) burning. 
‘to show others how strong I am’ rarely or 
never mentioned 
• Positive valence-low arousal affect state 
(e.g. relieved) showed substantial increase 
from before to after acts of NSSI. Negative 
valence-high arousal showed substantial 
decrease from before to after acts of NSSI 
(e.g. anger at self and/or others) 
• Results show positive associations (but not 
significant) between increase of positive 
affect and number of functions endorsed. 


















interview (DSM-IV) and 
questionnaire (EDES) 
Diagnosis: 44 AN-RT, 12 
AN-BP, 28 BN, 11 
EDNOS 
Measure: SIQ-TR  
No. of NSSI participants: 
38.9% (n=37) NSSI; 61.1% 
(n=58) non-NSSI 
Behaviours: 21.1% (n=20) 
cutting, 20% (n=19) hair 
pulling, 14.7% (n=14) 
scratching, 12.6% (n=12) 
• Participants with NSSI scored significantly 
higher on levels of evaluative concerns 
perfectionism (ECP; F=5.58, p<0.05) and 
perceived parental criticism (PPC; F=5.62, 
p<0.05) than those without. 
• Three functions of interest in study (self-
punishment, self-torturing and cry-for-help) 
all showed significantly positive 
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bruising, 4.2% (n=4) 
burning  
relationships with ECP (β=0.3, 0.3, 0.36 
respectively, p<0.05-0.01); cry-for-help 
function significantly negative relationship 
with PPC (β=-0.29, p<0.01) 
















Measure: Eating disorder 
section of DSM-IV and 
EDI-2 
Diagnosis: 19 AN-R, 8 
AN-BP, 19 BN, 5 EDNOS  
BMI: AN-R, mean=17.23, 
SD = 1.74; participants 
with binge/purging 
behaviours (AN-BP, BN, 
EDNOS), mean=22.84, SD 
= 6.76 
Measure: SIQ-TR 
No. of NSSI participants: 
33% (n=17) NSSI 
(lifetime) 
Behaviours: 19.6% severe 
cutting, 19.6% hitting, 
17.6% superficial cutting, 
13.7% head banging, 9.8% 
scratching, 5.9% burning 
 
• Four factors were found which explained 
77.63% of variance in NSSI functions 
assessed: (1) α=.72, 5 items, External-
Positive Reinforcement (increase of 
positive attention from others after NSSI); 
(2) α=.75, 2 items, External-Negative 
Reinforcement (avoid social activities); (3) 
α=.93, 2 items, Internal-Negative 
Reinforcement (avoid/suppress negative 
feelings); (4) α=.66, Three items, self-
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punishment, avoidance/escape of suicidal 
thoughts, numb state (not labelled) 
• Factors 1 and 2 not correlated with 
temperament, Factor 3 positively correlated 
with Negative Affectivity (r=.51, p<0.05), 
negatively correlated with Positive 
Affectivity/Extraversion (r=-.62, p<0.05). 
Factor 4 negatively correlated with 
Effortful Control (r=-.0.68, p<0.01) 

















interview (DSM-IV) and 
EDI-2 
Diagnosis: 20 AN-R, 16 
AN-BP, 41 BN, 22 BED 
Measure: SIQ-TR  
No. of NSSI participants: 
58.5% (n=56) NSSI 
Behaviours: 39.4% 
superficial cutting, 39.4% 
severe cutting, 37.4% 
scratching, 32.3% 
bruising/hitting, 28.3% 
head banging, 19.2% 
burning, 18.2% picking 
 
• Most strongly endorsed functions for NSSI 
were ‘to avoid or suppress negative 
feelings’ (M= 4.21, SD = 1.07) and ‘to 
punish myself’ (M= 3.93, SD = 1.28) 
• Participants with NSSI scored significantly 
higher for identity confusion 
(F(1,90)=7.45, p<0.01) and significantly 
lower for identity synthesis than 




• Three factors were found which explained 
42% of variance in NSSI functions 
assessed: (1) α=.76, 6 items, automatic 
positive reinforcement (obtaining desired 
internal state); (2) α=.72, 6 items, automatic 
negative reinforcement (reduce unwanted 
internal state); (3) α=.82, 2 items, social 
negative reinforcement (escape unwanted 
social situations/demands) 
• Automatic negative reinforcement function 
positively related to identity confusion 
(r=.34, p=sig.) and negatively related to 
identity synthesis (r=-.34, p=sig.) 
















female, 4 male 
Measure: SCID for DSM-
IV and the Eating Disorder 
Family History Interview 
Diagnosis: 66% AN, 7% 
BN, 27% EDNOS 
Measure: FASM 
No. of NSSI participants: 
62% (n=34) NSSI at least 
twice in past year 
Behaviours: 23% minor 
(hitting, biting, pulling 
• Functions endorsed by participants for 
NSSI: 85% automatic negative motivation, 
79% automatic positive reason, 50% social 






hair); 21% moderate/severe 
(erasing skin, burning, 
cutting); 56% both 
 
• Dependency predicted higher levels of 
automatic positive motivation only under 
low levels of self-criticism (p < .05, 95% 
CI = 0.61– 5.73).  
• Self-criticism predicted higher levels of 
automatic positive motivation only under 
low levels of dependency (p < .01, 95% CI 
= 0.86–4.79). 
• There were no other significant effects of 
dependency and self-criticism on the other 
functions found. 
Note: ED=eating disorder; NSSI=non-suicidal self-injury; EMA=Ecological Momentary Assessment; SD=standard deviation; SCID=structured clinical interview; DSM-
IV=Diagnostic and Statistical Manual of Mental Disorders, 4th edition; BN=bulimia nervosa; AN-RT=anorexia nervosa restrictive type; AN-BPT=anorexia nervosa binge-
purge type; BN-NP=bulimia nervosa non-purging; BN-P=bulimia nervosa purging; EDNOS=eating disorder not otherwise specified; N/A=not available; BED=binge eating 
disorder; EDES=eating disorder examination; SIQ-TR=self-injury questionnaire-treatment related; EDI-2=eating disorder inventory-2; FASM=functional assessment of self-
mutilation; BMI=body mass index 
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Functions assessed and results found. 
Many of the identified studies investigated functions of NSSI as a secondary research 
question. This section will summarise only the research questions and findings related to 
function. 
 
Claes, Klonsky, Muehlenkamp, Kuppens, & Vandereycken (2010) aimed to assess 
similarities and differences in self-reported functions across various types of NSSI and to 
specifically explore an affect regulation function by examining changes in affect valence 
and arousal before/after NSSI. The authors concluded that people with an ED diagnosis 
may engage in NSSI to regulate emotions. Similar conclusions were reached by 
Muehlenkamp et al. (2009), through the use of EMA to assess prospective real-time 
emotional states before and after acts of NSSI.  
 
Claes et al. (2014) sought to investigate dimensions of temperament and the associations 
and interactions they may have with NSSI and its functions in people with an ED 
diagnosis. Temperament was assessed using a validated tool which measured reactive 
(negative affectivity, extraversion/agency) and regulative (effortful control e.g. one’s 
ability to self-regulate emotional experience and expression) aspects of temperament. 
From their findings, the authors suggested that individuals who respond in a negative 
reactive way to stressful situations may not be able to control and regulate this response, 
turning to NSSI behaviours to achieve this instead.  
 
Claes et al. (2012) investigated whether perfectionism and perceived parental criticism 
(PPC) was related to three particular functions of NSSI: self-punishment, self-torturing 
and cry-for-help. Perfectionism was divided into two types: personal standards 
perfectionism (PSP) and evaluative concerns perfectionism (ECP). PSP involves an 
individual setting high personal standards, although this can include positive goal setting. 
ECP relates to concerns about making mistakes when attempting to achieve high personal 
standards and can involve negative evaluations of the self, leading to self-criticism. The 
authors concluded that ED patients with ECP may punish themselves through NSSI due 
to perceived failings in the standards they uphold for themselves, with PPC acting as a 
potential risk factor for the development of self-criticism.  
 
Itzhaky et al. (2016) cited findings from previous literature that self-criticism and 
dependency (being more dependent on others for emotional regulation) are associated 
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with ED. They set out to investigate the role of these two traits in NSSI in adolescents 
with an ED diagnosis and whether these traits would interact to predict individual 
motivation for NSSI, through the use of validated tools. A two-way interaction of 
dependency and self-criticism (e.g. high dependency with low self-criticism or high self-
criticism with low dependency) was found suggesting that individuals may be motivated 
to achieve a desired physiological state through NSSI in order to either feel comfort 
(dependency) or to punish themselves (self-criticism).  
 
Claes et al. (2015) investigated how identity formation is related to both ED and NSSI, 
using validated measures. A specific research question explored the association of 
problems in formation with characteristics of NSSI, including function. Identity 
formation (Erikson, 1994) is the process in which an individual successfully achieves 
greater identity synthesis over confusion, thus developing an internal feeling of having a 
solid identity that is continuous across time and context. Identity confusion leads to 
individuals having a disorganised sense of self with uncertainty about themselves or their 
role in society. The results suggested that individuals with ED may engage in NSSI in a 
bid to establish a pseudo-identity as a self-injurer, if they are experiencing difficulties in 
forming a cohesive sense of self. 




























Anestis et al. 
(2012) 











et al. (2013) 
58 1; ED IP 1  0; EMA 
questionnaire 
developed 
1 0 1  0 1; 
depression, 
BPD 




























1; ED IP 0  1; SIQ-TR 1 0 0 0 0 1; self-report 1 5 
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Note: ED=eating disorder; DAPP-BQ=Dimensional Assessment of Personality Pathology – Basic Questionnaire; EMA=Ecological Momentary Assessment; IP=inpatient; 
OP=outpatient; SIQ-TR=self-injury questionnaire-treatment related; FASM=functional assessment of self-mutilation; PANAS=positive and negative affect schedule
Claes et al. 
(2012) 
95 1; ED IP 1 1; SIQ 1 1  1  1 0 1; self-report 1 9 
Claes et al. 
(2014) 
51 1; ED OP 1 1; SIQ-TR 1 1 1  0 0 1; self-report 1 8 
Claes et al. 
(2015) 
99 1; ED IP & OP 1 1; SIQ-TR 1 1  1  0 1; depression 1; self-report 1 9 
Itzhaky et al. 
(2016) Study 
2 




1; self-report 1 6 
Muehlenkamp 
et al. (2009) 
131 1; Community 1 1; PANAS 1 1  1 0 0 2; additional point 




Question 3. How do the risk factors and functions identified for NSSI in studies of 
people with ED fit with Nock’s ITM? 
 Distal risk factors. 
None of the identified studies directly investigated the distal risk factors (genetic 
predisposition, childhood abuse, familial criticism) proposed by the ITM.  
 
However, two studies (Claes et al. 2012; Itzhaky et al. 2016) investigating the functions 
of NSSI in people with ED, discussed their results in relation to risk factors. The findings 
of these studies suggest that perfectionism, self-criticism and PPC may be linked to the 
distal risk factor of familial hostility/criticism in the ITM. However, the cross-sectional 
design and self-reported PPC do not allow inferences to be made regarding causality.  
  
 Intrapersonal and interpersonal vulnerability factors. 
The ITM suggests that distal risk factors may cause the development of intrapersonal 
vulnerabilities such as high emotional reactivity and an inability to manage distress. The 
two studies related to risk factors appear to partially fit within the intrapersonal 
vulnerability factor of experiencing high aversive emotions. However, they both 
demonstrate that there are particular aspects of affect dysregulation which increase the 
risk of individuals with an ED diagnosis engaging in NSSI.  
 
Vansteelandt et al. (2013) highlighted that negative affect in itself does not predict NSSI. 
They suggest it is rather the variability in levels of affective arousal that is more aversive 
and puts an individual at higher risk of engaging in NSSI. Anestis et al. (2012) 
demonstrated that experiencing frequent shifts in both affect valence and intensity (high 
affective lability) may be aversive. In addition, it was the interaction of previous suicide 
attempts with affective lability that predicted NSSI in their study, whereas the ITM does 
not explicitly consider suicide attempts as a risk factor.    
 
None of the identified studies reported findings related to the high aversive cognitions 
aspect of the intrapersonal vulnerability factors or to the interpersonal vulnerability 






Four function model: regulation of affective experiences (intrapersonal) and 
social situations (interpersonal). 
Claes et al. (2014) was the only study with an explicit aim to replicate the FFM (Nock & 
Prinstein, 2004) and exploratory factor analysis provided support for three of the 
functions outlined in the model. A fourth factor was identified which included self-
punishment, avoiding/escaping a numb state and suicidal thoughts. Self-punishment is 
captured within Nock and Prinstein’s (2004) definition of intrapersonal-positive 
reinforcement, however, the other two items found do not. The authors argued that these 
additional items could refer to either intrapersonal-positive or intrapersonal-negative 
reinforcement depending on the needs of the individual. However, they did not load onto 
other factors and this fourth factor was not named. The authors concluded that they 
achieved a partial replication of the FFM, hence, the results also partially fit with the ITM.  
 
Claes et al. (2015) identified intrapersonal-negative reinforcement and interpersonal-
negative reinforcement but differed from Claes et al. (2014) by identifying intrapersonal-
positive reinforcement as a third factor. Whilst both studies used the same questionnaire 
(SIQ-TR) to assess self-reported function of NSSI, Claes et al. (2015) expanded the list 
of motives to 18 from 14. Items that loaded onto interpersonal-positive reinforcement in 
Claes et al. (2014) e.g. ‘to show others how strong I am’ and ‘to get attention from others,’ 
alternatively loaded onto intrapersonal-positive reinforcement in Claes et al. (2015). In 
contrast, the findings of Itzhaky et al. (2016) endorsed all four functions identified by 
Nock & Prinstein (2004) but this may have been affected by the use of the same 
questionnaire (FASM; Lloyd et al., 1997) in both studies to assess function.  
 
Three studies (Claes et al., 2010; Claes et al., 2015; Itzhaky et al., 2016) reported that the 
most commonly endorsed motivations for engaging in NSSI were related to the 
intrapersonal-negative reinforcement function. Specifically, in Claes et al. (2010) and 
Claes et al. (2015) this was defined as the item ‘to avoid or suppress negative feelings’. 
In both studies this was followed by ‘to punish myself’ which is related to the 
intrapersonal-positive reinforcement function. In contrast to other studies, Claes et al. 
(2010) reported that participants rarely or never endorsed socially reinforced motives.  
 
Muehlenkamp et al. (2009) and Claes et al. (2010) found contrasting results with the 
former reporting no substantial change in levels of negative affect after NSSI and the 
latter reporting a significant reduction in levels. Muehlenkamp et al. (2009) questioned 
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whether self-reported relief from negative emotions after NSSI in other studies may have 
been caused by significantly increased positive affect diminishing the distress felt from 
negative emotions. Claes et al. (2010) did acknowledge that there was a considerable level 
of negative affect remaining after NSSI, despite their significant findings.  
 
The studies described above found direct evidence that NSSI can function to regulate 
internal emotional experiences and external social demands, in line with the interpersonal 
and intrapersonal reinforcing functions outlined in the ITM.  
 
 NSSI-specific vulnerability factors. 
Other studies identified additional factors that are related to and influence the 
intrapersonal and interpersonal reinforcing functions and these were more relevant to the 
specific vulnerability factors outlined in the ITM. The findings of Claes et al. (2012) 
regarding NSSI as a function of self-punishment arising from higher levels of ECP, fits 
with the ITM in both the intrapersonal-positive reinforcement function and specific 
vulnerability factor of self-punishment. ECP was also found to be positively related to a 
cry-for-help function which could be similar to the specific vulnerability factor of social 
signalling in the ITM.  
 
In contrast to these findings and the ITM, two studies demonstrated that there may be 
circumstances when individuals do not use social signalling. Claes et al. (2012) suggested 
that if an individual has learned that soliciting an emotional response from a caregiver 
could lead to a negative and aversive reaction then they may avoid others and not signal 
their distress. The findings of Itzhaky et al. (2016) that NSSI may function as self-
punishment when dependency on others is low, could be comparable to this. If self-
criticism has been theorised to develop from punishing parental figures, then self-critical 
individuals may become more autonomous and less dependent on others to help regulate 
their emotions and engage in NSSI as an alternative. 
 
The conclusion from Claes et al. (2015) that NSSI may help those with identity confusion 
through the development of a pseudo-identity as a self-injurer, fits with the specific 
vulnerability factor of implicit identification within the ITM. Causality cannot be 




The findings of Claes et al. (2014) fit with the ITM in that individuals who experience 
high negative reactivity may not be able to regulate their emotions in response to stress 
and instead turn to NSSI to suppress their negative affect. Additionally, their finding that 
self-punishment is associated with low effortful control could fit with the pragmatic 
hypothesis of the model. NSSI may be an attractive and easily accessible option to help 
individuals self-punish or avoid suicidal thoughts if they lack the control to effectively 
regulate their emotional experiences.   
 
The studies described above found evidence for the specific vulnerability factors of self-
punishment, social signalling, pragmatic and implicit identification hypotheses. 
However, none of the identified studies found evidence of the social learning or pain 
analgesia/opiate hypotheses.  
 
Discussion 
The current review sought to investigate the risk factors and functions of NSSI in people 
with ED diagnoses. Three key questions were addressed regarding risk factors that make 
people with ED diagnoses more likely to engage in NSSI, understanding the function of 
NSSI and whether Nock’s ITM was suitable within an ED population.  
 
With regards to risk factors for NSSI, only two studies met with the inclusion criteria. 
Both studies investigated how problems in specific aspects of affect regulation may make 
individuals with ED more vulnerable to engaging in NSSI. In particular, one found that 
high variability in the level of emotional arousal predicted retrospective engagement in 
NSSI. The other found that trait affective lability interacted with previous suicidal 
behaviours to predict the number of NSSI acts during the study duration. These studies 
and the risk factors they assessed did not fit with the distal risk factors outlined in the 
ITM. Instead, they are more comparable with the model’s intrapersonal vulnerability 
factors, which includes high aversive emotions and poor distress tolerance. Nock (2009) 
acknowledged that the vulnerability factors outlined in the model are a risk for a range of 
psychiatric disorders and that when these factors are controlled for, analyses have found 
that childhood abuse and other psychiatric disorders are not actually related to NSSI. They 
suggest this indicates that NSSI is associated with other disorders due to these shared 
intra- and interpersonal vulnerability factors. Therefore, it appears investigating whether 
vulnerability factors are predictive of NSSI within individuals with an ED diagnosis, may 
be helpful for understanding the etiological pathway for both conditions. The findings of 
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the studies in the current review appear important as they demonstrate that the presence 
of difficulties in these specific aspects of affect regulation make some individuals more 
likely to engage in both ED behaviours (e.g. purging, bingeing, restricting) and self-
injurious acts.  
 
The results of this current review may reflect the difficulties of measuring risk factors and 
vulnerabilities for NSSI in general, not just within an ED population. A recent meta-
analysis of risk factors for NSSI alone, found that risk factor magnitude was significant, 
yet weak (Fox et al., 2015). The three risk factors that produced the greatest effect in 
predicting NSSI were a prior history of NSSI, having a Cluster B diagnosis (e.g. 
borderline personality disorder) and hopelessness; none of which appear within the ITM.  
 
In relation to the functions of NSSI within people with an ED diagnosis, all studies found 
evidence that NSSI serves as a reinforcing behaviour for individuals, whether that be 
internally or socially. This fits well with the ITM. In particular, results provided support 
for individuals primarily engaging in NSSI to reduce internal unwanted negative feelings 
(intrapersonal-negative reinforcement). Studies slightly differed from one another, and 
from the FFM, with regards to how self-reported motives for NSSI loaded onto each 
factor. One reason for this may be due to measurement, as four studies used the SIQ-TR 
which has been updated over time to include a wider range of motives which vary slightly 
from the FASM utilised by Nock & Prinstein (2004). Another could be that these studies 
measured retrospective motivations for NSSI, asking participants to recall motivations 
for self-injurious acts from the past year. This may have left the results open to potential 
confounding factors due to limitations in memory. Participants may have found it 
challenging to recall internal motivations for engaging in NSSI, from a time when they 
may have experienced difficulty in regulating their emotions.  
 
A particularly interesting aspect of these studies was that they highlighted other factors 
which may interact with the reinforcing functions of NSSI. The specific vulnerability 
factors outlined in the ITM fit with some of the study findings related to identity confusion 
(implicit identification), low effortful control (pragmatic hypothesis) and ECP (self-
punishment and social signalling). These findings provided a greater understanding of 
why people may choose to engage in NSSI alongside ED behaviours. Perfectionism, 
alongside self-criticism that may develop from this, appeared relevant to the co-
occurrence of ED and NSSI. NSSI literature has focused on the role of impulsivity 
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(Hamza, Willoughby, & Heffer, 2015) without considering the more overcontrolled 
aspects of personality, such as perfectionism. In contrast, ED literature has demonstrated 
an association between perfectionism and eating disorders (Wade, O’Shea, & Shafran, 
2016). When this is considered alongside the findings of Claes et al. (2012) and Itzhaky 
et al. (2016) it may be that perfectionism and self-criticism would be an interesting avenue 
of further research within both NSSI and ED.  
 
The risk factors and functions identified in the studies of NSSI within ED fit with several 
aspects of the ITM, such as the intrapersonal vulnerability factors and intrapersonal and 
interpersonal reinforcing functions. However, there were other parts of the ITM which 
were not investigated or evidenced, including distal risk factors, interpersonal 
vulnerability factors and the specific vulnerability factors of social learning and pain 
analgesia. It may be that the dynamic and complex nature of the ITM makes it challenging 
to test in its entirety.  
 
Implications for future research 
The small number of studies found within the current review highlights that this is an area 
in need of further research. The overlap in authors on the majority of identified studies, 
indicates there is a small group of researchers conducting pioneering research in the field 
of NSSI and ED. The high scores awarded to these studies in the quality appraisal 
demonstrates this is not viewed as a disadvantage.  
 
A great deal of literature in this area has focused on correlates of NSSI within ED using 
cross-sectional studies, but these cannot be classified as risk factors as there is no 
indication of causality. More longitudinal studies are needed to improve the identification 
of risk factors. It is apparent improvements are needed for investigating risk factors and 
the two studies identified in the current review could have benefited from a longer follow-
up period. The findings of Vansteelandt et al. (2013) could have also been strengthened 
by measuring acts of NSSI during the study duration to demonstrate whether affective 
variability temporally preceded NSSI, rather than retrospectively predicted it.  
 
Future research would benefit from investigating factors, including identity formation and 
perfectionism, with a longitudinal design to understand whether they act as specific risk 
factors for engaging in NSSI in preference to other behaviours. Investigating the 
association of these factors widely in the general population of individuals who engage 
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in NSSI without an ED diagnosis could highlight whether they are more characteristic 
within an ED presentation only or NSSI in general.  
 
The use of EMA to measure real-time emotional states by Muehlenkamp et al. (2009) 
would have helped to reduce confounding factors of recalling emotion experienced from 
retrospective acts of NSSI. Combining this method with self-reported motivation for 
NSSI (as measured in the other studies) and ED behaviours would provide more reliability 
in measuring function. It could provide an insight into how long- or short-lasting these 
reinforcing functions are and may help explain why some individuals repeatedly engage 
in NSSI. Assessing functions of ED behaviours and comparing this with functions of 
NSSI could be beneficial for understanding why they co-occur so frequently. A question 
to be considered could be, do ED and NSSI behaviours serve the same functions or do 
they provide separate types of reinforcement across different contexts and situations? 
 
Measuring risk factors and functions with a combined sample of community and clinical 
participants, whilst controlling for ED severity and diagnosis, could be beneficial to 
ascertain whether clinical samples have a higher severity of ED.  
 
Clinical Implications 
The results of the current review would indicate that when working with individuals who 
have an eating disorder and/or engage in NSSI, a comprehensive risk assessment would 
be necessary. It would appear pertinent to assess difficulties in aspects of affect regulation 
and previous suicidal thoughts or behaviours.  
 
With regards to intervention, the identified studies for both risk factors and function 
suggest that working therapeutically to reduce negative affect or increase positive affect 
may not be enough. It may be more beneficial for intervention to focus on the stabilisation 
of affect if the individual is prone to experiencing high levels of affective lability or 
variability in affect arousal.  
 
The use of functional analysis has been recommended for investigating factors that 
reinforce NSSI and ED behaviours, across a range of situations (Andover, Holman, & 
Shashoua, 2014). This should then be used throughout intervention to test hypotheses and 




Dialectical behavioural therapy is perceived to be an appropriate psychological 
intervention for individuals with NSSI and ED, as it incorporates modules on Emotion 
Regulation, Distress Tolerance, Interpersonal Effectiveness and Mindfulness (Walsh & 
Eaton, 2014). The results of this review would indicate that this could be an appropriate 
intervention. Due to the findings that perfectionism and self-criticism appear to be 
important factors in the co-occurrence of NSSI and ED, it may be that interventions such 
as compassion focused therapy may prove helpful to encourage the development of a 
more soothing inner dialogue and healthier alternative behaviours. 
 
Limitations of the current review 
A number of limitations warrant mention. Although the key word search of titles and 
abstracts was informed by previous literature in the field, it may have been subject to bias 
as the choice of key words was decided on by the primary author and this may have 
impacted on the number of studies included. The search was also conducted solely by the 
primary author. 
 
The inclusion criteria were stringent with regards to including studies that confirmed ED 
diagnoses either clinically or by the research team in accordance with DSM/ICD 
classification systems. This resulted in the exclusion of studies that assessed ED by self-
reported questionnaires, even if these measures met with DSM criteria. It is 
acknowledged that these restrictions may have excluded populations of individuals with 
sub-clinical or undiagnosed ED and reduced the number of studies identified. However, 
this review set out to provide a more rigorous review than conducted before and with the 
inclusion of both community and clinical samples, it was considered important to ensure 
that diagnosis had been reliably confirmed by clinicians or the research team across 
studies.  
 
The search yielded a small number of studies, which makes it challenging to generalise 
to the wider population. None of the studies aimed to replicate the ITM and only a couple 
of studies explicitly made reference to the FFM (Nock & Prinstein, 2004). This review 
has imposed a theoretical framework onto their findings which they had not designed 
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Overview of borderline personality disorder and dialectical behaviour therapy 
Personality disorders are defined as complex and enduring maladaptive traits and patterns 
of behaviour that lead to significant personal distress and social dysfunction (American 
Psychiatric Association, 2000). The prevalence of personality disorder across North 
America and Western Europe has been reported as between 4-15% (Tyrer, Reed, & 
Crawford, 2015), with just under 1% of the UK general population having a diagnosis of 
borderline personality disorder (BPD; Coid, Yang, Tyrer, Roberts, & Ullrich, 2006). BPD 
is a type of personality disorder marked by instability in affect, behaviour, interpersonal 
relationships and sense of self (NIMH, 2016). Frequent parasuicidal behaviour, 
problematic substance misuse and emotional reactivity present a challenge to community 
mental health services attempting to provide effective treatment (Feigenbaum et al., 
2012). 
 
The National Institute for Clinical Excellence states that psychological interventions for 
the treatment of BPD should be provided for longer than three months and recommends 
the use of dialectical behaviour therapy (DBT) for females who engage in recurrent self-
harm (NICE; 2009). DBT is a long-term, manualised cognitive behavioural treatment of 
up to two years, offering repetition of the yearly cycle of four modules: mindfulness, 
distress tolerance, emotion regulation and interpersonal effectiveness (Linehan, 2014). 
These are delivered through different components: weekly skills-based group training and 
individual therapeutic sessions, skills coaching through phone consultation and weekly 
consultation meetings for clinicians. With regards to its efficacy, a meta-analysis of five 
randomised controlled trials (RCT) found that DBT significantly reduced suicidal 
attempts and self-injurious behaviours, when compared to treatment as usual (TAU; 
Panos, Jackson, Hasan, & Panos, 2014). 
 
The biosocial theory underpinning DBT proposes that individuals with BPD have a 
biological inability to regulate their emotions and behaviours, which is maintained and 
reinforced by an invalidating environment (Linehan, 2014). In the most severe cases this 
could involve abuse and neglect in childhood, but any environment that trivialises or 
dismisses the expression of emotion can become invalidating and teaches an individual 
that their understanding of experiences is wrong (McMain, Korman, & Dimeff, 2001). 
An understanding of this theory can assist the development of a non-pejorative, 
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compassionate and validating environment for clients (Swenson, Torrey, & Koerner, 
2002).   
 
Co-occurring BPD and substance misuse 
Significant comorbidity has been found between BPD and substance misuse (Tomko, 
Trull, Wood, & Sher, 2014; Trull, Sher, Minks-Brown, Durbin, & Burr, 2000), with 
additional complexity in clinical presentation due to higher levels of impulsivity and 
increased drop-out rates from therapy (Kienast, Stoffers, Bermpohl, & Lieb, 2014). 
Increased complexity requires specialist treatment, yet literature on the efficacy of 
psychological interventions targeting both disorders is limited. A systematic review (Lee, 
Cameron, & Jenner, 2015) concluded that DBT demonstrated generally good outcomes 
in comparison to TAU and other treatments, including dynamic deconstructive therapy 
(DDP) and dual-focused schema therapy (DFST). Lee et al. (2015) suggest further 
research is required as results were based on a small number of DBT interventions with 
all-female participants and outcomes relating to reduced substance use and self-harming 
behaviour were varied.  
 
Client and staff perspectives of DBT 
Literature suggests that understanding the clients’ perspective about the experience of 
therapy and factors that impact on therapeutic outcomes can both guide improvements to 
intervention and enhance theoretical understanding (Elliott, 2008). Studies focusing on 
the clients’ perspective of DBT have found that engagement can lead to the development 
of a life worth living with positive changes in interpersonal relationships and control of 
emotions (Cunningham, Wolbert, & Lillie, 2004). It is suggested that engaging in DBT 
can be challenging, with high levels of emotion and difficulty in understanding the skills 
training material representing potential obstacles that require commitment and support to 
overcome (Barnicot, Couldrey, Sandhu, & Priebe, 2015). Considering the challenges that 
clients may face during the course of DBT, a recent study also explored the staff 
perspective and found they experienced the implementation of DBT to be intensive, with 
pressure to complete training and provide therapy within a tight schedule (Johnson & 
Thomson, 2016). Staff also commented on how DBT impacted on their personal and 






Rationale and aims of the project 
The current study describes the evaluation of an innovative dual diagnosis DBT service 
in South West England that takes an integrated approach of one team addressing the needs 
of both BPD and substance misuse within one service setting. The rationale for the study 
was to expand upon literature by exploring both client and team member perspectives of 
a dual diagnosis DBT service, to gain a clearer understanding of factors that influence 
therapeutic outcomes and identify areas for service improvement. It aimed to:  
• Evaluate client satisfaction with DBT, including their views on its individual 
components in helping to meet their needs. 
• Explore team member perspectives about implementing DBT, their beliefs about 
what clients may value about the therapy being provided and their thoughts about 
current methods of measuring therapeutic outcomes and clinical effectiveness. 
• Consider whether aspects of the service could be improved for the benefit of 





The DBT service in Bath and North East Somerset (B&NES) was established by the 
Recovery and Therapies Team in 2007 and further developed in 2009 to run jointly with 
the B&NES Specialist Drugs and Alcohol Service (SDAS). The service comprises a range 
of professionals across the Therapies, Recovery and SDAS teams. The service has not 
previously conducted an evaluation.  
 
Ethical Approval 
Full ethical approval was gained from the University of Bath Psychology Department 
Ethics Committee (reference 16-132; Appendix B) and the Service Evaluation team of 
Avon and Wiltshire Mental Health Partnership AWP Trust (reference E2016.012 
Lindsay; Appendix C). 
 
Design 
A cross-sectional design was employed, using mixed method analysis of questionnaire 






Questionnaires and interview schedules were developed for use in this study through 
discussion with all members of the research team.  
 
 Clients. 
1. A 15-item questionnaire assessing satisfaction ratings for the service, the 
individual components of DBT and assessment phase (Appendix D).  
2. A semi-structured interview assessing satisfaction and exploring aspects of 
therapy that are helpful/unhelpful (Appendix E). 
Team members. 
1. A 14-item questionnaire assessing ratings of quality of care delivered to clients, 
measures used to capture change and improvement and DBT training received 
(Appendix F).  
2. A semi-structured interview assessing views on what clients might value about 




All current team members and clients were eligible to participate. The commissioners 
also wished to invite clients who had been discharged within the past six months, to 
capture the views of those with recent experience of completing the full course of therapy.  
 Clients. 
3/4 current clients and 1/2 previous clients completed both the questionnaire and 
interview.  
Team members. 
5/8 current team members completed both the questionnaire and interview. Due to limited 
availability, one team member completed the questionnaire only. 
 
Procedure 
Clients were informed of the project and given an information sheet. After a two-week 
period for reflection on participation, written consent was obtained and clients contacted 
by telephone/email to arrange an interview time with the primary researcher. Team 
members were approached during their weekly consultation meeting and the same 






Descriptive statistics (frequencies, percentages) were used to explore the data collected 
from the questionnaires.  
Qualitative analysis. 
7/9 interview transcripts were transcribed verbatim by the primary researcher. Two 
transcripts were transcribed verbatim by an independent researcher employed by the 
University of Bath. Thematic analysis was conducted according to the guidelines defined 
by Braun and Clarke (2006), shown in Table 2.1. They recommend that researchers 
decide on the approach and theoretical framework prior to analysis, hence, in this study 
themes were identified using an inductive approach, (e.g. driven by the data) and were 
analysed at a semantic level, reporting on the surface and explicit meaning of the data. 
 
Table 2.1 
Steps of thematic analysis as defined by Braun and Clarke (2006) 
Step 1: Immersing yourself with the data through transcription and re-reading 
Step 2: Generating initial codes by coding interesting parts of the data in a systematic 
way and gathering data extracts that match each code 
Step 3: Searching for themes by collating codes and all data that is relevant to the 
theme 
Step 4: Reviewing themes and generating a thematic map of the analysis 
Step 5: Defining and naming themes with ongoing analysis 
In addition to the methodology defined by Braun and Clarke (2006), inter-rater 
reliability was conducted within this step. An independent researcher was given four 
transcripts to check for emerging themes. Interpretation of the data was discussed until 
consensus was reached on the main themes. One study has commented on the debate 
regarding whether qualitative data should be subject to verification by independent 
researchers as it is subjective by nature (Burnard, Gill, Stewart, Treasure, & Chadwick, 
2008). However, they acknowledge that verification may increase rigour and reduce 
bias in analysis, which is the reason for its completion in this study.  










Clients had a mean age of 43.5 years (range= 40-47). One client was on their first cycle 
of DBT, two clients on their second and the fourth had recently been discharged. 
Demographics and clinical information are shown in Table 2.2. 
 
Table 2.2 
Demographic and clinical information of clients  
























Figures 2.1, 2.2 and 2.3 show results from the questionnaire within three overarching 
domains respectively: Satisfaction with DBT components; helpfulness of individual 



























































































Figure 2.3 Ratings of other aspects of DBT 
 
Team Members. 
The mean length of employment within the DBT service was 3.26 years (range=7 months 
– 9 years). Demographics and information regarding provision of components are shown 
in Table 2.3. 
Table 2.3 
Demographic and provision of components by team members  

















Components of DBT involved with 
Skills training group 








































































Figures 2.4, 2.5 and 2.6 show results from the questionnaire within three overarching 
domains respectively: Perceived quality and effectiveness of service delivered to clients; 










































































         






How effective do you
think the service are in
measuring change and
improvement?





How helpful do you
think the
resources/materials















































































































   
 
 

















































































































Three main themes were derived and are shown in Table 2.4. 
 
Table 2.4 
Themes identified from client data 
Main themes Sub-themes 
Building a life worth living 
Mixed emotions beginning DBT 
Commitment and time 
Shifting perspectives and moving 
forward 
Resources as an aid 
Challenging aspects of DBT 
Painful emotions evoked 
Difficulties with self-criticism and self-
confidence 
Individual differences in preference for 
and relevancy of skills 
 Difficulties with the presentation of skills 
The therapeutic environment 
Therapeutic relationships 
Shared experiences in group 
Continuous support by phone 
Inflexibility in group sessions 
Inconsistent reinforcement of rules 
Preference for individual sessions 
Size of the group 
Venue 
 
1. Building a life worth living 
1.1 Mixed emotions beginning DBT 
Many clients spoke about their belief that DBT could be a helpful therapy, when initially 
referred. However, one client described negative experiences prior to their DBT 
assessment, including a long waiting time and miscommunication. 
“I think people- mental health services think that people with personality disorders are 
difficult and awkward and can’t be treated” (1) 
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A couple of clients reported feeling “worried” they may not have been suitable for DBT 
and there may have been no alternative offered.  
 
1.2 Commitment and time 
All clients described starting DBT with the desire to achieve life-changing goals, 
including becoming “emotionally stable” and learning “to tolerate immediate distress.” 
Some spoke about wanting to learn “normal” coping mechanisms. One participant spoke 
about the DBT team managing their expectations during assessment.  
“It was helpful in so far as allowing me to understand what DBT could do and 
couldn't….so my expectations were managed more appropriately” (4) 
 
One client had the realisation that there was “no magic cure,” and that it may take time 
to overcome long-term difficulties. Clients described their decision to “give it a go” and 
commit to the long course of therapy. 
 
1.3 Shifting perspectives and moving forward 
For some clients, the content of skills training had helped to move forward with 
alternative coping strategies and the reduction of target behaviours.  
“DBT is more now about what it should be about, which is building a life worth living” 
(3) 
 
Others spoke about how DBT had shifted their perspective on situations. 
“Say there’s a situation that you can’t change, rather than trying to change it you think 
‘right that’s the way it is’” (2) 
 
1.4 Resources as an aid 
For some, the resources used in DBT were helpful for learning and practising skills 
between sessions.  
“Diary cards are really good and I think it’s probably something I would use even after 
because it just keeps me aware of my moods and things I’ve been doing” (2) 
 
Some clients spoke about their desire to have additional resources available, including 





2. Challenging aspects of DBT 
2.1 Painful emotions evoked 
Clients reported that engaging in individual and group sessions could be painful and 
upsetting.  
“Changing how you view a certain situation, as painful as that might be, it's still helpful 
to do” (4) 
 
One client described apprehension about sharing examples within the group, for fear of 
upsetting other clients. 
“They'll say ‘can you give us examples’, and you know what?, you can't because it 
could impact on somebody else” (3) 
 
2.2 Difficulties with self-criticism and self-confidence 
Some clients reported treatment goals of developing self-worth and confidence and 
described how modules could trigger negative feelings about themselves.  
“Each time we start with something new, a new session, I do have an emotional 
reaction straight away that I’m being told this is all my fault” (1) 
 
Clients spoke about how self-worth has acted as a barrier to engagement with aspects of 
therapy.  
“Learning about being nice to yourself, kind to yourself, that was an alien concept to 
me” (4) 
 
2.3 Individual differences in preference for and relevancy of skills 
Clients described not all skills taught as helpful or relevant to them personally. 
“I don't think I use any more than twenty percent of what I've been taught but that 
twenty percent is important” (3) 
 
Clients were respectful of one another and acknowledged how others may benefit from 
different skills. 
“Some of them I think, ‘actually this isn’t really for me’ but I accept that probably 






2.4 Difficulties with the presentation of skills 
All clients described negative aspects about the presentation of skills, including a “large 
volume of information,” culturally different examples and a gender bias in examples that 
favour women. 
“It’s Americanised as well…and wordy” (2) 
“The examples they are giving are of female domestic abuse and you’re thinking ‘well 
where are the male victims then?’” (3) 
 
Homework was described as challenging, with a suggestion that it may not be taken 
seriously by both clients and DBT team members, resulting in it not being completed. 
Some clients expressed a preference for more time to be given to understanding and 
practising homework. 
“I think probably right from the word go DBT facilitators have kind of joked about 
homework and how people find it really difficult to do” (1) 
 
3. Therapeutic environment 
3.1 Therapeutic relationships 
Clients spoke about the value of developing validating, respectful therapeutic 
relationships with their individual therapist. Some spoke about the importance of their 
therapist treating them as an individual, sharing humour and challenging them when 
needed. 
“I felt I could trust her with my thoughts and feelings - things that I'd never shared with 
anybody else and I never felt judged and having someone like that in my life was just 
yeah incredible” (4) 
 
Some clients described how group facilitators can help to create a “safe” and “non-
judgemental” space within skills training sessions. 
 
3.2 Shared experiences in group 
Some clients described being in group therapy perhaps not suiting them initially. 
“I’ve never done groups, I quite like my own company, like my own space” (2)  
 
However, all clients reported the importance of the peer aspect of the group in their 
experience of DBT.  
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“The helpful aspect of that was that it, you were in a room with like-minded people who 
suffered maybe in different ways but we all had a common reason for being there” (4) 
 
However, two clients commented on the rolling nature of the group and how “different 
people can change the dynamics of the group,” which can bring “anxiety.” 
 
3.3 Continuous support by phone 
For some clients, the provision and option of phone support between sessions was a 
valuable addition, with those who had used it describing how it brought comfort.  
“Just to hear their voice and feed it back and go ‘oh yeah ok that's fine’, cos it breaks 
your state, it breaks your emotional turmoil” (3) 
 
Some clients had experienced difficulties with this, including messages not being passed 
onto their individual therapist and not being able to call outside of working hours. One 
client didn’t like the thought of speaking to someone that they didn’t know and thought 
that “it may make it worse.” 
 
3.4 Inflexibility in group sessions 
Some clients found the set agenda of group sessions to be unhelpful, particularly when 
experiencing crisis or finding certain skills hard to learn.  
“There’s not a lot of flexibility; it would be difficult to kind of sidetrack off and say ‘I 
haven’t had a great week’ or ‘I’m struggling at the moment’” (1) 
 
One client described how this affected the way that they experienced group sessions.  
“I need to talk about that now, not in three days’ time, so I would go away very often 
completely disoriented and deflated and distressed” (3) 
 
3.5 Inconsistent reinforcement of rules 
Clients expressed that they did not agree with some rules of DBT and felt there were 
inconsistencies in their reinforcement across teams. 
“I think [SDAS] were maybe just a little bit more forgiving of people and their 
situations if they understood why somebody had missed appointments” (4) 
 
Another client reported calling ahead of their weekly session to cancel due to sickness 
but still receiving an absence letter.  
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“You still get a letter saying that if you don't turn up next week you're out and I find that 
a little bit childish and a little bit dictatorial really” (3) 
 
3.6 Preference for individual sessions 
All clients spoke about how important their individual therapy sessions were and for 
some, this was the most critical component of DBT.  
“I don't think I would be sat here to be honest if it weren't for the one-to-ones” (3) 
 
Clients spoke about valuing the “flexibility” and individualised nature of individual 
sessions.  
“If there are things you are struggling with you can work on those a bit further in those 
sessions” (4) 
 
3.7 Size of the group 
Two clients reported that whilst a smaller group encourages participation, it may benefit 
from being bigger.  
“I think it probably would help to be slightly bigger……I’m forced at the moment to 
take part. Not forced but if they say ‘think of an example’ I’ve got to think of an 
example, or I feel I’ve got to.” (1) 
 
One client expressed disbelief at the small number in the group within the region.  




Clients reported some issues with the current venue for group sessions, including 
difficulties with parking and disruptive noise. 
“When you're trying to meditate and things like that it was particularly difficult, so a 









 Team members. 
Two superordinate themes emerged, as shown in Table 2.5.  
 
Table 2.5 
Themes identified from team member data 
Superordinate themes Main themes Sub-themes 
Not a dedicated DBT 
service 
Lack of protected time 
DBT as ‘extra’ 
Consequences of lack of 
capacity 
Time needed as a team 
Growth 
Defining where the service 
sits within a treatment 
pathway 








Learning the material 
Overwhelming amount for 
the clients and the team 
 Continuous practising of 
skills 
Provision of DBT 
Consultation is critical 
Containing and safe space 
for the team 
Modelling the model 
The client experience 
Importance of individual 
sessions 
Peer aspect of the group 
Intensity and a high level 







4. Not a dedicated DBT service 
4.1 Lack of protected time 
4.1.1 DBT as ‘extra’ 
Team members reported that the provision of DBT is additional to their current caseloads. 
They expressed a desire to have “dedicated” time rather than having to “carve” out time 
in their already busy working weeks.  
 
4.1.2 Consequences of lack of capacity 
Team members discussed how limited capacity disrupts the provision of components, 
including individual sessions. One member described that the service was “not so great 
at” phone support. The separate geographic locations of the teams were raised as possibly 
affecting attendance at consultation and clients knowing which team number to phone for 
support. 
“When I’m not running the group, it can feel a real pressure, to come, to come to NHS 
House for two hours for consultation” (2) 
 
4.1.3 Time needed as a team 
Whilst consultation is a time to discuss business aspects and the overall running of the 
service, team members felt as though this was not enough and expressed a desire to 
arrange additional time as a team.  
“We could try for the service itself planning an Away day, an afternoon of just being 
able to plan ahead and be more thoughtful” (5) 
 
4.2 Growth 
4.2.1 Defining where the service sits within a treatment pathway  
One team member reported that defined treatment pathways for DBT were needed to help 
decide when it is the most appropriate treatment in relation to other therapies.  
“I think it’s important the service is considered as part of a broader pathway for service 
users with these difficulties” (1) 
 
Another team member spoke about uncertainty regarding whether DBT should only be a 






4.2.2 Expansion of the service 
Team members proposed ideas for how the service could be expanded to reach a greater 
number of people within the region, including becoming a dedicated service to be able to 
steadily accept referrals and developing additional skills training groups.  
“We do have that group of people that significantly lack skills and could benefit from 
distress tolerance, emotional regulation, mindfulness and interpersonal effectiveness 
but they're not self-harming or they're not engaging in life threatening behaviours” (5) 
 
4.2.3 Improving retention 
For some team members, they believe that spending more time providing additional “pre-
DBT” sessions may prevent people “from dropping out” by allowing more time to 
understand what DBT will involve.  
 
4.3 Evaluating outcomes  
4.3.1 Inconsistency and uncertainty about measurement 
Some team members were “unsure” of which measures were used and how often they 
were administered, whilst others acknowledged that there was inconsistency in this.  
“They haven’t been given regularly at the end when people have finished the service” 
(1) 
 
One member described that the team “haven’t got a proper process” for storing measures 
and that it was unclear who had responsibility for scoring and interpreting them. Team 
members reported that diary cards can be useful for monitoring target behaviours. One 
member questioned whether the completion of modules and learning DBT terminology 
may “train them [clients] to answer the questionnaires”, affecting scores captured at the 
beginning and end of therapy. 
 
4.3.2 Qualitative feedback 
Many team members acknowledged that they did not know how satisfied clients were 




5. Provision of DBT 
5.1 Learning the material 
5.1.1 Overwhelming amount for clients and the team 
Some members described the skills training material as overwhelming for both clients 
and therapists. 
“We’re trying to teach some really important skills and encouraging important insight 
into behaviours and I think that gets lost because of the volume of information that we 
have to impart” (2) 
 
Some team members described feeling “unprepared” to deliver individual and group 
sessions after the short period of training they received.   
 
5.1.2 Continuous practicing of skills 
All team members reported that DBT training was “helpful” and encouraged in-vivo 
practice of skills that mirrored the delivery of skills training to clients.  
“We were being told to do repairs and forced to do things in front of other people, 
which was slightly uncomfortable, which I think was no bad thing” (3) 
 
Many team members felt that continued practise of skills and “learning on the job” 
helped to deepen their knowledge of DBT. 
 
5.2 Consultation is critical 
5.2.1 Containing and safe space for the team 
All team members discussed the importance and value of attending consultation, 
describing the “containment” it offered, with reflection on difficulties and anxieties that 
may arise from working with high-risk clients. 
“It's really valuable and it's really worth ring fencing….it helps in terms of clinician 
burnout” (4) 
 
5.2.2 Modelling the model 
Some team members reported that consultation is helpful when it is structured and adheres 
to the DBT model, including the use of mindfulness and assigning roles of chair and 
minute taker.  
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“[bringing a supervision question] reminds us what the DBT model is and it’s more like 
DBT supervision as opposed to more just general feedback” (1) 
 
5.3 The client experience 
5.3.1 Importance of individual sessions 
Team members reported that individual sessions are “essential”, as they allow 
personalisation and tailoring of skills to benefit each client. They described it as a private 
space to discuss target behaviours and personal circumstances away from the group.  
 
5.3.2 Peer aspect of the group 
It was acknowledged that clients derive benefits from being in a group with peers.  
“Being in a group with other people is helpful for other service users, each service user, 
because they can see they’re not on their own, that there are similar struggles, different 
struggles that people are experiencing.” (2) 
 
5.3.3 Intensity and a high level of input provides containment 
Team members perceived that clients value the high level of input provided with DBT 
and described how this is a “significant increase in the delivery of care” that other 
services may offer. There was acknowledgement that the structure and validating 
therapeutic relationships may be important for this client group.  
“DBT is the container in which people are allowed to have an intensive therapeutic 
relationship with someone, and someone who’s not kind of blown away by their kind of 
chaos and kind of difficulties they are having in their life, which I think for a lot of 
people they have had” (3) 
 
Discussion 
This study was designed to explore client and team member perspectives of DBT. The 
first aim was to evaluate client satisfaction with components of DBT in helping to meet 
their needs. Results from the clients’ quantitative analysis demonstrated that, generally, 
they have high levels of satisfaction with the service, aspects of DBT and the therapists 
who deliver it. Patterns indicated clients’ preference for individual sessions, which they 
rated as being more helpful in learning to cope better with difficulties and in reducing 
behaviours that may be distressing. Qualitative analysis reflected this pattern of results, 
with clients valuing the personalisation of individual sessions and the development of 




The second aim was to explore team member perspectives about implementing DBT and 
their thoughts about what clients may value about the service they receive. The 
quantitative analysis suggested they are a team that perceive themselves to be providing 
a good level of service which their clients value but they do not think they are capturing 
change and improvement in the most effective way. Qualitative analysis demonstrated 
that the team experience a pressured working environment, with a lack of dedicated time 
and resources available to deliver a level of service they aim for. 
 
Similarities between the client and team member data 
There were several similarities between the data of clients and team members. Clients’ 
ratings of high levels of overall satisfaction with the service was comparable to the team’s 
perceived client satisfaction. Clients (‘Preference for individual sessions’) and team 
members (‘Importance of individual sessions’) spoke about the value of individual 
sessions in providing a flexible space for clients. Team members acknowledged the 
benefit that clients reported gaining from being in a group with others who experience 
similar difficulties (team: ‘Peer aspect of group’; client: ‘Shared experiences in group’). 
 
The team member sub-theme ‘Intensity and a high level of input provides containment’ 
reflected on how the structure of DBT empowered clients and provided a “sense of 
agency.” This is similar to the client sub-theme ‘Therapeutic Relationships,’ which 
captured how they perceived positive therapist qualities, including empathy and a non-
judgemental stance, as important factors in developing a trusting therapeutic alliance. 
Research has found reduced levels of non-suicidal self-injury amongst clients in DBT 
who perceive higher levels of understanding and involvement from their therapist 
(Bedics, Atkins, Harned, & Linehan, 2015). Although team members infrequently 
mentioned the therapeutic alliance, there was an inherent sense of compassion and 
sincerity towards clients that underpinned their data and this may be what helps clients to 
feel validated and valued. It is unknown whether team members were being modest about 
the personal qualities that they may bring to DBT, or perhaps interview questions were 
not specific enough to capture their views on this. In any case, when working with a client 
group that may experience significant disturbance in interpersonal relationships (Bender, 




The experience of team members in learning the DBT material (main theme ‘Learning 
the Material) appeared to mirror that of clients (sub-theme ‘Difficulties in the presentation 
of skills) as they both acknowledged the pressure and challenge of attempting to learn the 
information. Comparable to the clients finding it difficult to use skills, team members also 
demonstrated they can find it challenging to consistently practise skills and stick to the 
model, particularly within consultation. The negative aspects of the presentation of skills 
reported by clients was similar to a previous qualitative study with individuals who had 
either completed or dropped out of DBT (Barnicot et al., 2015). The authors of this study 
suggested that DBT therapists could consider these barriers to skills training as ‘therapy 
interfering behaviours’ and monitor these by adapting diary cards, to help validate and 
respond to client difficulties. One male client spoke about how the gender bias they 
perceive in DBT material can negatively affect their engagement with particular skills. 
Females do appear to be given a diagnosis of BPD more frequently than males (Bjorklund, 
2006) and DBT was developed specifically for females with BPD, with the literature into 
its efficacy focusing on female samples. In contrast, literature into the use of DBT with 
male populations tends to focus within forensic settings, without acknowledging that 
males may not always be perpetrators of violence. This perhaps suggests the need for 
more research that considers adaptations of the DBT material, making it more 
generalisable to males.   
 
Working as a team 
In relation to the team member superordinate theme of ‘Not a dedicated DBT service,’ it 
is recognised that mental health services in NHS England are significantly underfunded 
and that this can impact on the wellbeing of staff (Mental Health Taskforce, 2016). The 
lack of protected time for DBT reported by the service may be one of the reasons that 
they view consultation to be a vital aspect of their role as it provides much needed support 
from colleagues. One team member recognised the power of using consultation to protect 
against clinician burnout when working with a high-risk client group. Working across 
three teams appears to bring an additional layer of complexity and highlights the practical 




Based on the findings, recommendations were made which could lead to improvements 




Recommendation for service improvement 
Client-focused recommendations 
1. Improving client experience 
• Based on client feedback regarding negative experiences of 
miscommunication and the provision of limited information about DBT 
prior to a referral being made, it may be beneficial to provide information 
sessions/leaflets for GPs, primary care assessment teams, care 
coordinators that explain the overarching aims of DBT. 
• Reiterating rationale for the structure and rules of DBT (e.g. not 
discussing target behaviours in group sessions) may help clients to 
understand why rules are in place. 
• Based on client feedback, it would be helpful to have improved 
consistency across the three teams, regarding letters being sent out 
after non-attendance of group and individual sessions. 
2. Presentation of skills in group sessions 
• To help reduce painful and upsetting emotions that may have been evoked 
and to aid understanding of skills covered in session, checking 
understanding and allowing discussion before finishing the session may 
be helpful. 
• Reiterating the importance of homework and allowing time in session 
to discuss it and possibly complete a dummy run, may improve 
compliance of homework and encourage therapeutic change.  
• Adjust skills-training examples from the DBT manual to become more 
culturally relevant for all clients. 
• The use of DBT YouTube videos, phone applications and websites may 
encourage further learning and practice at home and increase client agency 
in the use of skills. 
3. Phone consultation 
• Advising clients of availability for phone support during office hours 
9-5pm (e.g. days of work) may prevent disappointment for clients if they 
know that team members are not working.   
• Ensure clients are aware of contact numbers for urgent situations (e.g. 
intensive team/A&E) 
• It may be helpful to compile a list of team member office phone 
numbers for clients to know which number is most appropriate. 
• Ensuring that administrative staff know who DBT team members are 
and how they can be contacted, may prevent messages not being passed 
on and clients’ phone calls not being returned 
Team-focused recommendations 
4. Measuring outcome and improvement 
• To improve the practical aspects of data record-keeping: 
o Designate storage space for paper copies of measures 
o Set up a shared spreadsheet and file for electronic storage of 
data from outcome measures.  
o Keep master copies of measures in one file with guidance for 
scoring and interpretation 
• To improve validity of questionnaires: 
o Discuss the client’s understanding of measures during 
assessment 
• To improve consistency in measurement: 
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o Decide as a team about the best time to administer outcome 
measures (e.g. yearly review) and what data would be helpful to 
capture (e.g. diary card target behaviours, A&E admittance, verbal 
feedback) 
o Ensure measures are completed upon discharge from the 
service  
5. Consultation meetings 
• Based on team member feedback it could be helpful to improve the 
structure of consultation meetings and adhere to the DBT model on a more 
regular basis: 
o Assign a chair and minute taker (a rotation list could help to 
make these fair) 
o Setting the agenda at the start; prioritising topics and allocating 
time  
o Bring a supervision question regarding a case or the discussion of 
a particular skill - this could help to provide a refresher of 
information about skills 
o Allow short amount of time for informal discussion, colleague 
support if needed  
o Do something positive or motivating at start if staff lethargic, 
stressed – based on feedback, mindfulness may help with this  
6. Time together as a team 
• As team members suggested, organising a team Away Day could provide 
valuable protected time to discuss the implementation of ideas that the 
team already have e.g. peer involvement, additional pre-DBT sessions  
• This could involve discussion about how to liaise with commissioners 
regarding becoming a dedicated service and considering treatment 
pathways for DBT 
 
Feedback and dissemination 
Quantitative data, main themes from the thematic analysis and recommendations were 
presented to the DBT clients and team. Team members described the results as “positive” 
and were pleased to hear that clients reported good overall levels of satisfaction with the 
service. The clients reported that the results reflected what they had said. The team 
welcomed recommendations and appeared keen to implement those related to 
consultation and the presentation of skills. An Away day has been arranged for June 2017, 
which will provide the team with time to consider other recommendations and the primary 
researcher has been invited to attend.   
 
Limitations 
This evaluation utilised a cross-sectional design with a small sample of participants, 
which limits its ability to generalise the results. The small sample makes it difficult to 
ascertain whether saturation was achieved in the qualitative data, however, there was a 
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high response rate from participants who were approached. With team members working 
across difference services and DBT not being their primary focus of work, this may have 
contributed to the lack of saturation in their data, as they may have various working 
practices and approaches. 
 
The small sample of clients was not fully representative of all individuals who may have 
been eligible to participate as there were three additional clients who had started DBT 
within the past year and dropped out of therapy in the early phases of treatment. It was 
not possible to contact these individuals regarding participation but this may have 
introduced bias into the findings. Including their perspectives could have provided 
valuable insight into factors that contributed to their discontinuation with DBT and may 
have had an impact on the recommendations made for service improvement. It is possible 
that clients who commit to two years of treatment will have a level of satisfaction that 
maintains their engagement.  
 
In conclusion, this study aimed to evaluate an integrated dual diagnosis DBT service by 
exploring client and team member perspectives. Results showed that clients had a high 
level of satisfaction with the service, citing the therapeutic relationship and individual 
sessions as important, with difficulties experienced in the presentation of skills and the 
inflexibility of group sessions. Team members described delivering a service that they 
perceived to be of good quality that they felt clients were satisfied with. They spoke about 
finding it difficult to provide some components due to not being a dedicated DBT service 
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With a general population that is living longer than ever before, it is currently predicted 
that by the year 2020 one in two people will receive a diagnosis of cancer in their lifetime. 
Advances in detection and treatment has increased survival rates with 50% of people 
diagnosed in England and Wales surviving for at least ten years (Cancer Research UK). 
The term ‘cancer survivor’ has been defined as broadly referring to any individual from 
the time of diagnosis, throughout the rest of their life (Denlinger et al., 2014): this 
definition will be used here. Currently, there are approximately two million cancer 
survivors living in the UK, of whom up to a quarter are estimated as experiencing poor 
physical and psychological health, as a consequence of living with the illness (Macmillan 
Cancer Support, 2013; Maddams, Utley, & Møller, 2012). The present study intended to 
improve understanding of poor psychological health and quality of life, occurring as a 
consequence of cancer survivorship. 
 
Although many people show satisfactory psychosocial adjustment and resilience after 
cancer treatment (Costanzo, Ryff, & Singer, 2009; Stein, Syrjala, & Andrykowski, 2008), 
others thus struggle to adjust to life after treatment and experience anxiety and uncertainty 
about their future (Brennan, 2004). Physical and psychological problems can persist for 
months to decades (Stanton, Rowland, & Ganz, 2015) and in many ways cancer 
survivorship for some is experienced as a chronic illness, often characterized by a range 
of debilitating experiences such as mood changes, fatigue and pain (White, 2001).  
 
Cancer-related fatigue (CRF) and moderate to severe cancer pain are two of the most 
prevalent physical consequences of living with cancer occurring in up to 75% and 33% 
of survivors respectively (Macmillan Cancer Support, 2013). CRF is one of the most 
common symptoms experienced by cancer survivors, defined as tiredness and exhaustion 
which appears out of proportion to levels of exertion and is not relieved by rest (Berger, 
Gerber, & Mayer, 2012). It may be a consequence of either the cancer itself or treatment 
(Berger et al., 2012) and may be experienced before, during and after treatment, leading 
to impairment in daily activities and lower quality of life (Hofman, Ryan, Figueroa-
Moseley, Jean-Pierre, & Morrow, 2007). A systematic review found that CRF is 
consistently associated with depression and to a lesser extent anxiety, although the 
direction of causality of these relationships is difficult to measure due to multiple 
interacting factors (Brown & Kroenke, 2009).  
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Cancer pain is commonly experienced as a consequence of the condition and is 
experienced by individuals at varying stages of their cancer trajectory, including during 
active treatment and after completion of curative treatment (van den Beuken-van 
Everdingen, Hochstenbach, Joosten, Tjan-Heijnen, & Janssen, 2016). It has been found 
to be associated with poorer physical and social functioning (Green, Hart-Johnson, & 
Loeffler, 2011), anxiety, depression and catastrophising (Belfer et al., 2013). Findings 
suggest that cancer pain may have a direct effect on CRF (Beck, Dudley, & Barsevick, 
2005) and when poorly managed it can contribute to daytime fatigue (Franklin & Packel, 
2006). It has also been found to share some of the features of chronic fatigue syndrome 
(CFS; Bourke, Johnson, Sharpe, Chalder, & White, 2014; Surawy, Hackmann, Hawton, 
& Sharpe, 1995) in terms of the experience of both physical and psychological symptoms.  
 
The relationship between physical and psychological symptoms in the context of cancer 
survivorship will be influenced by the meanings attached (White, 2001). Leventhal’s 
illness cognitions and Self-Regulation Model of health suggests individuals use cognitive 
and emotional processes to interpret health threats and consider their identity (e.g. label 
assigned to the symptom), perceived cause, expected duration and possible consequences 
(Leventhal, Leventhal, & Contrada, 1998). These illness representations subsequently 
affect one’s understanding and coping strategies; threat beliefs in particular may be best 
considered within the context of cognitive approaches to anxiety, pain and health fears 
(Warwick & Salkovskis, 1990). 
 
Cognitive theories of pain have suggested negative cognitions, such as catastrophising 
and pain-related fear, can perpetuate the illness, developing acute pain into a chronic 
condition (Lethem, Slade, Troup, & Bentley, 1983; Vlaeyen, Kole-Snijders, Boeren, & 
van Eek, 1995). Attentional focus and hypervigilance to bodily sensations may lead to 
catastrophic interpretations that they are a sign of deterioration, increasing fear of injury 
and avoidance of activity; maintaining the vicious cycle of fear-avoidance and 
exacerbating disability, pain and distress (Schütze, Rees, Preece, & Schütze, 2010). 
Similarly, the experience of chronic fatigue is affected by an individual’s interpretation 
of the cause and meaning of bodily sensations and symptoms experienced (Afari & 
Buchwald, 2003). As with pain, individuals with fatigue may interpret the presence of 
symptoms as an indication that their condition is worsening, resulting in an avoidance of 
activity (Surawy et al., 1995). In both conditions, increasing chronicity is accompanied 
by preoccupation with symptoms, a perceived lack of control, demoralisation and a sense 
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of hopelessness (Osborn & Smith, 1998; Surawy et al., 1995). Thus, CRF and cancer pain 
are crucial in the experience of distress and poor quality of life; however, psychological 
factors can be regarded as influencing this. Potential factors will be considered next.   
 
Experiencing ongoing physical symptoms as a cancer survivor, such as cancer pain and 
CRF, is associated with elevated ‘fear of cancer recurrence’ (FCR) and increased 
psychological distress (Crist & Grunfeld, 2013). Many cancer survivors report 
experiencing FCR which is defined as fear, worry, or concern that cancer may return or 
progress in the same or a different part of the body (Lebel et al., 2016). A degree of FCR 
is understandable and supports ongoing helpful behaviours, such as engagement with 
medical follow-ups and healthy lifestyles (Simonelli, Siegel, & Duffy, 2016). However, 
persistent and prominent levels of FCR can lead to greater psychological distress and 
lower quality of life (Simard et al., 2013).  
 
To develop a shared understanding of FCR, a formulation has been proposed which 
outlines how internal (e.g. physical symptoms) and external (e.g. medical appointments) 
stimuli may trigger cognitions, such as one’s perception of the likelihood of experiencing 
recurrence, previous memories of cancer and knowledge about survival rates (Lee‐jones, 
Humphris, Dixon, & Bebbington Hatcher, 1997). These thoughts give rise to anxious 
emotions and individuals may engage in health-related checking behaviours (e.g. 
reassurance-seeking and body checking) in an attempt to relieve anxiety.    
 
There are similarities between FCR and health anxiety, including high levels of 
preoccupation with health, maladaptive coping behaviours and the misinterpretation of 
symptoms as more serious than they really are. However, health anxiety is rarely 
mentioned in the context of cancer survivors, although it has been considered that it may 
become a problem in cancer remission, with increased reassurance-seeking behaviours 
(Stark et al., 2004).  
 
Some survivors experiencing physical symptoms, such as pain and fatigue which they 
relate to cancer, may experience particularly intense fears of recurrence, potentially 
attributing these symptoms to the return of cancer. This corresponds to the construct of 
catastrophising, in which a person thinks the worst based on their interpretation of 
symptoms. Physical symptom catastrophising is characteristic of health anxiety. The 
construct of ‘mental defeat’ is a subtly different type of catastrophising, reflecting highly 
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negative beliefs about the self and, in particular a “loss of agency”. Mental defeat is 
defined as a perceived loss of autonomy and identity as a human being, to the extent that 
individuals abandon attempts to retain this (Ehlers et al., 1998). Mental defeat has been 
found to be an important psychological phenomenon within chronic pain (Tang, 
Beckwith, & Ashworth, 2015; Tang, Goodchild, Hester, & Salkovskis, 2010; Tang, 
Salkovskis, & Hanna, 2007), post-traumatic stress disorder (PTSD; Ehlers et al., 1998; 
Ehlers, Maercker, & Boos, 2000) and depression (Gilbert & Allan, 1998).  
 
In chronic pain, individuals with mental defeat feel overcome by pain and hold negative 
beliefs about themselves in relation to it, catastrophising about the way in which pain is 
controlling and destroying their life, autonomy and identity (Tang et al., 2007). The 
presence of mental defeat has been found to be a strong predictor of psychological distress 
and is associated with higher levels of functional and psychosocial disability, sleep 
interference (Tang et al., 2010) and more recently with suicidal ideation (Tang et al., 
2015). The literature on mental defeat in depression and PTSD (Ehlers et al., 1998; 
Gilbert, 2006) has also found it to be a cognitive predictor of symptom severity and poor 
treatment outcomes. The persistence of both pain and fatigue in cancer survivors would 
be likely to engender particularly higher levels of mental defeat, related to the perceived 
impact on the cancer survivor’s life and future. Figure 3.1 indicates how quality of life 
and psychological distress will be impacted by these catastrophic interpretations in 






Illness Representations  
Perception of likelihood that 







Fear of cancer recurrence: Physical catastrophising and 
misinterpretation of symptoms as possible cancer 
recurrence  
Mental defeat: self-catastrophising about perceived impact 




Withdrawal, safety seeking behaviours 
Selective attention 
Figure 3.1 Diagrammatic representation indicating the hypothesised theoretical associations between the constructs 
of interest in the current study and the impact on quality of life and psychological distress 
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In summary, research on the experience of cancer survivors demonstrates that negative 
subjective interpretations about the cause and consequences of physical symptoms and 
sensations is linked to psychological distress. There is limited research investigating the 
presence of mental defeat amongst cancer survivors, although a recent study found that 
mental defeat and FCR were significant predictors of psychological distress amongst 
breast cancer survivors (Grozdziej, 2015). No studies to date have explored mental defeat 
amongst cancer survivors, in relation to physical symptoms experienced after treatment 
and the relationship between mental defeat and CRF. The present study aims to extend 
the literature by directly examining the role of mental defeat, FCR and health-related 
beliefs on psychological distress and quality of life, in cancer survivors who experience 
cancer pain and/or CRF. It is anticipated that this could elucidate cognitive factors 
underpinning the relationship between physical and psychological symptoms, which may 
have implications for designing therapeutic interventions. It had two stages: firstly, the 
deployment of a very brief screening tool evaluating fatigue, pain, depression and anxiety 
across a range of cancer survivors, then a more detailed and focused evaluation of those 
experiencing relatively higher fatigue and/or pain or not.  
 
The primary aims of the study were therefore: 1) to develop and pilot an easily deployed 
screening tool to identify the perceived psychological and physical difficulties 
experienced by cancer survivors, 2) to identify cancer survivors experiencing CRF, cancer 
pain, both and a benchmark group experiencing neither, from the results of the screening 




 Screening tool (first stage). 
1. Cancer survivors experiencing pain will experience higher levels of anxiety relative 
to those experiencing fatigue, who are more likely to experience higher levels of 
depression.   
 
Second study. 
2. Individuals with CRF and cancer pain will have higher levels of psychological distress 
and lower levels of quality of life than those without. 
3. The degree of distress and quality of life will be associated with psychological factors, 
including mental defeat, beliefs about fatigue and pain, health anxiety and FCR. 
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4. Cancer survivors experiencing cancer pain will experience higher levels of anxiety 
and mental defeat relative to those experiencing CRF, who are more likely to be 
depressed. 
5. Those experiencing both cancer pain and CRF will show higher levels of anxiety, 





The study comprised two stages: the first involved piloting a screening tool and the 
second used a between-group cross-sectional questionnaire design. Ethical approval was 
granted by the Black Country National Research Ethics Service (NRES) Committee 
(IRAS 201581; Appendix J), the University of Bath (16-301; Appendix K) and three NHS 
R&D departments (University Hospitals Bristol NHS Foundation Trust, Royal United 
Hospitals Bath NHS Foundation Trust and Gloucestershire Hospitals NHS Foundation 




Participants were 117 cancer survivors recruited from online platforms, including 
Macmillan Voices, social media websites and online forums, and outpatient oncology 
clinics at: St Michael’s Hospital, Bristol; Bristol Oncology and Haematology Centre 
(BHOC); Royal United Hospital, Bath (RUH); Cheltenham General Hospital (CGH) and 
Gloucestershire Macmillan Next Steps Cancer Rehabilitation.  
 
The screening tool aimed to assess perceived psychological and physical difficulties 
experienced by all cancer survivors, regardless of cancer type or stage. Participants were 
eligible to complete the screening tool if they: (i) were aged 18 years or older and (ii) had 
a confirmed past or current diagnosis of cancer. Participants were excluded from 
completing the screening tool if they: (i) were not sufficiently fluent in English to 







Second stage.  
Participants were 33 cancer survivors who had completed the screening tool and met 
inclusion criteria for this stage: (i) were aged 18 years or older; (ii) had a past or current 
diagnosis of cancer (stages 0-III); (iii) had completed primary treatment with a curative 
intent and (iv) may still have been receiving medical follow-up care to reduce the risk of 
relapse e.g. hormone therapy or for cosmetic purposes. There were no set criteria 
regarding cancer type or time since diagnosis, as physical and psychological symptoms 
may persist after treatment for up to 15-20 years (Stanton et al., 2015). 
 
Participants were excluded from this stage if they: (i) had a diagnosis of metastatic (stage 
IV) cancer; (ii) experienced cancer recurrence during the study duration; (iii) had a 
diagnosis of a pre-existing comorbid chronic pain and/or fatigue condition; (iv) were not 
sufficiently fluent in English to understand the questionnaires and (v) lacked capacity to 
consent.   
 
Measures (Appendices M&N) 
 Screening tool. 
A brief 5-item screening tool was developed by the research team to assess a combination 
of physical and psychological symptoms frequently reported by cancer survivors. The 
tool focused on clinical factors, such as time experienced and interference, as no other 
tool was available to measure these with the combination of symptoms that were of 
interest in the current study. Measuring interference provided an assessment of how much 
symptoms impacted on daily functioning and has been used as a measurement in previous 
relevant research (Tang et al., 2010). The symptoms measured in the screening tool 
included 1) pain, in any part of the body, 2) fatigue and tiredness, not relieved by resting, 
3) depression and low mood, 4) general anxiety, about anything not related to health, 5) 
anxiety related to health and FCR.  
 
Participants were asked to indicate how many hours in a day they were affected by each 
symptom and how much this interfered with daily life on a scale of 0 (“Not at all”) to 8 
(“Very severely”), when present. For the item related to FCR, participants were advised 
they did not have to complete the question if they had a diagnosis of metastatic cancer 




It is intended that telephone diagnostic screening will be completed to provide validation 
of the screening tool in a random subsample of participants who rated the symptoms 
positively, in comparison to a sample of those who rated them negatively.  
 
Second stage.  
Demographic and clinical characteristics. 
This was used to gather information about participants’ age, gender, relationship status, 
employment status and ethnicity. With regards to clinical diagnosis, participants were 
asked about their type of cancer, date of initial diagnosis, time since completion of 
treatment and type of treatment/s received. 
 
 Beliefs about pain and fatigue. 
The Pain Catastrophizing Scale (PCS; Sullivan, Bishop, & Pivik, 1995) is a 13-item self-
report scale which asks respondents to indicate the extent to which they experience the 
thoughts and feelings outlined on a scale of 0 (“Not at all”) to 4 (“All the time”), when in 
pain. This gives a total score and subscale scores on rumination, magnification and 
helplessness. The PCS has demonstrated adequate to excellent internal consistency. 
 
The Beliefs about Fatigue Scale (BAFS; Wilson, Salkovskis, & O'Dowd, 2015) is a 8-
item self-report scale assessing unhelpful beliefs about the consequences of fatigue and 
activity, on a scale of 1 (“Strongly disagree”) to 10 (“Strongly agree”). An initial study 
demonstrated it has good internal consistency but requires further testing (Wilson et al., 
2015).  
 
These scales were chosen to reflect pain and fatigue experienced by all participants, rather 
than focusing specifically on CRF or cancer pain due to two reasons: 1) individuals may 
find it challenging to disaggregate general symptoms and those related to cancer and 2) 
to obtain ratings from those who do not regard themselves as having CRF or cancer pain.   
 
  Fear of cancer recurrence. 
The Fear of Cancer Recurrence Inventory-Severity Subscale (FCRI; Simard & Savard, 
2009) is a 9-item self-report scale measuring the severity of intrusive thoughts about FCR 
on a scale of 0-4. Higher scores indicate greater levels of FCR, with item 5 reverse coded. 




 Health anxiety. 
The Health Anxiety Inventory – Short Form (HAI-SF; Salkovskis, Rimes, Warwick, & 
Clark, 2002) is a 14-item self-report questionnaire measuring levels of health anxiety on 
a scale of 0-3 with higher scores indicating greater levels of health anxiety. The short 
version has high test-retest reliability, good internal consistency and correlates highly 
with the longer version. 
 
 Mental defeat. 
The Pain Self Perception Scale (PSPS; Tang et al., 2007) is a 24-item measure adapted 
for use in this study, by placing “because of my physical symptoms” above statements 
related to a recent episode of intense physical symptoms. Scores are captured on a scale 
of 0 (“Not at all”) to 4 (“Very strongly”), with higher scores indicating higher levels of 
mental defeat. It has high levels of internal consistency and test-retest reliability. 
 
 Quality of life. 
The Quality of Life Index (QLI; Ferrans & Powers, 1985) measures the satisfaction and 
importance of various aspects of an individual’s life, on a scale of 1 (“Very 
dissatisfied”/“Very unimportant”) to 6 (“Very satisfied”/“Very important”). It has been 




The Patient Health Questionnaire (PHQ-9; Kroenke, Spitzer, & Williams, 2001) is a 9-
item self-report scale measuring the severity of depression. Scores on individual items 
range from 0 (“Not at all”) to 3 (“Nearly every day”), with total scores of 5,10, 15 and 20 
representing clinical cut-off points of mild, moderate, moderately severe and severe 
depression respectively.  
 
 General anxiety. 
The Generalized Anxiety Disorder Questionnaire (GAD-7; Spitzer, Kroenke, Williams, 
& Löwe, 2006) is a 7-item self-report scale measuring the severity of anxiety. Scores on 
individual items range from 0 (“Not at all”) to 3 (“Nearly every day”), with total scores 






In oncology services, suitable participants were either identified by clinicians or 
approached by the lead researcher when attending for review appointments. Consenting 
participants completed the screening tool whilst waiting for their appointment and could 
opt-in to being contacted in the main study if they wished. Eligibility for the main study 
was completed by telephone with the lead researcher.  
 
Suitable participants recruited through Macmillan Voices and other online platforms were 
invited to make initial contact by email. The screening tool and eligibility assessment 
were completed by telephone with the lead researcher. All participants who were eligible 
for the main study were sent a questionnaire pack by post, with an information sheet 
(Appendix O) and consent form (Appendix P). Participants were encouraged to contact 
the lead researcher or their named cancer nurse in the event of experiencing any distress 










 Symptom checklists 
completed  
(n=117) 
• By clinician (n=22) 
• By lead researcher in 
clinic (n=69) 



















• Didn’t leave contact 
details (n=26) 
• Metastatic disease 
(n=24) 
• Pre-existing comorbid 
chronic physical health 
condition (n=3) 
• Still in active treatment 
(n=3) 
• Declined during 
eligibility phonecall 
(n=1) 
• Uncontactable (n=11) 
 
   













          
• Experienced recurrence 
of cancer (n=1) 
• Questionnaires not 
returned (n=15) 
 





   
   




The data analytic strategy was developed a priori and analysis was performed using SPSS 
22, with statistical significance set at p< 0.05. To evaluate the screening tool, interference 
ratings of three symptoms (pain, depression and general anxiety) were to be entered into 
a hierarchical multiple regression to investigate whether they could predict fatigue 
interference. In turn, the interference ratings of fatigue, depression and general anxiety 
were to be entered into a hierarchical multiple regression to investigate whether they 
could predict pain interference (hypothesis 1).  
 
Cross tabulation was to be conducted to evaluate the associations between pain and 
fatigue interference, to help with the identification of four groups: those with both higher 
levels of cancer pain and CRF interference, those with higher levels of cancer pain 
interference only, those with higher levels of CRF interference only and those with lower 
levels of cancer pain and CRF interference. Higher levels of physical symptom 
interference were defined by the research team as a rating of ≥ 4/8 (“definitely”) on the 
screening tool. There were insufficient participants to allow for this strategy to be used. 
The strategy was adapted to identify two groups: those with lower levels of both cancer 
pain and CRF interference (rated as ≤ 3/8 on the screening tool) and those with a higher 
level of either or both cancer pain and/or CRF (rated as ≥ 4/8 on the screening tool). This 
allowed us to compare a higher symptomatic group with a lower symptomatic group.  
 
Independent samples t-tests were carried out to test group differences in levels of 
psychological distress and quality of life (hypothesis 2). Mental defeat, FCR and beliefs 
about fatigue and pain were entered into stepwise multiple regressions to evaluate 
whether they were associated with distress and quality of life respectively (hypothesis 3).  
 
The sample size did not allow the analysis of hypotheses 4 and 5 which required the 
identification of four groups, however, two additional hypotheses were formulated and 
were analysed using stepwise multiple regression. These were to investigate whether pain, 
fatigue, depression and health-related anxiety interference from the screening tool could 
predict quality of life and FCR respectively. 
 
Power considerations. 
An a priori power analysis was conducted using G*Power (Faul, Erdfelder, Buchner, & 
Lang, 2009) to estimate the required sample size of testing hypotheses four and five of 
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the main part of the study with four groups. However, with a lack of comparable studies, 
results are tentative. A medium effect size (f²=0.15) and power at 0.8 gave a required 
sample size of approximately 180 participants for analysing results with four groups (45 




Means and standard deviations for each symptom in the screening tool are shown in Table 
3.1. By NHS recruitment site: 41% were recruited from St. Michael’s Hospital, Bristol; 
14% from BHOC; 13% from CGH; 6% from RUH and 4% from Gloucestershire 
Macmillan Next Steps Cancer Rehabilitation. 22% were recruited from online platforms.  
 
Results found 26% (n=29) of all participants indicated experiencing no pain and fatigue 
(hours affected equal to zero), 18% (n=21) indicated experiencing fatigue only (hours 
affected equal to zero), 6% (n=7) indicated experiencing pain only and 50% (n=56) 




Means and standard deviations of symptoms in screening tool 
Variable Number Mean 
Standard 
deviation (range) 
Pain in hours 
(hh:mm) 
114 4:14 6:54 (0:00-24:00) 
Pain interference 116 2.03 2.25 (0-8) 
Fatigue in hours 
(hh:mm) 
113 4:31 6:09 (0:00-24:00) 
Fatigue 
interference 
116 3.03 2.58 (0-8) 
Depression in 
hours (hh:mm) 
110 3:05 5:48 (0:00-24:00) 
Depression 
interference 
116 2.31 2.49 (0-8) 
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General anxiety in 
hours (hh:mm) 
114 2:10 3:49 (0:00-24:00) 
General anxiety 
interference 
117 2.2 2.29 (0-8) 
Health-related 











87 2.56 2.34 (0-8) 
 
 Regression analysis – pain and fatigue interference (hypothesis 1). 
Hierarchical multiple regression analyses were performed to 1) examine the individual 
strength of depression, general anxiety and pain interference in predicting fatigue 
interference and 2) the strength of general anxiety, depression and fatigue interference in 
predicting pain interference. Regarding fatigue interference, in the first step depression 
interference contributed significantly to the regression model, accounting for 40% of the 
variance. The addition of general anxiety interference contributed a further 1% but this 
was not significant. In the third step, pain interference explained an additional 8% of the 
variance and this change was significant. Altogether, the variables accounted for 49% of 
the variance, with depression and pain interference remaining significant predictors of 











Hierarchical multiple regression for variables predicting fatigue interference 
Model R² Adjusted F B β t 
Step 1 
Constant    1.431  5.516** 
Depression 
interference 
.400 .394 74.543 .658 .632 8.634** 
Step 2 
Constant    1.292  4.678** 
Depression 
interference 
   .582 .558 6.256** 
General anxiety 
interference 
.410 .400 2.043 .145 .128 1.429 
Step 3       
Constant    .891  3.244* 
Depression 
interference 
   .412 .395 4.297** 
General anxiety 
interference 
   .151 .133 1.593 
Pain interference .491 .478 17.505 .377 .327 4.184** 
Note: *p<.01; **p<.001 
Regarding pain interference, in the first step general anxiety interference contributed 
significantly to the regression model, accounting for 7.5% of the variance. The addition 
of depression interference in the second step explained an additional 16.6% of the 
variance and this change was significant. Within this step, general anxiety interference 
was no longer a significant predictor. The third step resulted in fatigue interference 
explaining a further 10.4% of the variance which contributed significantly to the model. 
With all predictors in this step, general anxiety interference remained nonsignificant. All 
three predictors accounted for 34.5% of the variance, with fatigue interference found to 









Hierarchical multiple regression for variables predicting pain interference 
Model R² Adjusted F B β t 
Step 1 
Constant    1.483  5.244*** 
General anxiety 
interference 
.075 .066 9.024 .269 .273 3.004** 
Step 2 
Constant    1.061  3.913*** 
General anxiety 
interference 
   -.015 -.016 -.154 
Depression 
interference 
.241 .227 24.366 .450 .500 4.936*** 
Step 3       
Constant    .591  2.135* 
General anxiety 
interference 
   -.068 -.069 -.726 
Depression 
interference 
   .239 .265 2.413* 
Fatigue interference .345 .327 17.505 .364 .420 .4.184*** 

















Distribution of pain and fatigue (hours and interference). 
Figures 3.3 and 3.4 show pain in hours and interference and fatigue in hours and 
































Study 2: Second stage 
Demographic and clinical characteristics of participants in this stage are shown in Table 
3.4. Participants did not significantly differ on these characteristics. Means and standard 
deviations of demographic and clinical characteristics is shown in Table 3.5. 
 
Table 3.4 
Demographic and clinical characteristics of participants 
Variable Lower levels of pain 
and fatigue number 
(%) 
(n=14) 
Higher levels of pain 























































































































   














































































Means and standard deviations of demographic and clinical information 
Variable Lower levels of pain and 
fatigue mean (SD) 
(n=14) 
Higher levels of pain 
and/or fatigue mean 
(SD) 
(n=19) 
Age 56.79 (14.1) 50.42 (11.74) 
Years spent in education 
since age 5 
14.46 (3.09) 15.91 (4.35) 
Time since diagnosis 
(months) 
41.5 (37.63) 37.11 (47.7) 
Time since completion of 
treatment (months) 
23.77 (29.76) 28.68 (46.77) 
Depression 4.93 (5.11) 10.32 (6.34) 
Anxiety 3.71 (4.16) 8.74 (6.41) 
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Quality of Life 208.46 (17.86) 185.32 (34.18) 
Pain Catastrophising 12.21 (9.16) 19.44 (16.03) 
Beliefs about fatigue 25.07 (10.31) 34.21 (8.93) 
FCR 20.15 (7.55) 21.42 (8.06) 
Mental Defeat 42.79 (23.56) 57.76 (29.21) 
Health Anxiety 28.36 (8.98) 31.79 (8.44) 
 
 
Comparisons between lower levels of pain and fatigue interference group and 
higher levels of pain and/or fatigue interference group (hypothesis 2). 
Independent samples t-tests were conducted (equal variances assumed) to compare those 
with lower levels of pain and fatigue interference and those with higher levels of pain 
and/or fatigue interference, on the measures of depression, anxiety, quality of life, health 
anxiety, FCR, mental defeat, pain catastrophising and beliefs about fatigue. Results for 
the primary outcomes (depression, anxiety and quality of life) indicated that those with 
higher levels of pain and/or fatigue interference had higher levels of depression (t(31)=-
2.612, p<.05) and anxiety (t(31)=-2.556, p<.05) and lower levels of quality of life 
(t(30)=2.234, p<.05). There were no significant group differences on any of the other 
measures.  
 
Due to the non-normal distribution of the data, non-parametric tests (Mann Whitney U) 
were also conducted. Results showed the same significant findings that those with higher 
levels of pain and/or fatigue interference had higher levels of depression (U=62, p<.01) 
and anxiety (U=70, p<.025) and lower levels of quality of life (U=59, p<.025).  
 
 Regression analysis – psychological distress and quality of life (hypothesis 3).  
As the secondary analysis, stepwise multiple regression analyses were performed to 
examine the individual strength of mental defeat, FCR, beliefs about fatigue and pain 
catastrophising in predicting 1) depression and 2) anxiety. Regarding depression, the only 
variable to enter was mental defeat, accounting for 59.6% of the variance. Table 3.6 
illustrates this. Regarding anxiety, the first variable to enter was mental defeat, accounting 
for 72.9% of the variance. The second variable to enter was FCR, accounting for an 






Stepwise multiple regression for variables predicting depression 
Model R² Adjusted F B β t 
Step 1 
Constant    -.992  -.603 




Stepwise multiple regression for variables predicting anxiety 
Model R² Adjusted F B β t 
Step 1 
Constant    -2.859  -2.258* 
Mental defeat .729 .720 75.461 .188 .854 8.687*** 
Step 2 
Constant    -5.415  -3.453** 
Mental defeat    .154 .700 6.335*** 
Mental defeat 
+ FCR 
.778 .762 5.953 .205 .270 2.440* 
Note: *p<.05, **p<.01, ***p<.001 
 
A stepwise multiple regression analysis was performed to examine the individual strength 
of mental defeat, FCR, beliefs about fatigue and pain catastrophising in predicting quality 
of life. Mental defeat was the only variable to enter, accounting for 70% of the variance. 
Table 3.8 illustrates this.  
 
Table 3.8 
Stepwise multiple regression for variables predicting quality of life 
Model R² Adjusted F B β t 
Constant    244.367  35.369* 
Mental 
defeat 





Regression analysis –  symptoms from screening tool in predicting quality of 
life and FCR. 
As an additional analysis, stepwise multiple regression analyses were performed to 
examine the individual strength of pain, fatigue, depression and health-related anxiety 
interference, as measured at screening, in predicting quality of life and FCR respectively. 
Regarding quality of life, a significant model accounting for approximately 55% of the 
variance was found. Depression interference was the strongest predictor of quality of life 
scores, followed by fatigue interference. Table 3.9 illustrates this. 
 
Table 3.9 
Stepwise multiple regression for screening tool variables predicting quality of life 
Model R² Adjusted F B β t 
Step 1 
Constant    218.069  34.391**** 
Depression 
interference 
.448 .429 23.542 -7.668 -.669 -4.852**** 
Step 2 
Constant    225.192  34.375**** 
Depression 
interference 
   -5.171 -.451 -2.897** 
Depression 
interference + fatigue 
interference 
.545 .512 5.931 -4.820 1.979 -2.435* 
Note: *p<.05, **p<.01, ***p<.001, ****p<.0001 
With regards to FCR, health-related anxiety interference was the only variable to enter, 
accounting for 38% of the variance. Table 3.10 illustrates this.  
 
Table 3.10 
Stepwise multiple regression for screening tool variables predicting FCR 
Model R² Adjusted F B β t 
Constant    15.580  9.267* 
Health-related 
anxiety interference 






This study was conducted to examine the psychological mechanisms which may be 
involved in cancer pain and CRF experienced by cancer survivors, in order to evaluate 
the impact these may have on psychological distress and quality of life. Psychological 
mechanisms considered included mental defeat, FCR and health-related beliefs. The 
screening tool was found to be applicable and effective at identifying the range of physical 
symptoms and psychological distress known to be present amongst many cancer 
survivors. Additionally, ratings of depression and fatigue interference were found to 
prospectively predict the outcome of quality of life in the second study, whilst health-
related anxiety interference prospectively predicted FCR.   
 
In the second study, participants identified at screening as experiencing higher levels of 
interference from cancer pain and/or CRF were found to have significantly higher levels 
of psychological distress and poorer quality of life, relative to participants with lower 
levels of interference from cancer pain and CRF. This finding highlights the detrimental 
impact the experience of physical symptoms can have on cancer survivors. These results 
are consistent with previous research conducted into the effect of cancer-related pain and 
fatigue on levels of depression, anxiety and quality of life (Brown & Kroenke, 2009; 
Hofman et al., 2007; Syrjala et al., 2014; Wu & Harden, 2015). For those in the current 
study with higher levels of cancer pain and/or CRF interference, the range of time since 
completion of treatment was from one month up to 18 years with a mean of approximately 
two years (29 months). Research suggests that symptoms experienced by cancer 
survivorship may reduce or resolve within the first five years post-treatment, however 
there are a minority who continue to experience long-term effects (Stanton et al., 2015) 
and current results are suggestive of this.   
 
There were no significant group differences between those with higher levels of 
interference from cancer pain and/or CRF and those with lower levels of interference 
from cancer pain and CRF on measures of mental defeat, FCR or health-related beliefs. 
This finding did not support the hypothesised associations between the experience of 
physical symptoms and physical and self-catastrophising. Mental defeat was however, 
found to be a significant predictor of psychological distress and quality of life, accounting 
for 60-73% of the variance within these items. This high correlation between mental 
defeat, depression, anxiety and quality of life indicates the important role mental defeat 
may play in affecting psychological adjustment after cancer diagnosis and treatment. 
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These results are consistent with other studies investigating the role of mental defeat in 
cancer survivors (Grozdziej, 2015). A better understanding of the impact of cancer on 
survivors’ sense of self and agency may be timely. 
 
The finding that there were no group differences in levels of FCR experienced is in 
contrast to several studies that have found the presence of physical symptoms such as 
fatigue and pain to be predictive of elevated levels of FCR (Simard et al., 2013). 
Interestingly, the means of FCR across all participants within the current study (20-21) 
indicated a level which would be viewed as warranting clinical assessment, regardless of 
the presence of physical symptoms or not (Costa, Dieng, Cust, Butow, & Kasparian, 
2016). 
 
With regards to the screening tool, results found that approximately 50% of cancer 
survivors experienced both pain and fatigue to some degree. For all participants 
completing the screening tool, depression interference was a significant predictor of 
fatigue interference, followed by pain interference, accounting for 48% of the variance. 
This finding fit with the hypothesis and was in line with previous literature. Pain 
interference was significantly predicted by fatigue interference, followed by depression 
interference, accounting for 27% of the variance found. In contrast with previous 
literature and the hypothesis stated, general anxiety interference was not found to be a 
significant predictor of pain interference.  
 
Results from the screening tool found that depression interference was a significant 
prospective predictor of fatigue interference and in turn, fatigue interference was the best 
predictor of pain interference. Additional findings demonstrated that levels of depression 
interference in the screening tool significantly predicted quality of life for participants 
who completed both stages of the study. These results suggest high rates of comorbidity 
between elevated levels of depression, fatigue and pain. Cancer survivorship literature 
has discussed the possibility that these symptoms may ‘cluster’ together within one 
individual (Fleishman, 2004). It is difficult to disentangle the causality between each of 
these symptoms, particularly as they each often present as a clinical symptom of the other 
e.g. fatigue as a symptom of depression (Bower, 2014) and pain as a symptom of chronic 
fatigue (Bourke et al., 2014). This suggests it may be more beneficial to consider 
treatment options for relieving symptoms and improving quality of life in people 
experiencing comorbidity in these symptoms.  
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Limitations and implications for future research 
The sample obtained in the main part of the study is less than the a priori power 
calculation. This affected the initial data analytic strategy for the second part of the study; 
this had been devised to explore the role of mental defeat and FCR in different groups of 
people with varying levels of cancer pain, CRF, both and neither and two hypotheses 
related to this were not able to be tested. The present analysis was identified as a fall-back 
strategy in the event of recruitment problems. An increased sample size would have 
allowed for improved explorations of the psychological constructs proposed and the 
creation of additional groups would have made it possible to differentiate between the 
experience of pain and that of fatigue. It should also be noted that the data appeared 
skewed. 
 
The cross-sectional nature of the second study limits the generalisability of results. 
Longitudinal designs may allow for exploration of cancer pain and CRF over time. The 
use of the screening tool did bring a level of increased validity, with the findings that 
health-related anxiety interference at screening was predictive of FCR during the second 
stage and that depression interference predicted quality of life. An interesting avenue of 
future research would be to investigate whether there is a group difference between 
individuals experiencing pain and fatigue within the first few months and years after the 
completion of treatment and those who experience increased chronicity of physical 
symptoms several years after.  
 
Incorporating a screening question related to sleep disturbance may have been useful to 
consider the impact of pain and fatigue on this. Research suggests sleep may mediate the 
effect of pain on fatigue (Beck et al., 2005). The distribution of pain and fatigue in hours 
on the screening tool suggested there may be individuals who experience a level of 
interference that disrupts sleep.  
 
In addition, the sample in the second stage was largely homogenous with regards to 
gender and ethnicity, which may reduce the generalisability of results. Whilst the 
screening tool was designed to be completed briefly, the collection of basic demographic 
information, such as gender, age and cancer type would have been useful. Due to the 
focus of this study on physical symptoms, it is possible that individuals with higher levels 





The current study provides evidence for higher levels of psychological distress and poorer 
quality of life amongst people who experience higher levels of cancer pain and/or CRF 
interference; this suggests focused interventions may improve quality of life. It has been 
found that cancer patients experiencing pain may not report this for many reasons, 
including not wanting to distract their oncologist and believing that nothing could be done 
to improve it (Syrjala et al., 2014). A brief screening tool, such as the one in the current 
study, could be used clinically to assess the psychological impact of symptoms and inform 
clinicians of patients who may require additional psychological support, beyond 
pharmacological treatment. An additional screening question related to mental defeat 
could also allow for earlier detection.  
 
It may be beneficial for oncology psychological health services to liaise with medical 
teams and specialist pain and fatigue services to consider treatment pathways and options 
for cancer survivors experiencing these physical symptoms at a disruptive level which 
impacts on mood and quality of life.  
 
Conclusion 
In summary, this study suggests that people experiencing higher levels of cancer pain 
and/or CRF interference have higher levels of psychological distress and poorer quality 
of life, in comparison to people who experience lower levels of cancer pain and CRF. 
Mental defeat was found to be predictive of psychological distress and quality of life. The 
screening tool used appeared to be effective in identifying the physical and psychological 
symptoms experienced by many cancer survivors and was found to be useful in 
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Advances in cancer detection and treatment have increased survival rates, with 
approximately half of those diagnosed in England and Wales now surviving for at least 
ten years. However, this brings new difficulties as many cancer survivors experience a 
range of physical and emotional sequelae which can persist for months and years. Cancer-
related fatigue (CRF) and cancer pain are two of the most prevalent physical symptoms 
experienced by cancer survivors and many people experience co-occurrence of both 
symptoms. The presence of these symptoms has been found to be associated with 
depression, anxiety and lower quality of life.  
 
The experience of ongoing physical symptoms has been found to be related to elevated 
levels of ‘fear of cancer recurrence’ (FCR) which is the fear and worry that cancer may 
return or progress. Whilst a level of FCR can be adaptive, with engagement in medical 
follow-ups and healthy lifestyles, it can become disruptive to one’s life with increased 
anxiety and the use of maladaptive coping behaviours (e.g. body-checking, 
hypervigilance to physical symptoms). For some individuals, catastrophic beliefs about 
physical symptoms can lead to the development of ‘mental defeat.’ This perceived loss 
of autonomy and control due to symptoms experienced, can lead to functional impairment 
and disability and is associated with higher levels of distress. The present study aimed to 
extend the literature by directly exploring the role of mental defeat, fear of cancer 
recurrence and health anxiety on psychological distress and quality of life, in cancer 
survivors who experience cancer pain and/or CRF.  
 
The study had two stages. The first involved the use of a brief screening tool evaluating 
fatigue, pain, depression and anxiety. 117 cancer survivors, of all cancer types and stages, 
completed this stage. The second stage comprised 33 participants who had completed the 
screening tool and involved a more focused evaluation of those experiencing higher levels 
of cancer pain and/or CRF interference and those with lower levels of cancer pain and 
CRF interference. Questionnaires measured levels of depression, anxiety, quality of life, 
FCR, mental defeat and health-related beliefs. 
 
The findings indicated that the screening tool was effective at identifying the range of 
physical and psychological symptoms known to be present amongst many cancer 
survivors and was useful in prospectively predicting quality of life and FCR. For those 
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completing the screening tool, depression interference was found to be a significant 
predictor of fatigue interference, followed by pain interference. Pain interference was 
significantly predicted by fatigue interference, followed by depression interference. In the 
second part of the study, participants identified at screening as experiencing higher levels 
of cancer pain and/or CRF interference were found to have significantly higher levels of 
psychological distress and poorer quality of life, in comparison to those with lower levels 
of cancer pain and CRF interference. There were no significant group differences found 
on measures of mental defeat, FCR or health-related beliefs. Mental defeat was however, 
found to be a significant predictor of psychological distress and quality of life, accounting 
for 60-73% of variance within these items. 
 
Results should be viewed in light of a considerably smaller sample size within the second 
stage than anticipated which impacted on research questions and hypotheses that could 
be tested. An increased sample size would have allowed for greater exploration of the 
psychological constructs of mental defeat and FCR amongst cancer survivors 
experiencing cancer pain and CRF. With regards to future research, it could be beneficial 
to complete longitudinal studies to monitor the progress and interference of physical 
symptoms amongst cancer survivors over time. This could help to identify any difference 
between the experience of symptoms that persist in the early stages after treatment, in 
comparison to chronic symptoms that persist for years and decades. A measure of sleep 
disturbance may have also helped to identify its role within the experience of physical 
symptoms.  
 
In relation to clinical practice, the brief screening tool was effective in identifying 
disruptive levels of physical and psychological symptoms and in prospectively predicting 
further difficulties, which suggests that it could be used clinically. As patients may find 
it difficult to communicate the negative impact of these symptoms, possibly for fear that 
nothing could be done to help, a screening tool could be useful to inform clinicians about 
patients who may be in need of psychological support. It could also be beneficial to 
include an additional screening question for mental defeat.  
 
Additionally, the results suggested a high level of comorbidity between depression, pain 
and fatigue experienced by participants. Psychological health services in oncology 
settings could liaise with medical teams and specialist pain and fatigue services to 
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consider treatment pathways and options for cancer survivors experiencing levels of pain 








My experience prior to training involved working within research teams which provided 
me with the opportunity to understand how research projects could be developed and 
conducted within a team. I was aware that my strengths in research lay in engaging with 
participants and handling the data collection element of studies. However, I was less 
knowledgeable about the design and analysis aspects of research and felt apprehensive 
about this when I began training. The experience of completing numerous research 
projects during the course has been incredibly challenging but I feel a sense of pride for 
what I have achieved so far. In this section I will reflect on the journey of completing case 




Writing a case study on each placement has been invaluable for drawing theory-practice 
links and learning how to evaluate clinical work. I naively thought that case studies would 
become easier over time but unfortunately, this has not happened. One difficulty lies in 
not being able to predict the course of the placement and your individual caseload over 
the six-month period. When attempting to meet the course and BABCP criteria for case 
studies, in addition to completing two single-case experimental design studies (SCED), 
this can become challenging when clients either don’t engage or drop out of treatment. In 
addition, the three baseline measurements required for a SCED can become challenging 
to complete when observing a supervisor during an initial assessment who does not 
routinely use outcome measures. There can be a fine line between assertiveness and 
appearing disrespectful of their practice. 
 
Case studies have encouraged me to think objectively about what a ‘good outcome’ looks 
like in clinical practice. A client can remark that they ‘feel better’ but this does not provide 
evidence of an effective intervention. I have learned that clinical tools for evaluating 
intervention outcomes may be formal, idiosyncratic, or qualitative and can be used 
therapeutically for the client and the therapist. I endeavour to take what I have learned 
from completing case studies into my future clinical work. I have further developed my 
understanding of the importance of evaluating clinical practice through the completion of 





Service Improvement Project (SIP) 
I have always been interested in working with people with severe and enduring mental 
health problems and my first placement working with adults in a community mental 
health team provided me with the opportunity to do so. During this placement, a clinical 
psychologist in the team proposed a SIP to investigate the extent to which NICE 
guidelines for first episode psychosis were being implemented in the Early Intervention 
for Psychosis (EI) team, conducting both a clinical audit and interviews with staff. I 
attempted to seek an internal supervisor from the course team prior to submitting a 
proposal but was unable to do so. The proposal did not pass as it appeared more 
appropriate as a consultancy project than a SIP. I didn’t want to disappoint the 
psychologist who had proposed the project so I persisted in attempting to amend the 
design. However, I was informed that it would not be possible to complete it as a SIP and 
that I should find an alternative project. By this time, the course had assigned Emma 
Griffith as my internal supervisor and through her connections she discovered that the 
dual diagnosis DBT team in Bath and North East Somerset (B&NES) were eager for a 
service evaluation to be completed. This fit within my interest of severe mental health 
problems and the DBT team were enthusiastic about the project.  
 
I enjoyed the process of meeting with my external supervisor (a clinical psychologist in 
the DBT team) to consider what the service wanted to achieve from the evaluation and 
what was going to be valuable and useful. She left to go on maternity leave during the 
development of the questionnaires and interview schedules but enlisted help from another 
clinical psychologist within the team. Gaining AWP R&D evaluation and University of 
Bath psychology ethics felt relatively straightforward and data collection was completed 
by November 2016. Conducting the interviews was time-consuming to arrange and 
complete, as staff were at full capacity with limited availability and there was a shortage 
of room availability within the NHS setting.  
 
I completed nine interviews, varying in length between 30-90 minutes and by this time, I 
was falling behind with my GANTT chart. I was advised that it may be wise to leave the 
qualitative analysis until after the final submission in May 2017 so that I could prioritise 
my main research project (MRP). However, there was a stubborn part of me that wanted 
to complete the qualitative analysis and demonstrate the time and effort that I had put into 
it. I was also concerned that the quantitative data may lack a richness of information as it 
had primarily been developed as an adjunct to the interviews. I liaised with Emma about 
137 
 
this and she suggested that I could possibly analyse a sample of interviews. My 
understanding after that meeting was that a sample involved analysing half of the client 
data and half of the team member data. I ploughed on, completing the transcription and 
analysis of this sample. Due to placement commitments and my interim external 
supervisor going on long-term sick leave, the only opportunity to present my findings to 
the DBT team was during a period of annual leave in April 2017. This was arranged 
hastily and Emma was not able to review my findings beforehand. Unfortunately, it was 
at this point that Emma and I realised that there had been miscommunication between us, 
as her understanding of analysing a sample meant either all of the client data or all of the 
team data; not a combination of both. Due to continued difficulties with my MRP, I was 
advised to complete the full analysis by both Emma and Paul Salkovskis to strengthen 
my research portfolio. Re-analysing my qualitative data with the addition of five 
interviews, in the month prior to submission, has been a rollercoaster as I have felt panic 
and fear about completing it on time. I have primarily learned the importance of 
communicating effectively so that everyone involved in a project can have a shared 
understanding of how it is progressing. I have been fortunate that both the team and clients 
have provided positive feedback about the findings and recommendations that I’ve 
presented and their enthusiasm from start to finish has maintained my motivation to 
complete a project that is meaningful for them. 
 
Critical Review of the Literature 
Staying within the area of severe mental health difficulties, I sought out Falguni Nathwani 
to supervise my literature review after she proposed the idea of exploring the nature and 
traits of non-suicidal self-injury (NSSI) during our research fair in December 2014. This 
captured my interest as I didn’t know a lot about NSSI and wanted to explore what could 
make individuals more likely to choose this behaviour over a safer alternative. Falguni 
encouraged me to perform a preliminary search of the literature to look for studies of 
NSSI within different clinical presentations. From this search, I found that there was a 
small but developing literature base about NSSI in people with eating disorders.  
 
Falguni left the university in May 2015 but stayed on as an external supervisor whilst 
Cara Davis took over as internal supervisor in October 2015. Around this time, I 
discovered that a whole book had been published on the topic of NSSI in eating disorders 
which raised uncertainty about whether I should continue with the literature review that I 
had started to work on. Cara was very supportive and liaised with the research team on 
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my behalf, which thankfully led to the conclusion that I should continue with my review, 
as it would be an academic journal article with a systematic search of the literature. I must 
admit that the literature review was the one project that got pushed to the bottom of my 
priority list at times, to make way for other projects that ran in accordance to the schedules 
of ethics committees and services. In the summer of 2016, I used extra study days to 
complete literature searches, however, I noticed that I was struggling to narrow down 
articles and was left with the prospect of reading over 50 full text-articles. During that 
summer, Cara informed me that she was redistributing her research supervision and would 
no longer be my supervisor but that Ailsa Russell (my clinical tutor) would take over this 
role. Ailsa reviewed my progress to date and helped me to operationalise my methodology 
which shaped up the review. Completing the review took a great deal of time but I enjoyed 
immersing myself within the literature, using quality appraisal tools to critically analyse 
studies and making use of a theoretical framework to synthesise the literature. This project 
felt like it was under my control and it was down to my own motivation to complete it. 
The review at times felt like a breath of fresh air in comparison to completing the main 
research project.  
 
Main Research Project (MRP) 
For many years, clinical health psychology has been my main area of interest, with a 
particular focus in oncology. My mum is a Macmillan Palliative Care Nurse and I believe 
that the passion she has for her work sparked my interest, which was strengthened when 
I worked with cancer patients after completing my undergraduate degree. Unfortunately, 
my Mum was diagnosed with cancer herself in 2012 but returned to work later that year 
after successful treatment. When I started training, I knew that I wanted to explore cancer 
survivorship and I approached Andrew Medley at the research fair to discuss my ideas 
about exploring grief and loss after cancer treatment. His passion for research in the area 
enthused me, however, he left the course team in early 2015, with Maria Loades taking 
over interim supervision, before Jo Daniels stepped in during the summer of 2015. The 
project design evolved dramatically during that time, with each supervisor suggesting a 
new idea about how I could proceed.  
 
Reading the literature, I began to get a sense of the link between psychological difficulties 
and prevalent physical symptoms experienced by many cancer survivors. I submitted two 
proposals for this project between July – November 2015 but neither were accepted as 
the design was deemed not advanced enough for doctoral research. I had become 
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frustrated by this point and reached a low point of motivation at the end of 2015. I was 
advised to meet with Paul and he rapidly helped me to develop a design involving two 
stages; a screening tool and a questionnaire pack. The proposal was eventually passed in 
January 2016. On the course, the process of submitting research proposals has now been 
replaced with the verbal presentation of proposals to a panel. I acknowledge the 
challenges that there must be in developing and evolving a doctoral course but I believe 
that I lost about six months due to amending, submitting and waiting for the outcome of 
research proposals.   
 
With regards to supervision at this stage, I was thrown into uncertainty as Jo unfortunately 
went on sick leave. However, Paul was willing to step in and provide supervision, in 
addition to my external supervisor, Sam Cole. I was offered another interim supervisor 
but I turned this down. I have wondered if this was foolish but at that time, I almost felt 
disconnected with the project due to the way it had evolved so far beyond my original 
idea and I think that I needed to take ownership back.  
 
I made contact with several NHS oncology services in the area with varying success. Two 
clinical psychologists in two separate services wanted to focus on their own research and 
did not want to administer my screening tool. Other clinical psychologists I liaised were 
only able to provide me with access to their clients and I realised that I needed to cast the 
net further to contact oncologists, matrons and general managers of outpatient oncology 
departments. I had email correspondence and face-to-face meetings with several people 
in different services but without the project having ethical approval, they didn’t want to 
commit. With that, I continued to gain IRAS and HRA ethical approval. This process was 
long-winded and monotonous as it felt like I was completing the same questions over and 
over, when I just wanted to get on with data collecting. In addition, the system changed 
in April 2016 and it felt as though nobody understood the changes. Attending the ethics 
panel meeting on my own in September 2016 was a daunting experience but the panel 
were good-humoured and I completed amendments quickly. I had a further wait for HRA 
approval but NHS R&D departments would not consider my application until they 
received this. 
 
At this point, St Michael’s Hospital in Bristol and Royal United Hospital in Bath, had 
both agreed to recruit participants. Cheltenham Royal Hospital, Bristol Haematology and 
Oncology Centre (BHOC) and Salisbury General Hospital were all potentially interested 
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but were unsure about the methodology. I had initially planned for the screening tool to 
be handed out by clinicians or reception staff and as it had very little exclusion criteria I 
anticipated that it could be administered to hundreds of patients. However, some services 
believed that their reception staff would not be able to do this and they queried whether 
clinicians would remember to hand the tool out during appointments. Whilst fine-tuning 
the procedure in each service, I received R&D approval from all but Salisbury General 
Hospital. Unfortunately, they cannot support student research unless the individual is 
currently working in their trust. I didn’t fit this criterion and they weren’t keen to offer an 
honorary contract but at that stage there wouldn’t have been time to do this anyway.  
 
During the period between October 2016 – January 2017, I spent most of my time 
repeatedly contacting services, being passed to different people within each team to get 
their personal approval and attending MDTs to introduce my project to whole teams. By 
mid-January, three services (Royal United Hospital, Cheltenham General and St 
Michael’s) took a batch of screening tools to hand out. After meeting with Paul and Sam, 
we decided that I should widen recruitment to target charities, online forums and social 
media, which involved resubmitting my university ethics application for amendment. 
Once that was approved I created social media pages, paid Facebook to promote my study 
and completed an application to Macmillan Voices for them to advertise my project. 
Some online forums and charities are very protective of their users which I commend and 
respect, however, this resulted in them declining to promote my project as they didn’t 
want to advertise too many student projects.  
 
A month after delivering the batches of screening tools, my NHS service contacts were 
not responding to me and internet recruitment had resulted in only four participants. I 
persisted in contacting services and they all finally confirmed that they hadn’t handed out 
any screening tools. I was left with the option of going into services and handing out the 
screening tool myself and I committed a total of five study days to this, which was 
difficult given that we only received one study day per week. The second stage was also 
time-consuming as it involved calling potential participants (it wasn’t possible to review 
each screening tool in clinic due its fast-paced nature) to check eligibility criteria and 
sending a questionnaire pack out in the post. The numbers eventually began to rise but 
the ratio of participants eligible to complete the second stage was as I had expected, as 
many completing the screening tool had metastatic cancer, were still in treatment, or had 
no interest in participating further. I personally disliked going into the oncology clinics 
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to hand out screening tools as there is no privacy in waiting rooms and there were a 
proportion of people in every clinic who did not have a cancer diagnosis but were due to 
receive test results that day. Without the help of clinicians or reception staff to identify 
these patients, I was unable to know this in advance and I learned to adapt the way that I 
introduced myself to avoid upset. 
 
I have developed a love-hate relationship with the MRP and I have been left feeling that 
psychological and student research, is not supported in a physical health setting. When 
speaking to participants, many of them felt as though they didn’t receive adequate 
psychological support, despite the continued development of clinical health psychological 
services and this reminded me of why I believe it is an important area of research that can 
benefit many people. If I could restart this project, I would begin data collection at least 
6-9 months earlier and would incorporate the help of a research assistant. I would take 
more time to consider how the procedure could be adapted for effective online use and 
would include a qualitative element, to capture the voices of cancer survivors.  
 
Future aspirations 
Despite the challenges that I’ve faced with supervisory changes and recruitment, I have 
learned a great deal from conducting research. I’ve gained experience of research 
governance from completing ethics applications and I’ve learned that conducting research 
within pressurised NHS environments requires time and commitment to establish and 
maintain professional relationships to gain the service cooperation with recruitment.  
As I move towards qualified clinical practice, I would like to continue to be involved in 
research and develop further as a scientist-practitioner, contributing to the evidence base. 
From the completion of the research components in training, I believe that service 
development is a key type of research to become involved in.  This is a critical time for 
our profession and continued service development could help to demonstrate our value 
and worth in the NHS. Within a team, I would like to become involved with wider 
research projects, as I believe that collaborating with colleagues could benefit the process 
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Appendix A: European Eating Disorders Review Author Guidelines for Service 
Improvement Project 
Author Guidelines 
Manuscript style. All submissions, including book reviews, should be double-spaced and clearly 
legible. 
The first page should contain the title of the paper, full names of all authors, the address where 
the work was carried out, and the full postal address including telephone, fax number and email 
to whom correspondence and proofs should be sent. The name(s) of any sponsor(s) of the 
research contained in the paper, along with grant number(s) should also be included. 
 
The second sheet should contain an abstract of up to 150 words. An abstract is a concise 
summary of the whole paper, not just the conclusions, and is understandable without reference to 
the rest of the paper. It should contain no citation to other published work. Include up to 
five keywords that describe your paper for indexing purposes. 
• Research articles reporting new research of relevance as set out in the aims and scope 
should not normally exceed 6000 words with no more than five tables or illustrations. They 
should conform to the conventional layout: title page, summary, introduction, materials and 
methods, results, discussion, acknowledgements and references. Each of these elements 
should start on a new page. Authors may not find it necessary to use all of these subdivisions, 
and they are listed here only as a guide. 
• Review articles should offer a synthesis of current knowledge in a field where rapid or 
significant progress has been made. The text should ideally not exceed 7000 words, 50 
references and 5 figures or tables. 
• Brief reports should concisely present the essential findings of the author's work and be 
compromised of the following sections: Abstract, Introduction and Aims, Method, Results, 
Discussion, and References. Tables and/or figures should be kept to a minimum, in number 
and size, and only deal with key findings. In some cases authors may be asked to prepare a 
version of the manuscript with extra material to be included in the online version of the 
review (as supplementary files). Submissions in this category should not normally exceed 
2500 words in length. 
Brief reports bring with them a whole host of benefits including: quick and easy submission, 
administration centralised and reduced and significant decrease in peer review times, first 
publication priority (this type of manuscript will be published in the next available issue of 
the journal). 
• Case Reports The journal does not accept case reports for publication. Authors of case 
reports are encouraged to submit to the Wiley Open Access journal, Clinical Case 
Reports www.clinicalcasesjournal.com which aims to directly improve health outcomes by 
identifying and disseminating examples of best clinical practice. 
 
Reference style. The APA system of citing sources indicates the author's last name and the date, 
in parentheses, within the text of the paper. 
A. A typical citation of an entire work consists of the author's name and the year of 
publication. 
Example: Charlotte and Emily Bronte were polar opposites, not only in their personalities but in 
their sources of inspiration for writing (Taylor, 1990). Use the last name only in both first and 
subsequent citations, except when there is more than one author with the same last name. In that 
case, use the last name and the first initial. 
B. If the author is named in the text, only the year is cited. 
Example: According to Irene Taylor (1990), the personalities of Charlotte. . . 
C. If both the name of the author and the date are used in the text, parenthetical reference 
is not necessary. 
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Example: In a 1989 article, Gould explains Darwin's most successful. . . 
D. Specific citations of pages or chapters follow the year. 
Example: Emily Bronte "expressed increasing hostility for the world of human relationships, 
whether sexual or social" (Taylor, 1988, p. 11). 
E. When the reference is to a work by two authors, cite both names each time the reference 
appears. 
Example: Sexual-selection theory often has been used to explore patters of various insect matings 
(Alcock & Thornhill, 1983) . . . Alcock and Thornhill (1983) also demonstrate. .  
F. When the reference is to a work by three to five authors, cite all the authors the first time 
the reference appears. In a subsequent reference, use the first author's last name followed 
by et al. (meaning "and others"). 
Example: Patterns of byzantine intrigue have long plagued the internal politics of community 
college administration in Texas (Douglas et al., 1997) When the reference is to a work by six or 
more authors, use only the first author's name followed by et al. in the first and all subsequent 
references. The only exceptions to this rule are when some confusion might result because of 
similar names or the same author being cited. In that case, cite enough authors so that the 
distinction is clear. 
G. When the reference is to a work by a corporate author, use the name of the organization 
as the author. 
Example: Retired officers retain access to all of the university's educational and recreational 
facilities (Columbia University, 1987, p. 54). 
H. Personal letters, telephone calls, and other material that cannot be retrieved are not listed 
in References but are cited in the text. 
Example: Jesse Moore (telephone conversation, April 17, 1989) confirmed that the ideas.  
I. Parenthetical references may mention more than one work, particularly when ideas have 
been summarized after drawing from several sources. Multiple citations should be arranged 
as follows. 
Examples: 
• List two or more works by the same author in order of the date of publication: (Gould, 1987, 
1989) 
• Differentiate works by the same author and with the same publication date by adding an 
identifying letter to each date: (Bloom, 1987a, 1987b) 
• List works by different authors in alphabetical order by last name, and use semicolons to 
separate the references: (Gould, 1989; Smith, 1983; Tutwiler, 1989). 
 
All references must be complete and accurate. Where possible the DOI for the reference should 
be included at the end of the reference. Online citations should include date of access. If necessary, 
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Appendix C: AWP Research and Development approval letter 
 
 
Avon and Wiltshire Mental Health Partnership AWP Trust 
AWP Quality Academy 




0117 378 4238/ 07825 725296 
Dawn Lindsay,  
Clinical Psychologist in Training,  
University of Bath  
Email: d.lindsay@bath.ac.uk 
 
Date: 14th March 2016 
 
Dear Dawn Lindsay 
An evaluation of the dual diagnosis Dialectical Behaviour Therapy Service in Bath and North 
East Somerset (BaNES) 
AWP Reference: E2016.012 Lindsay 
 
This letter is to confirm that your evaluation is now approved and also provides you with our 
reference number.   
If you do need any further support or information, please contact us using the contact details 
above, quoting our reference number for your study.   
The importance of disseminating all evaluation work cannot be over emphasised. It is only by 
sharing our learning that we can improve services across AWP. For this reason, the findings of 
all evaluation work should be reported to the Evaluation team via email. The team will 
champion the results of service evaluations, and work with evaluators to ensure those results 
are disseminated and acted upon, and that the results of evaluations are reflected in future 
service delivery. The team will also work with evaluators to produce publications for the public 
domain. 












Appendix D: Client questionnaire (Service Improvement Project) 
 
Bath and North East Somerset (BaNES) 
Dialectical Behaviour Therapy (DBT) Service 
Client Questionnaire 
1. What gender do you identify with (please circle)? 
Male Female Other 
2. What is your age? 
_____________________________________________________________________ 
3. Which modules of DBT have you completed (please circle all that apply)? 
Mindfulness 
 




4. How would you rate the quality of care that you receive from the DBT service 
(please circle one answer)? 
Very poor Poor Fair Good Very good 
1 2 3 4 5 
5. How satisfied were you with the information provided to you about the 
service and what the therapy would involve when you had your first 
appointment (please circle one answer)? 








1 2 3 4 5 
 
6. How satisfied are you with the weekly DBT skills-based group sessions (please 
circle one answer)? 








1 2 3 4 5 
Client questionnaire 
V1 May 2016 
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7. How satisfied are you with your individual DBT therapy sessions (please circle 
one answer)? 








1 2 3 4 5 
8. How helpful have the two parts of the DBT treatment been in reducing 
behaviours that were, or are distressing to you? 
a. Weekly skills-based group sessions (please circle one answer): 







1 2 3 4 5 
b. Individual therapy sessions (please circle one answer): 







1 2 3 4 5 
9. How helpful have the two parts of the DBT treatment been in learning to 
cope with difficulties you are having, in a better way? 
a. Weekly skills-based group sessions (please circle one answer): 







1 2 3 4 5 
b. Individual therapy sessions (please circle one answer): 







1 2 3 4 5 
10. How important have you found the relationship with your DBT therapist/s to 












1 2 3 4 5 
Client questionnaire 




11. How helpful have you found it to have weekly skills-based group sessions and 
individual therapy sessions at the same time (please circle one answer)? 







1 2 3 4 5 
11. How satisfied are you with the availability of your individual therapist or 
another staff member of the DBT team (please circle one answer)? 








1 2 3 4 5 
12. Have you ever contacted your individual DBT therapist by telephone for 
support between sessions (please circle one answer)? 
Yes No 
13. Overall, how satisfied are you with the service that you receive from the DBT 
service (please circle one answer)? 








1 2 3 4 5 
14. If somebody you knew was in need of similar therapy, how likely would you 
be to recommend this service to them (please circle one answer)? 







1 2 3 4 5 
Client questionnaire 
V1 May 2016 
 







Appendix E: Client interview schedule (Service Improvement Project) 
 
Coming into the DBT service 
1. How did you first become aware of the DBT service? 
 
2. Name up to 3 things that you hoped to achieve when you started DBT? 
 
3. How close do you think the service has come to meeting your expectations?  
 
4. How did you find the assessment experience?  
 
a. Did you feel that you had time to explore things that were concerning you? 
 
b. Did you feel understood? What helped with this? 
 
5. What was helpful/unhelpful about the information given to you during your first 
appointment? 
 
6. How could this information be improved? 
 
Modules 
7. What have you found helpful/unhelpful about each of the modules that you’ve 
completed?  
 




Weekly group vs individual 
9.  How have the weekly skills-based group sessions/individual therapy sessions 
helped/not helped in reducing distressing behaviours?  
• Has one been more helpful than the other? 
 
10. How have the weekly skills-based group sessions/individual therapy sessions 
helped/not helped in learning to cope with difficulties? 
• Has one been more helpful than the other? 
11. Is there anything else that is particularly helpful/unhelpful about the weekly 
skills-based group sessions?  
 
12. How could they be improved? 
 
13. Is there anything else that is particularly helpful/unhelpful about your individual 
therapy sessions?  
 
14. How could they be improved? 
 
Relationship with team members 
15.  What do you think is the main thing that helps to build a good relationship 




16. If you were to give one piece of to a DBT therapist – what advice would you 
give them? 
 
17. If you were to give one piece of advice to a group facilitator – what advice 
would you give them? 
 
Phone consultation 
18.  Yes – What was helpful/unhelpful about it?  
 
No – Has there been anything that stops from calling your therapist for support 
between sessions? What would help you to use it more often? 
 
General points about DBT service 
19. Which parts of DBT do you prefer the most?  
(Prompt – do they have any preference over group sessions/individual 
sessions?) 
 
20. What is helpful/unhelpful about the resources used within therapy, e.g. diary 
cards, measures/questionnaires/handouts? 
 
21. How could they be improved?  
 
22. Thinking about the DBT service as a whole can you name up to 3 ways that you 
think it could be improved? 
 
23. What one piece of advice would you give to somebody who was going to start 
DBT? 
 

















Appendix F: Team member questionnaire (Service Improvement Project) 
 
 Bath and North East Somerset (BaNES) 
Dialectical Behaviour Therapy (DBT) Service 
Team Member Questionnaire 
1. What gender do you identify with (please circle)? 
Male Female Other 
2. What is your job title? 
_____________________________________________________________________ 
3. How long have you been working for the DBT service? 
_____________________________________________________________________ 
4. Which parts of the DBT service are you involved with (please circle all that 
apply)? 
Weekly skills based group 
meeting 
Individual therapy sessions Phone consultation 
Weekly consultation group DBT assessments  
5. How would you rate the quality of care that is delivered by the DBT service 
(please circle one answer)? 
Very poor Poor Fair Good Very good 
1 2 3 4 5 
6. How effective do you think the DBT service is in meeting the complex needs 
of the service users (please circle one answer)? 








1 2 3 4 5 
7. Overall, how satisfied do you think service users are with the DBT service 
(please circle one answer)? 








1 2 3 4 5 
Team member questionnaire 
V1 May 2016 
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8. How effective do you think the DBT service is at measuring change and 
improvement (please circle one answer)? 








1 2 3 4 5 
9. How helpful do you think the current outcome measures used are (please 
circle one answer)? 







1 2 3 4 5 
10. How helpful do you think the resources and materials (e.g. diary 
cards/handouts) currently used by service users are (please circle one 
answer)? 







1 2 3 4 5 
11. How helpful are the weekly consultation meetings (please circle one 
answer)? 







1 2 3 4 5 
12. How helpful was the DBT training that you received (please circle one 
answer)? 







1 2 3 4 5 
13. How effective do you think the training was for preparing you to run weekly 
skills-based group sessions (please circle one answer)? 








1 2 3 4 5 
Team member questionnaire 





14. How effective do you think the training was for preparing you to deliver 
individual therapy sessions to service users (please circle one answer)? 








1 2 3 4 5 
Team member questionnaire 
V1 May 2016 



























Appendix G: Team member interview schedule 
Additional follow-up questions will be asked where appropriate to clarify 
responses 
(Italics indicate prompt to interviewer) 
 
Effectiveness and service user perspective 
1. What do you think the DBT service does well in meeting the service users’ 
needs? 
2. How do you think the service could be improved to meet the needs of the service 
users in a more effective way? 
3. What do you think service users value about the therapy they receive? 
4. How do you think service users would want the DBT service to improve, if at 
all? 
Measuring change 
5. How does the DBT service currently measure change and improvement (e.g. 
measures used and how often these are completed)?  
6. How do you think change and improvement could be measured in a more 
effective way? 
7. Are there any symptoms or behaviours shown by service users that you think 
should be measured that aren’t currently? 
Consultation meetings 
8. What is helpful/unhelpful about the weekly consultation meeting? 
9. How do you think the consultation meetings could be improved? 
DBT training 
10. What was helpful/unhelpful about the DBT training and how it prepared you for 
delivering the service? 
11. Are there any barriers to offering individual therapy sessions? 
12. What do you think are the benefits of offering individual therapy sessions? 
Improvements in general 
13. Do you have any other suggestions about how you think the DBT service could 
be improved? 
14. Is there anything else that you would like to add that we have not spoken about? 
158 
 
Appendix H: British Journal of Clinical Psychology Author Guidelines for Critical 
Review of the Literature 
Author Guidelines 
The British Journal of Clinical Psychology publishes original contributions to scientific 
knowledge in clinical psychology. This includes descriptive comparisons, as well as studies of 
the assessment, aetiology and treatment of people with a wide range of psychological problems 
in all age groups and settings. The level of analysis of studies ranges from biological influences 
on individual behaviour through to studies of psychological interventions and treatments on 
individuals, dyads, families and groups, to investigations of the relationships between explicitly 
social and psychological levels of analysis. 
 
All papers published in The British Journal of Clinical Psychology are eligible for Panel A: 
Psychology, Psychiatry and Neuroscience in the Research Excellence Framework (REF). 
The following types of paper are invited: 
• Papers reporting original empirical investigations 
• Theoretical papers, provided that these are sufficiently related to the empirical data 
• Review articles which need not be exhaustive but which should give an interpretation of the 
state of the research in a given field and, where appropriate, identify its clinical implications 
• Brief reports and comments 
 
Length 
The word limit for papers submitted for consideration to BJCP is 5000 words and any papers that 
are over this word limit will be returned to the authors. The word limit does not include the 
abstract, reference list, figures, or tables. Appendices however are included in the word limit. The 
Editors retain discretion to publish papers beyond this length in cases where the clear and concise 
expression of the scientific content requires greater length. In such a case, the authors should 
contact the Editors before submission of the paper. 
Submission and reviewing 
All manuscripts must be submitted via Editorial Manager. The Journal operates a policy of 
anonymous (double blind) peer review. We also operate a triage process in which submissions 
that are out of scope or otherwise inappropriate will be rejected by the editors without external 
peer review to avoid unnecessary delays. Before submitting, please read the terms and conditions 
of submission and the declaration of competing interests. You may also like to use the Submission 
Checklist to help you prepare your paper. 
 
Manuscript requirements 
• Contributions must be typed in double spacing with wide margins. All sheets must be numbered. 
• Manuscripts should be preceded by a title page which includes a full list of authors and their 
affiliations, as well as the corresponding author's contact details. You may like to 
use this template. When entering the author names into Editorial Manager, the corresponding 
author will be asked to provide a CRediT contributor role to classify the role that each author 
played in creating the manuscript. Please see the Project CRediTwebsite for a list of roles. 
• The main document must be anonymous. Please do not mention the authors’ names or 
affiliations (including in the Method section) and refer to any previous work in the third person. 
• Tables should be typed in double spacing, each on a separate page with a self-explanatory title. 
Tables should be comprehensible without reference to the text. They should be placed at the end 
of the manuscript but they must be mentioned in the text. 
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• Figures can be included at the end of the document or attached as separate files, carefully labelled 
in initial capital/lower case lettering with symbols in a form consistent with text use. Unnecessary 
background patterns, lines and shading should be avoided. Captions should be listed on a separate 
sheet. The resolution of digital images must be at least 300 dpi. All figures must be mentioned in 
the text. 
• All papers must include a structured abstract of up to 250 words under the headings: Objectives, 
Methods, Results, Conclusions. Articles which report original scientific research should also 
include a heading 'Design' before 'Methods'. The 'Methods' section for systematic reviews and 
theoretical papers should include, as a minimum, a description of the methods the author(s) used 
to access the literature they drew upon. That is, the abstract should summarize the databases that 
were consulted and the search terms that were used. 
• All Articles must include Practitioner Points – these are 2–4 bullet points to detail the positive 
clinical implications of the work, with a further 2–4 bullet points outlining cautions or limitations 
of the study. They should be placed below the abstract, with the heading ‘Practitioner Points’. 
• For reference citations, please use APA style. Particular care should be taken to ensure that 
references are accurate and complete. Give all journal titles in full and provide DOI numbers 
where possible for journal articles. 
• SI units must be used for all measurements, rounded off to practical values if appropriate, with 
the imperial equivalent in parentheses. 
• In normal circumstances, effect size should be incorporated. 
• Authors are requested to avoid the use of sexist language. 
• Authors are responsible for acquiring written permission to publish lengthy quotations, 
illustrations, etc. for which they do not own copyright. For guidelines on editorial style, please 
consult the APA Publication Manual published by the American Psychological Association. 
If you need more information about submitting your manuscript for publication, please email 
Melanie Seddon, Managing Editor (bjc@wiley.com) or phone +44 (0) 1243 770 108. 
 
Brief reports and comments 
These allow publication of research studies and theoretical, critical or review comments with an 
essential contribution to make. They should be limited to 2000 words, including references. The 
abstract should not exceed 120 words and should be structured under these headings: Objective, 
Method, Results, Conclusions. There should be no more than one table or figure, which should 
only be included if it conveys information more efficiently than the text. Title, author name and 
address are not included in the word limit. 
Supporting Information 
BJC is happy to accept articles with supporting information supplied for online only publication. 
This may include appendices, supplementary figures, sound files, videoclips etc. These will be 
posted on Wiley Online Library with the article. The print version will have a note indicating that 
extra material is available online. Please indicate clearly on submission which material is for 
online only publication. Please note that extra online only material is published as supplied by the 
author in the same file format and is not copyedited or typeset. Further information about this 
service can be found at http://authorservices.wiley.com/bauthor/suppmat.asp 
 
Colour illustrations 
Colour illustrations can be accepted for publication online. These would be reproduced in 
greyscale in the print version. If authors would like these figures to be reproduced in colour in 
print at their expense they should request this by completing a Colour Work Agreement form 
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Appendix I: Psycho-Oncology Author Guidelines for Main Research Project 
Author Guidelines 
MANUSCRIPT CATEGORIES AND REQUIREMENTS 
Psycho-Oncology publishes a number of different article types including: 
• Original Paper 
Original research papers should contain reports of new research findings or conceptual analyses 
that make a significant contribution to knowledge. Original papers should not exceed 4,000 
words (including no more than four figures and/or tables) plus up to 40 references. 
• Reviews 
Reviews should be critical reviews of the literature, including systematic reviews and meta-
analyses and should not exceed 6,000 words, excluding references. Please complete and supply 
an AMSTAR checklist for systematic reviews which are narrative reviews and not meta-
analyses. 
• Editorials 
Editorials are usually invited but unsolicited material may be considered. Please approach the 
Editorial Office (Psycho-Oncology@wiley.com) before submitting this material. Editorials have 
a limit of 1,000 words. 
• Letters to the Editor 
Letters to the Editor are welcomed and should not exceed 400 words. Please note that if Letters 
to the Editor include a comment on a previously published paper the authors of said paper 
should be allowed 4 weeks in which to respond. If there is no response after 4 weeks, the Letter 
will simply be accepted with an Editor’s footnote: “The authors of [title of previously published 
paper] offered no comments” 
• Book Review 
Proposal for book reviews, may be submitted to the book review Editor, Errol Philip 
(ejphilip@gmail.com) 
• Clinical Correspondence 
Clinical Correspondence may include feasibility studies, case studies, phase I/II clinical trials, 
questionnaire development studies, service development, commentary and novel clinical 
techniques. They must include five succinct key points (and no abstract), not exceed 1,500 
words (including no more than two figures and/or tables), excluding reference. They should also 
be limited to ten references maximum. 
• Invited Perspective 
Invited perspectives are opinion pieces written by select individuals within the field on certain 
topics. They are usually invited by the Editors. 
• Invited Commentary 
Commentaries are usually written by an expert investigator who is invited by the Editors. They 
are usually written in response to a previously published article or Editorial. 
Qualitative manuscript submissions should usually be based on a minimum of 20 respondents. 
Authors may contact the Editors (hollandj@mskcc.org; maggie.watson@live.co.uk) if they 
require further details. 
 
PREPARING YOUR SUBMISSION 
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Manuscripts must be submitted as a Word or rtf file and should be written in English. The 
manuscript should be submitted in separate files: main text file; figures. 
Text file 
The text file should be presented in the following order: 
(i) Title; (ii) a short running title of less than 70 characters; (iii) the full names of the authors; 
(iv) the author's institutional affiliations at which the work was carried out, (footnote for 
author’s present address if different to where the work was carried out); (v) abstract; (vi) main 
text, (vii) acknowledgements, (viii) conflict of interest statement, (ix) references, (x) tables 
(each table complete with title and footnotes) (xi) figure legends, (xii) appendices (if relevant). 
Figures and supporting information should be supplied as separate files. 
Title 
The title should be a short informative title that contains the major key words. The title should 
not contain abbreviations (see Wiley's best practice SEO tips) 
Authorship 
Please refer to the journal’s authorship policy the Editorial Policies and Ethical Considerations 
section for details on eligibility for author listing. 
Acknowledgements 
Contributions from anyone who does not meet the criteria for authorship should be listed, with 
permission from the contributor, in an Acknowledgments section. Financial and material 
support should also be mentioned. Thanks to anonymous reviewers are not appropriate. 
Conflict of Interest Statement 
You will be asked to disclose conflicts of interest during the submission process. See the section 
‘Conflict of Interest’ in the Editorial Policies and Ethical Considerations section for details on 
what to include in this section. Please ensure that you liaise with all co-authors to confirm 
agreement with the final statement. The Conflict of Interest statement should be included within 
the main text file of your submission. 
Abstract 
Please provide an abstract of no more than 250 words. Abstracts should be structured according 
to the following headings: objective, methods, results, conclusions. 
Keywords 
Please provide up to 10 keywords and list them in alphabetical order. Please ensure that the 
keywords, cancer and oncology, are used for indexing purposes. Keywords should be taken 
from those recommended by the US National Library of Medicine's Medical Subject Headings 
(MeSH) browser list at https://www.nlm.nih.gov/mesh/. 
Main text 
Where possible, the text should be divided into the following sections: Background, Methods 
(including statistical methods), Results and Conclusions. All papers must include within the 
Conclusions section a paragraph explaining the study limitations (with subtitle “study 




A statement explicitly describing the ethical background to this study and any institutional or 
national ethical committee approval (including approval number) must be included within the 
manuscript. 
For clinical trial reports, the clinical trial registration number must be included within the 
manuscript. 
References 
All references should be numbered consecutively in order of appearance and should be as 
complete as possible. In text citations should be superscript numbers. Journal titles are 
abbreviated; abbreviations may be found in the following: MEDLINE, Index Medicus, 
or CalTech Library. 
Submissions are not required to reflect the precise reference formatting of the journal (use of 
italics, bold etc.), however it is important that all key elements of each reference are included. 
Please see below for examples of reference content requirements. 
For more information, please see the Vancouver Reference Style Guide 
Sample references follow: 
Journal Article 
1. Wood WG, Eckert GP, Igbavboa U, Muller WE. Statins and neuroprotection: a prescription 
to move the field forward. Ann N Y Acad Sci 2010; 1199:69-76. 
Book 
2. Hoppert, M. Microscopic techniques in biotechnology. Weinheim: Wiley-VCH; 2003. 
Electronic Material 
3. Cancer-Pain.org [homepage on the internet]. New York: Association of Cancer Online 
Resources, Inc.; c2000–01 [Cited 2015 May 11]. Available from: http://www.cancer-pain.org/. 
 
Tables 
Tables should be self-contained and complement, but not duplicate, information contained in the 
text. They should be supplied as editable files, not pasted as images. Legends should be concise 
but comprehensive – the table, legend and footnotes must be understandable without reference 
to the text. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should 
be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such 
as SD or SEM should be identified in the headings. 
Figure Legends 
Legends should be concise but comprehensive – the figure and its legend must be 
understandable without reference to the text. Include definitions of any symbols used and 
define/explain all abbreviations and units of measurement. 
Preparing Figures 
Although we encourage authors to send us the highest-quality figures possible, for peer-review 
purposes we are happy to accept a wide variety of formats, sizes, and resolutions. 
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Click here for the basic figure requirements for figures submitted with manuscripts for initial 
peer review, as well as the more detailed post-acceptance figure requirements. 
 
Guidelines for Cover Submissions 
If you would like to send suggestions for artwork related to your manuscript to be considered to 
appear on the cover of the journal, please follow these general guidelines. 
 
Appendices 
Appendices will be published after the references. For submission they should be supplied as 
separate files but referred to in the text. Supporting Information 
Supporting Information 
Supporting information is information that is not essential to the article but that provides greater 
depth and background. It is hosted online, and appears without editing or typesetting. It may 
include tables, figures, videos, datasets, etc. Click here for Wiley’s FAQs on supporting 
information. 
Note, if data, scripts or other artefacts used to generate the analyses presented in the paper are 
available via a publicly available data repository, authors should include a reference to the 
location of the material within their paper. 
General Style Points 
The following links provide general advice on formatting and style. 
• Abbreviations: In general, terms should not be abbreviated unless they are used repeatedly and 
the abbreviation is helpful to the reader. Initially use the word in full, followed by the 
abbreviation in parentheses. Thereafter use the abbreviation only. 
• Units of measurement: Measurements should be given in SI or SI-derived units. Visit the 
Bureau International des Poids et Mesures (BIPM) website at http://www.bipm.fr for more 
information about SI units. 
• Trade Names: Chemical substances should be referred to by the generic name only. Trade 
names should not be used. Drugs should be referred to by their generic names. If proprietary 
drugs have been used in the study, refer to these by their generic name, mentioning the 
proprietary name, and the name and location of the manufacturer, in parentheses. 
Data storage and documentation 
Psycho-Oncology encourages data sharing wherever possible, unless this is prevented by 
ethical, privacy or confidentiality matters. Authors publishing in the journal are therefore 
encouraged to make their data, scripts and other artefacts used to generate the analyses 
presented in the paper available via a publicly available data repository, however this is not 
mandatory. If the study includes original data, at least one author must confirm that he or she 
had full access to all the data in the study, and takes responsibility for the integrity of the data 
and the accuracy of the data analysis. 
 
Ethics 
A statement explicitly describing the ethical background to this study and any institutional or 
national ethical committee approval must be included within the manuscript. 
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Human Studies and Subjects 
For manuscripts reporting medical studies involving human participants, we require a statement 
identifying the ethics committee that approved the study, and that the study conforms to 
recognized standards, for example: Declaration of Helsinki; US Federal Policy for the 
Protection of Human Subjects; or European Medicines Agency Guidelines for Good Clinical 
Practice. 
Images and information from individual participants will only be published where the authors 
have obtained the individual's free prior informed consent. Authors do not need to provide a 
copy of the consent form to the publisher, however in signing the author license to publish 
authors are required to confirm that consent has been obtained. Wiley has a standard patient 
consent form available. 
 
Conflict of Interest 
Psycho-Oncology requires that all authors disclose any potential sources of conflict of interest. 
Any interest or relationship, financial or otherwise that might be perceived as influencing an 
author's objectivity is considered a potential source of conflict of interest. These must be 
disclosed when directly relevant or directly related to the work that the authors describe in their 
manuscript. Potential sources of conflict of interest include, but are not limited to, patent or 
stock ownership, membership of a company board of directors, membership of an advisory 
board or committee for a company, and consultancy for or receipt of speaker's fees from a 
company. The existence of a conflict of interest does not preclude publication. If the authors 
have no conflict of interest to declare, they must also state this at submission. It is the 
responsibility of the corresponding author to review this policy with all authors and collectively 
to disclose with the submission ALL pertinent commercial and other relationships. The Conflict 
of Interest statement should be included within the main text file of your submission. 
 
Funding 
Authors should list all funding sources in the Acknowledgments section. Authors are 
responsible for the accuracy of their funder designation. If in doubt, please check the Open 
Funder Registry for the correct nomenclature: http://www.crossref.org/fundingdata/registry.html 
 
Authorship 
The list of authors should accurately illustrate who contributed to the work and how. All those 
listed as authors should qualify for authorship according to the following criteria: 
1) Have made substantial contributions to conception and design, or acquisition of data, or 
analysis and interpretation of data; 
2) Been involved in drafting the manuscript or revising it critically for important intellectual 
content; 
3) Given final approval of the version to be published. Each author should have participated 
sufficiently in the work to take public responsibility for appropriate portions of the content; and 
4) Agreed to be accountable for all aspects of the work in ensuring that questions related to the 
accuracy or integrity of any part of the work are appropriately investigated and resolved. 
 
Contributions from anyone who does not meet the criteria for authorship should be listed, with 
permission from the contributor, in an Acknowledgments section (for example, to recognize 
contributions from people who provided technical help, collation of data, writing assistance, 
acquisition of funding, or a department chairperson who provided general support). Prior to 




Additional authorship options 
Joint first or senior authorship: In the case of joint first authorship a footnote should be added to 
the author listing, e.g. ‘X and Y should be considered joint first author’ or ‘X and Y should be 




Appendix J: HRA and IRAS ethics approval letters with amendments 
HRA Approval Letter 
  
  
Miss Dawn Lindsay    
Clinical Psychologist in Training  Email: hra.approval@nhs.net  
Taunton and Somerset NHS Foundation Trust  
Trainee Base, 10W, Clinical Psychology Department  
University of Bath, Claverton Down  
Bath  
BA2 7AY  
  
22 November 2016  
  
Dear Miss Lindsay    
Letter of HRA Approval  
  
Study title:  Exploring the role of mental defeat, fear of cancer  
recurrence, and health related beliefs in distress and quality of life 
amongst cancer survivors experiencing persistent pain and fatigue  
IRAS project ID:  201581   
REC reference:  16/WM/0420    
Sponsor  University of Bath  
  
I am pleased to confirm that HRA Approval has been given for the above referenced 
study, on the basis described in the application form, protocol, supporting 
documentation and any clarifications noted in this letter.   
  
Participation of NHS Organisations in England   
The sponsor should now provide a copy of this letter to all participating NHS 
organisations in England.   
  
Appendix B provides important information for sponsors and participating NHS 
organisations in England for arranging and confirming capacity and capability. Please 
read Appendix B carefully, in particular the following sections:  
• Participating NHS organisations in England – this clarifies the types of 
participating organisations in the study and whether or not all organisations 
will be undertaking the same activities  
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• Confirmation of capacity and capability - this confirms whether or not each 
type of participating NHS organisation in England is expected to give formal 
confirmation of capacity and capability. Where formal confirmation is not 
expected, the section also provides details on the time limit given to 
participating organisations to opt out of the study, or request additional time, 
before their participation is assumed.  
• Allocation of responsibilities and rights are agreed and documented (4.1 of HRA 
assessment criteria) - this provides detail on the form of agreement to be used 
in the study to confirm capacity and capability, where applicable.  
Further information on funding, HR processes, and compliance with HRA criteria and 
standards is also provided.  
  
It is critical that you involve both the research management function (e.g. R&D office) 
supporting each organisation and the local research team (where there is one) in 
setting up your study. Contact details and further information about working with the 
research management function for each organisation can be accessed from 
www.hra.nhs.uk/hra-approval.   
  
Appendices  
The HRA Approval letter contains the following appendices:  
• A – List of documents reviewed during HRA assessment  
• B – Summary of HRA assessment  
  
After HRA Approval  
The document “After Ethical Review – guidance for sponsors and investigators”, issued 
with your REC favourable opinion, gives detailed guidance on reporting expectations 
for studies, including:   
• Registration of research  
• Notifying amendments  
• Notifying the end of the study  
The HRA website also provides guidance on these topics, and is updated in the light of 
changes in reporting expectations or procedures.  
  
In addition to the guidance in the above, please note the following:  
• HRA Approval applies for the duration of your REC favourable opinion, unless 
otherwise notified in writing by the HRA.  
• Substantial amendments should be submitted directly to the Research Ethics 
Committee, as detailed in the After Ethical Review document. Non-substantial 
amendments should be submitted for review by the HRA using the form 
provided on the HRA website, and emailed to hra.amendments@nhs.net.   
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• The HRA will categorise amendments (substantial and non-substantial) and 
issue confirmation of continued HRA Approval. Further details can be found on 
the HRA website.  
  
Scope   
HRA Approval provides an approval for research involving patients or staff in NHS 
organisations in England.   
  
If your study involves NHS organisations in other countries in the UK, please contact 
the relevant national coordinating functions for support and advice. Further 
information can be found at http://www.hra.nhs.uk/resources/applying-for-
reviews/nhs-hsc-rd-review/.  
   
If there are participating non-NHS organisations, local agreement should be obtained 
in accordance with the procedures of the local participating non-NHS organisation.  
  
User Feedback  
The Health Research Authority is continually striving to provide a high quality service 
to all applicants and sponsors. You are invited to give your view of the service you have 
received and the application procedure. If you wish to make your views known please 
email the HRA at hra.approval@nhs.net. Additionally, one of our staff would be happy 
to call and discuss your experience of HRA Approval.   
  
HRA Training  
We are pleased to welcome researchers and research management staff at our 
training days – see details at http://www.hra.nhs.uk/hra-training/   
  
Your IRAS project ID is 201581. Please quote this on all correspondence.  
  
Yours sincerely  
  
Alison Thorpe  
Senior Assessor  
Email: hra.approval@nhs.net   
Copy to:  Professor Jonathan Knight, University of Bath, Sponsor Contact    
Diana Benton, University Hospitals Bristol NHS Foundation Trust, Lead 
NHS R&D Contact  





IRAS Approval Letter 
West Midlands - Black Country Research Ethics Committee  
The Old Chapel  
Royal Standard Place   
Nottingham  
NG1 6FS  
  
  
 Please note:  This is the favourable opinion of the REC only and does not allow 
you to start your study at NHS sites in England until you receive HRA Approval   
   
  
  
28 October 2016  
  
Miss Dawn Lindsay  
Clinical Psychologist in Training  
Taunton and Somerset NHS Foundation Trust  
Trainee Base, 10W, Clinical Psychology Department  
University of Bath, Claverton Down  
Bath  
BA2 7AY  
  
  
Dear Miss Lindsay   
  
Study title:  Exploring the role of mental defeat, fear of cancer 
recurrence, and health related beliefs in distress 
and quality of life amongst cancer survivors 
experiencing persistent pain and fatigue  
REC reference:  16/WM/0420  
Protocol number:  N/A  
IRAS project ID:  201581  
  
Thank you for your letter of 19 October 2016, responding to the Committee’s 
request for further information on the above research and submitting revised 
documentation.  
The further information has been considered on behalf of the Committee by the 
Chair together with another Committee member.  
We plan to publish your research summary wording for the above study on the 
HRA website, together with your contact details. Publication will be no earlier 
than three months from the date of this opinion letter.  Should you wish to 
provide a substitute contact point, require further information, or wish to 
make a request to postpone publication, please contact the REC Manager, 
Miss Georgia Copeland, nrescommittee.westmidlands-blackcountry@nhs.net.  
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Confirmation of ethical opinion  
  
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion 
for the above research on the basis described in the application form, protocol 
and supporting documentation as revised, subject to the conditions specified 
below.  
Conditions of the favourable opinion  
  
The REC favourable opinion is subject to the following conditions being met prior 
to the start of the study.  
Management permission must be obtained from each host organisation prior to the 
start of the study at the site concerned.  
  
Management permission should be sought from all NHS organisations involved in 
the study in accordance with NHS research governance arrangements. Each NHS 
organisation must confirm through the signing of agreements and/or other 
documents that it has given permission for the research to proceed (except 
where explicitly specified otherwise).   
Guidance on applying for NHS permission for research is available in the 
Integrated Research Application System, www.hra.nhs.uk or at 
http://www.rdforum.nhs.uk.    
  
Where a NHS organisation’s role in the study is limited to identifying and 
referring potential participants to research sites ("participant identification 
centre"), guidance should be sought from the R&D office on the information it 
requires to give permission for this activity.  
  
For non-NHS sites, site management permission should be obtained in 
accordance with the procedures of the relevant host organisation.   
  
Sponsors are not required to notify the Committee of management permissions 
from host organisations  
  
Registration of Clinical Trials  
  
All clinical trials (defined as the first four categories on the IRAS filter page) must 
be registered on a publically accessible database within 6 weeks of recruitment 
of the first participant (for medical device studies, within the timeline 
determined by the current registration and publication trees).    
There is no requirement to separately notify the REC but you should do so at the 
earliest opportunity e.g. when submitting an amendment.  We will audit the 
registration details as part of the annual progress reporting process.  
To ensure transparency in research, we strongly recommend that all research is 
registered but for non-clinical trials this is not currently mandatory.  
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If a sponsor wishes to contest the need for registration they should contact 
Catherine Blewett (catherineblewett@nhs.net), the HRA does not, however, 
expect exceptions to be made. Guidance on where to register is provided within 
IRAS.   
It is the responsibility of the sponsor to ensure that all the conditions are complied 
with before the start of the study or its initiation at a particular site (as applicable).  
Ethical review of research sites  
  
NHS sites  
The favourable opinion applies to all NHS sites taking part in the study, subject to 
management permission being obtained from the NHS/HSC R&D office prior to 
the start of the study (see "Conditions of the favourable opinion" below).   
Approved documents  
The final list of documents reviewed and approved by the Committee is as 
follows:  
Document    Version    Date    
Covering letter on headed paper [Cover letter]   1   19 October 2016   
Evidence of Sponsor insurance or indemnity (non NHS Sponsors 
only) [Evidence of University of Bath Insurance]   
      
IRAS Application Form [IRAS_Form_20102016]      20 October 2016   
Letter from sponsor [Sponsorship approval from University of Bath]   1   18 August 2016   
Letters of invitation to participant [Letter of Invitation for Stage 2 ]   1   23 August 2016   
Non-validated questionnaire [Screening Tool (Symptom Checklist)]   1   23 August 2016   
Non-validated questionnaire [Screening Tool (Symptom Checklist)]   2   12 October 2016   
Non-validated questionnaire [Treatment Info for Questionnaire 
Pack] 
2   12 October 2016   
Non-validated questionnaire [Demographic Info for Questionnaire 
Pack]   
2   18 October 2016   
Participant consent form [Stage 2 Consent Form]   1   23 August 2016   
Participant consent form [Stage 2 Consent Form]   1   23 August 2016   
Participant information sheet (PIS) [Stage 1 Information Sheet]   2   18 October 2016   
Participant information sheet (PIS) [Stage 1 Information Sheet 
Clean]   
2-1   18 October 2016   
Participant information sheet (PIS) [Stage 2 Information Sheet]   2   19 October 2016   
Participant information sheet (PIS) [Stage 2 Information Sheet 
Clean]   
2-1   19 October 2016   
Research protocol or project proposal [Research Protocol]   2   12 October 2016   
Summary CV for Chief Investigator (CI) [Summary CV for CI]   1   23 August 2016   
Summary CV for supervisor (student research) [Summary CV for 
academic supervisor]   
1   23 August 2016   
Summary, synopsis or diagram (flowchart) of protocol in non 
technical language [Lay Summary]   
1   23 August 2016   
Validated questionnaire [Pain Catastrophizing Scale]         
173 
 
Validated questionnaire [Health Anxiety Inventory Short Form]         
Validated questionnaire [Pain Self Perception Scale]         
Validated questionnaire [Quality of Life Index]         
Validated questionnaire [Patient Health Questionnaire PHQ 9]         
Validated questionnaire [Beliefs about Fatigue Symptoms]         
Validated questionnaire [Generalized Anxiety Disorder 
Questionnaire GAD 7]   
      
Validated questionnaire [Fear of Cancer Recurrence Severity 
Subscale]   
      
  
Statement of compliance  
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees and complies fully with the Standard Operating Procedures 
for Research Ethics Committees in the UK.  
After ethical review  
Reporting requirements  
  
The attached document “After ethical review – guidance for researchers” gives 
detailed guidance on reporting requirements for studies with a favourable opinion, 
including:  
  
• Notifying substantial amendments  
• Adding new sites and investigators  
• Notification of serious breaches of the protocol  
• Progress and safety reports  
• Notifying the end of the study  
  
The HRA website also provides guidance on these topics, which is updated in the light of 
changes in reporting requirements or procedures.  
User Feedback  
The Health Research Authority is continually striving to provide a high quality service to 
all applicants and sponsors. You are invited to give your view of the service you have 
received and the application procedure. If you wish to make your views known please 
use the feedback form available on the HRA website:  
http://www.hra.nhs.uk/about-the-hra/governance/quality-assurance/     
HRA Training  
We are pleased to welcome researchers and R&D staff at our training days – see details 
at http://www.hra.nhs.uk/hra-training/    
  
16/WM/0420                          Please quote this number on all correspondence  
  




Yours sincerely  
PP   




Enclosures:    “After ethical review – guidance for  
    
  
  researchers”   
Copy to:   Professor Jonathan Knight  
Diana Benton, University Hospitals Bristol NHS Foundation Trust  
  
  
Approval for amendment 
 
Dear Miss Dawn Lindsay, 
  
IRAS Project ID: 201581 
Short Study Title: 
Psychological factors, pain and 
fatigue in cancer survivors 
Date complete amendment submission 
received: 
17/01/2017 
Amendment No./ Sponsor Ref: 
NSA #1 - Minor change to Screening 
tool (Symptom Checklist) 
Amendment Date: 17/01/2017 
Amendment Type: Non-substantial 
  
Thank you for submitting the above referenced amendment. In line with the UK 
Process for Handling UK Study Amendments I can confirm that this amendment has 
been categorised as: 
  
Category C - An amendment that has no implications that require management or 
oversight by the participating NHS organisations 
  
As such, the sponsor may implement this amendment as soon as any relevant 
regulatory approvals are in place (for participating organisations in England, please 




As Chief Investigator/Sponsor, it remains your responsibility to ensure that the research 
management offices and local research teams (if applicable) at each of your 
participating organisations are informed of this amendment. 
  
Note: you may only implement changes described in the amendment notice or letter. 
  
Participating NHS Organisations in England – Confirmation of Assessment 
Arrangements 
Further to the details above, I can confirm that no HRA assessment of this 
amendment is needed. 
  
• If this study has HRA Approval, this amendment may be implemented at 
participating NHS organisations in England once the conditions detailed in the 
categorisation section above have been met 
• If this study is a pre-HRA Approval study, this amendment may be implemented 
at participating NHS organisations in England that have NHS Permission, once 
the conditions detailed in the categorisation section above have been met.  For 
participating NHS organisations in England that do not have NHS Permission, 
these sites should be covered by HRA Approval before the amendment is 
implemented at them, please see below; 
• If this study is awaiting HRA Approval, I have passed your amendment to my 
colleague in the assessment team and you should receive separate notification 
that the study has received HRA Approval, incorporating approval for this 
amendment. 
  

















Appendix K: University of Bath psychology ethics approval emails 
Approval email  
 
From: psychology-ethics 
Sent: 08 November 2016 15:32 
To: Dawn Lindsay 




16-301: Exploring the role of mental defeat, fear of cancer recurrence and quality of life 
amongst cancer survivors experiencing persistent pain and fatigue 
  
I am happy to approve this ethics application via Chair’s Action, please use the code 16-301 as 
proof of approval.  
 
Best of luck with your data collection, 
  
Dr. Nathalia Gjersoe 
Chair, Psychology Ethics Committee 
 
 
Approval for amendment made 
 
From: psychology-ethics 
Sent: 20 January 2017 14:52 
To: Dawn Lindsay 




Thank you very much for the ethics application form and for all the attachments. I am happy to 
confirm that you have full ethical approval to widen your recruitment strategy as specified. 
  
Best of luck with your data collection, 
Dr. Nathalia Gjersoe 










Appendix L: R&D approval emails 
University Hospitals Bristol approval 
Hi Dawn 
Confirmation of Capacity and Capability at University Hospitals Bristol NHS 
Foundation Trust 
IRAS ID:                                201581 
Full Study Title:                 Exploring the role of mental defeat, fear of cancer 
recurrence, and health related beliefs in distress and quality of life amongst cancer 
survivors experiencing persistent pain and fatigue 
This email confirms that University Hospitals Bristol NHS Foundation Trust has the 
capacity and capability to support the above referenced study, as a Participating 
Identification Centre.  Please find attached our agreed Statement of Activities as 
confirmation. 
We agree to start this study on a date to be agreed when you as sponsor give the green 
light to begin. 
Please contact the Research Management Office should you require further 
clarifications.   




Research Management Facilitator 
Research & Innovation | University Hospitals Bristol NHS Foundation Trust | Level 3, 
Education and Research Centre | Upper Maudlin Street | Bristol | BS2 8AE | Tel. 0117 
34 20106 | catherine.down@uhbristol.nhs.uk | http://www.uhbristol.nhs.uk/research-
innovation/  | Working with the NIHR, Industry and Charities to improve patient care 
through high quality research 
  
Royal United Hospital Bath approval 
Dear Dawn 
  
RE: IRAS 201581  Confirmation of Capacity and Capability at Royal United Hospitals 
Bath NHS Foundation Trust. 
  
Full Study Title: Exploring the role of mental defeat, fear of cancer recurrence, and 
health related beliefs in distress and quality of life amongst cancer survivors 




This email confirms that Royal United Hospitals Bath NHS Foundation Trust has the 
capacity and capability to deliver the above referenced study (PIC only). Please find 
attached the completed Statement of Activities as confirmation. 
  
Please can you confirm by email the start and finish dates of this projects. 
  












IRAS 201581 Confirmation of Capacity and Capability at Gloucestershire Hospitals NHS 
Foundation Trust 
RE: Exploring the role of mental defeat, fear of cancer recurrence, and health related 
beliefs in distress and quality of life amongst cancer survivors experiencing persistent 
pain and fatigue 
R&D Ref: 16/092/GHT 
  
This email acknowledges that Gloucestershire Research Support Service is able to 
confirm capacity and capability to deliver the above referenced study on behalf of 
Gloucestershire Hospitals NHS Foundation Trust. 
  
Please do not hesitate to contact Mark Walker or myself if you have any queries about 
this.  A formal letter of access will follow shortly. 
  





Nigel Johnson| Research Governance Support Officer| Gloucestershire Hospitals NHS 
Foundation Trust/2gether NHS Foundation Trust/Gloucestershire Care 








Appendix M: Screening tool information sheet and symptom checklist 
     
Psychological factors, pain and fatigue in cancer survivors 
Participant Information Sheet 
We would like to invite you to complete a symptom checklist. Before you decide, it is 
important for you to understand why this is being done and what it will involve. Please take 
time to read the following information carefully. 
Why is this being done? 
Many cancer survivors experience physical symptoms, including pain and fatigue. We know 
that feeling low about these symptoms, fearing that cancer may return in the future and 
worrying about health in general, are common and very normal. 
We would like to find out how often people are affected by physical and psychological 
symptoms and how much they interfere with daily life. Information collected from this 
symptom checklist will help us to update figures on how often and how much these symptoms 
affect people and this can help health professionals to provide support. 
Who can take part? 
We would like to invite people who are aged 18 years or above and have received a diagnosis 
of cancer.  
What will I have to do? 
If you wish to take part then please complete the attached symptom checklist, either before or 
after your appointment. Once complete, please return it to reception. 
What are the benefits and risks of taking part? 
Although there are no direct or immediate benefits to you completing the checklist, it is 
anticipated that the results will help us to understand how frequent and disruptive these 
symptoms are.   
We consider there to be minimal risk in completing the checklist. However, if you do 
experience distress then you may discontinue the questions at any point. We would encourage 
you to discuss this with your oncologist, cancer clinical nurse specialist, or another member of 
your healthcare team.  
Will my information be kept confidential? 
Yes. In accordance with the Data Protection Act of 1998, all of the information you provide will  
IRAS Project ID: 201581  Participant Information Sheet  




be handled in strict confidence and will be anonymised with your name and personal 
information removed. The data collected will be stored securely in locked cabinets and password 
protected computer files and only the research team will have access to this. Data will be kept 
for 5 years after the close of the study and will be destroyed after.     
We will analyse the data collected and hope to report our findings within academic/health 
related journal and present them at conferences. The findings will also contribute to Dawn 
Lindsay’s Doctorate in Clinical Psychology. You will not be identified in any reports or 
publications arising from the study. 
The answers you give to this checklist will not be discussed with your oncologist or any other 
member of your healthcare team. However, we would encourage you to discuss any upsetting 
or distressing symptoms with a health professional so that they can support you with this. 
What happens next? 
You do not have to complete this symptom checklist and your decision whether to do so will 
not affect your appointment, or any current or future treatment you may receive.  
This symptom checklist is the first part of a project that aims to find out which psychological 
factors (e.g. feeling ‘defeated’ by physical symptoms or fearing that cancer may return in the 
future) have the biggest effect on mood, anxiety and quality of life. We would also like to 
explore whether what people think and feel is affected by the physical symptoms that they 
experience. This could help us to design more effective psychological therapies to support 
people to manage their emotional wellbeing better. 
If you would be interested in finding out more about participating in the next part of this 
project, then please leave your contact details in the provided space at the bottom of the 
symptom checklist and the researcher will be in contact shortly.  
Additionally, we would like to contact a few people who have completed this symptom 
checklist to check its accuracy. Please leave your contact details in the provided space at the 
bottom of the symptom checklist if you would be interested in this.  
 
If you have any questions or concerns, please contact the primary researcher: 
Dawn Lindsay 
Clinical Psychologist in Training, University of Bath 
10W, Department of Clinical Psychology, 
Claverton Down, Bath BA2 7AY 
T: 01225 385506 Email: d.lindsay@bath.ac.uk 
M: 07922 168468 
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[INSERT SERVICE LOGO]    
ID: [INSERT] 
Date……………………………………………   
Symptom checklist 
We are going to ask you about some physical symptoms and emotional reactions that are 
common in people who have had a diagnosis of cancer and have received treatment for this. 
If you have completed this checklist previously, please indicate by ticking this box   
1. 1. Pain 
a. a. For how many hours in a day are you affected by pain, in any part of your body? 
 
………………………………………….hours 




 Slightly  Definitely  Markedly  
Very 
severely 
0 1 2 3 4 5 6 7 8 
 
2. 2. Fatigue 








 Slightly  Definitely  Markedly  
Very 
severely 
0 1 2 3 4 5 6 7 8 
 
3. Depression and sadness 
g. a. For how many hours in a day are you affected by feeling down or low in mood? 
 
………………………………………….hours 




 Slightly  Definitely  Markedly  
Very 
severely 
0 1 2 3 4 5 6 7 8 
 
3. 4. General anxiety and worry 








 Slightly  Definitely  Markedly  
Very 
severely 







6. 5. Anxiety focusing on your future health and fear of cancer recurrence 
7. Please indicate whether you have a diagnosis of metastatic (secondary) cancer  
8. If you ticked this box you do not have to complete questions 5a and 5b. 
 









 Slightly  Definitely  Markedly  
Very 
severely 
0 1 2 3 4 5 6 7 8 
 
Please return your completed symptom checklist to reception 
---------------------------------------------------------------------------------------------------------------- 
The next stage of this project aims to find out which psychological factors have the biggest effect 
on mood, anxiety and quality of life, and will explore whether what people think and feel is 
affected by the physical symptoms that they experience.  
We would like to invite people who are aged 18 years or above and: 
• Have received a past diagnosis of cancer 
• Have completed primary cancer treatment 
• Do NOT have any existing co-morbid chronic physical health problems 
If this sounds like you and you would be interested in finding out more about participating in the 
next part of this project, then please leave your contact details below and the researcher will be 
in contact shortly.  
 
If this does not sound like you but you would be interested in being contacted to help us check 
the accuracy of this symptom checklist, then please tick the box and leave your contact details 
below  
 













Appendix N: Questionnaire pack used in second stage of study 
Psychological factors, pain and fatigue in cancer survivors 
QUESTIONNAIRE PACK 
Once complete, please return this pack to the researcher in the pre-paid 
envelope 
Background information 




2. What gender do you identify with (please circle)?  
 
Male/Female/Other (please specify___________) 
 
3. What is your ethnicity (please state)? 
 ________________________________________ 
4. What is your employment status (please tick)? 
Employed (full time)  
Employed (part time)  
Employed (self)  
Currently on sick leave  
Unemployed (Seeking work)  
Unemployed  
Benefits  
Student (Full time)  
Student (Part time)  
Homemaker  
Volunteer  












6. What is your relationship status (please tick)? 
Single  
In a relationship  
Cohabiting  
Engaged  
























1. When were you first diagnosed as having cancer? 
 _____________________________________________________________ 
2. What type of cancer were you diagnosed with? 
 _____________________________________________________________ 




Hormone therapy  
Targeted (Biological) 
therapies  
e.g. angiogenesis inhibitors, 




Stem cell and bone marrow 
treatment 
 


















5. Do you currently take any medication(s) (please tick)? 
 
On prescription  
  Yes  No  
 'Over the counter' 
  Yes  No 
























(Kroenke, Spitzer & Williams 2001) 












Little interest or pleasure in doing 
things. 
0 1 2 3 
Feeling down, depressed, or 
hopeless. 
0 1 2 3 
Trouble falling or staying asleep, 
or sleeping too much. 
0 1 2 3 
Feeling tired or having little 
energy. 
0 1 2 3 
Poor appetite or overeating. 0 1 2 3 
Feeling bad about yourself, or 
that you are a failure, or have let 
yourself or your family down. 
0 1 2 3 
Trouble concentrating on things, 
such as reading the newspaper or 
watching television. 
0 1 2 3 
Moving or speaking so slowly that 
other people could have noticed?  
Or the opposite being so fidgety 
or restless that you have been 
moving around a lot more than 
usual. 
0 1 2 3 
Thoughts that you would be 
better off dead, or of hurting 
yourself in some way. 




(Spitzer, Kroenke, Williams & Lowe 2006) 


































Feeling nervous, anxious or on edge 0 1 2 3 
Not being able to stop or control 
worrying 
0 1 2 3 
Worrying too much about different 
things 
0 1 2 3 
Trouble relaxing 0 1 2 3 
Being so restless that it is hard to sit 
still 
0 1 2 3 
Becoming easily annoyed or irritable 0 1 2 3 
Feeling afraid as if something awful 
might happen 




(Salkovskis, Rimes, Warwick, & Clark, 2002) 
These questions relate to worries about your physical health. Each question consists of 
a group of four statements. Please read each group of statements carefully, then select 
the one which best describes your feelings over the past six months. Identify the 
statement by circling the letter next to it.  
1 A I do not worry about my health 
B I occasionally worry about my health 
C I spend much of my time worrying about my health 
D I spend most of my time worrying about my health 
 
2 A I notice aches/pains less than most other people (of my age) 
B I notice aches/pains as much as most other people (of my age) 
C I notice aches/pains more than most other people (of my age) 
D I am aware of aches/pains in my body all the time 
 
3 A As a rule, I am not aware of bodily sensations or changes 
B Sometimes I am aware of bodily sensations or changes 
C I am often aware of bodily sensations or changes 
D I am constantly aware of bodily sensations or changes 
 
4 A Resisting thoughts of illness is never a problem 
B Most of the time I can resist thoughts of illness 
C I try to resist thoughts of illness but am often unable to do so 
D Thoughts of illness are so strong that I no longer even try to resist them 
 
5 A As a rule I am not afraid that I have a serious illness 
B I am sometimes afraid that I have a serious illness 
C I am often afraid that I have a serious illness 
D I am always afraid that I have a serious illness 
 
6 A I do not have images (mental pictures) of myself being ill 
B I occasionally have images of myself being ill 
C I frequently have images of myself being ill 
D I constantly have images of myself being ill 
 
7 A I do not have any difficulty taking my mind off thoughts about my health 
B I sometimes have difficulty taking my mind off thoughts about my 
health 
C I often have difficulty in taking my mind off thoughts about my health 




8 A I am lastingly relieved if my doctor tells me there is nothing wrong 
B I am initially relieved but the worries sometimes return later 
C I am initially relieved but the worries always return later 
D I am not relieved if my doctor tells me there is nothing wrong 
 
9 A If I hear about an illness I never think I have it myself 
B If I hear about an illness I sometimes think I have it myself 
C If I hear about an illness I often think I have it myself 
D If I hear about an illness I always think I have it myself 
 
10 A If I have a bodily sensation or change I rarely wonder what it means 
B If I have a bodily sensation or change I often wonder what it means 
C If I have a bodily sensation or change I always wonder what it means 
D If I have a bodily sensation or change I must know what it means 
 
11 A I usually feel at very low risk for developing a serious illness 
B I usually feel at fairly low risk for developing a serious illness 
C I usually feel at moderate risk for developing a serious illness 
D I usually feel at high risk for developing a serious illness 
        
12 A I never think I have a serious illness 
B I sometimes think I have a serious illness 
C I often think I have a serious illness 
D I usually think that I am seriously ill 
 
13 A If I notice an unexplained bodily sensation I don't find it difficult to think 
about other things 
B If I notice an unexplained bodily sensation I sometimes find it difficult to 
think about other things. 
C If I notice an unexplained bodily sensation I often find it difficult to think 
about other things 
D If I notice an unexplained bodily sensation I always find it difficult to 
think about other things 
 
14 A My family/friends would say I do not worry enough about my health 
B My family/friends would say I have a normal attitude to my health 
C My family/friends would say I worry too much about my health 






(Tang, Salkovskis & Hanna 2007) 
This questionnaire includes a number of statements that describe thoughts and feelings 
that people sometimes experience at a time when they are experiencing physical 
symptoms. Please rate the extent to which these statements apply to your experience 
during the episode of physical symptoms by circling the appropriate number. There are 
no right or wrong answers to these questions. Please remember that this questionnaire 
is about how you felt and thought at the time of intense physical symptoms.   
 













1. I feel defeated by life 1 2 3 4 5 
2. I feel I have lost my 
standing in the world 
1 2 3 4 5 
3. I feel that life has 
treated me like a 
punchbag 
1 2 3 4 5 
4. I feel powerless 1 2 3 4 5 
5. I feel that my 
confidence has been 
knocked out of me 
1 2 3 4 5 
6. I don’t feel able to 
deal with things that life 
throws at me 
1 2 3 4 5 
7. I feel that I have sunk 
to the bottom of the 
ladder 
1 2 3 4 5 
8. I feel completely 
knocked out of action 
1 2 3 4 5 
9. I feel that I am one of 
life’s losers 
1 2 3 4 5 
10. I feel that I have 
given up 
1 2 3 4 5 
11. I feel down and out 1 2 3 4 5 
12. I feel I have lost 
important battles in life 
1 2 3 4 5 
13. I feel that there is no 
fight left in me 
1 2 3 4 5 
14. I feel I am losing my 
will power 
1 2 3 4 5 
15. I don’t care what 
happens to me anymore 
1 2 3 4 5 
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16. I feel defeated 1 2 3 4 5 
17. I feel less like a 
human being 
1 2 3 4 5 
18. In my mind, I give up 1 2 3 4 5 
19. I feel destroyed as a 
person 
1 2 3 4 5 
20. I felt like I wanted to 
die 
1 2 3 4 5 
21. I feel like I am losing 
my inner resistance 
1 2 3 4 5 
22. I feel like an object 1 2 3 4 5 
23. I feel completely at 
the mercy of what is 
happening it me 
1 2 3 4 5 
24. I feel humiliated and 
that I am losing my sense 
of inner dignity 





























Beliefs about Fatigue Symptoms 
(Wilson, Salkovskis & O’Dowd, 2015) 
We would like to know more about your beliefs about fatigue symptoms. Please indicate 
to what extent you personally agree or disagree with each statement by circling a 
number on the scale. Please circle only one box per line. 
 
1. My fatigue problems can be caused by over-activity: 
Strongly 
Disagree 





2. It is important to avoid exercise when I feel tired: 
Strongly 
Disagree 





3. I believe that my fatigue problems are caused by a virus or infection: 
Strongly 
Disagree 





4. Doing less activity than usual helps to improve my fatigue problems: 
Strongly 
Disagree 





5. My fatigue problems can be caused by failing to get enough rest: 
Strongly 
Disagree 





6. Doing exercise is harmful to me: 
Strongly 
Disagree 





7. My fatigue problems can be caused by stress: 
Strongly 
Disagree 





8. I should avoid doing physical activity: 
Strongly 
Disagree 














Worrying about cancer recurrence 
 (Simard & Savard, 2009) 
Most people who have been diagnosed with cancer are worried, to varying degrees, that there 
might be a recurrence of the cancer. By recurrence, we mean the possibility that the cancer 
could return or progress in the same place or in another part of the body. This questionnaire 
aims to better understand the experience of worries about cancer recurrence. 
Please read each statement and indicate to what degree it applied to you during the past month 
by circling the appropriate number. 
1. I am worried or anxious about the possibility of cancer recurrence. 
0 








A great deal 
2. I am afraid of cancer recurrence. 
0 








A great deal 
3. I believe it is normal to be worried or anxious about the possibility of cancer 
recurrence. 
0 
Not at all  
1 






A great deal 
4. When I think about the possibility of cancer recurrence, this triggers other 
unpleasant thoughts 
or images (such as death, suffering, the consequences for my family). 
0 








A great deal 
5. I believe that I am cured and that the cancer will not come back. 
0 








A great deal 
6. In your opinion, are you at risk of having a cancer recurrence? 
0 
Not at all at 
risk 
1 





A lot at risk 
4 
A great deal 
at risk 




A few times a 
month 
2 
A few times a 
week 
3 





8. How much time per day do you spend thinking about the possibility of cancer 
recurrence? 
0 









A few hours 
4 
Several hours 
9. How long have you been thinking about the possibility of cancer recurrence? 
0 
I don’t think 
about it 
1 




















Ferrans and Powers 
QUALITY OF LIFE INDEX© 
CANCER VERSION - III 
PART 1. For each of the following, please choose the answer that best describes how 
satisfied you are with that area of your life. Please mark your answer by circling the 

















































































1. Your health? 1 2 3 4 5 6 
2. Your health 
care? 
1 2 3 4 5 6 
3. The amount of 
pain that you have? 
1 2 3 4 5 6 
4. The amount of 
energy you have 
for everyday 
activities? 
1 2 3 4 5 6 
5. Your ability to 
take care of 
yourself without 
help? 
1 2 3 4 5 6 
6. The amount of 
control you have 
over your life? 
1 2 3 4 5 6 
7. Your chances of 
living as long as you 
would like? 
1 2 3 4 5 6 
8. Your family’s 
health? 
1 2 3 4 5 6 
9. Your children? 1 2 3 4 5 6 
10. Your family’s 
happiness? 
1 2 3 4 5 6 
11. Your sex life? 1 2 3 4 5 6 
12. Your spouse, 
lover, or partner? 
1 2 3 4 5 6 
13. Your friends? 1 2 3 4 5 6 
14. The emotional 
support you get 
from your family? 
1 2 3 4 5 6 
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15. The emotional 
support you get 
from people other 
than your family? 
1 2 3 4 5 6 
16. Your ability to 
take care of family 
responsibilities? 
1 2 3 4 5 6 
17.  How useful you 
are to others? 
1 2 3 4 5 6 
18. The amount of 
worries in your life? 
1 2 3 4 5 6 
19. Your 
neighbourhood? 
1 2 3 4 5 6 
20. Your home, 
apartment, or place 
where you live? 
1 2 3 4 5 6 
21. Your job (if 
employed)? 
1 2 3 4 5 6 
22. Not having a 
job (if unemployed, 
retired, or 
disabled)? 
1 2 3 4 5 6 
23. Your 
education? 
1 2 3 4 5 6 
24. How well can 
you take care of 
your financial 
needs? 
1 2 3 4 5 6 
25. The things you 
do for fun? 
1 2 3 4 5 6 
26. Your chances 
for a happy future? 
1 2 3 4 5 6 
27. Your peace of 
mind? 
1 2 3 4 5 6 
28. Your faith in 
God? 




1 2 3 4 5 6 
30. Your happiness 
in general? 
1 2 3 4 5 6 
31. Your life in 
general? 
1 2 3 4 5 6 
32. Your personal 
appearance? 
1 2 3 4 5 6 
33. Yourself in 
general? 




PART 2. For each of the following, please choose the answer that best describes how 
important that area of your life is to you. Please mark your answer by circling the 

















































































1. Your health? 1 2 3 4 5 6 
2. Your health 
care? 
1 2 3 4 5 6 
3. Having no pain? 1 2 3 4 5 6 
4. Having enough 
energy for 
everyday activities? 
1 2 3 4 5 6 
5. Taking care of 
yourself without 
help? 
1 2 3 4 5 6 
6. Having control 
over your life? 
1 2 3 4 5 6 
7. Living as long as 
you would like? 
1 2 3 4 5 6 
8. Your family’s 
health? 
1 2 3 4 5 6 
9. Your children? 1 2 3 4 5 6 
10. Your family’s 
happiness? 
1 2 3 4 5 6 
11. Your sex life? 1 2 3 4 5 6 
12. Your spouse, 
lover, or partner? 
1 2 3 4 5 6 
13. Your friends? 1 2 3 4 5 6 
14. The emotional 
support you get 
from your family? 
1 2 3 4 5 6 
15. The emotional 
support you get 
from people other 
than your family? 
1 2 3 4 5 6 
16. Taking care of 
family 
responsibilities? 
1 2 3 4 5 6 
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17.  Being useful to 
others? 
1 2 3 4 5 6 
18. Having no 
worries? 
1 2 3 4 5 6 
19. Your 
neighbourhood? 
1 2 3 4 5 6 
20. Your home, 
apartment, or place 
where you live? 
1 2 3 4 5 6 
21. Your job (if 
employed)? 
1 2 3 4 5 6 
22. Not having a 
job (if unemployed, 
retired, or 
disabled)? 
1 2 3 4 5 6 
23. Your 
education? 
1 2 3 4 5 6 
24. Being able to 
take care of your 
financial needs? 
1 2 3 4 5 6 
25. Doing things for 
fun? 
1 2 3 4 5 6 
26. Having a happy 
future? 
1 2 3 4 5 6 
27. Peace of mind? 1 2 3 4 5 6 
28. Your faith in 
God? 
1 2 3 4 5 6 
29. Achieving your 
personal goals? 
1 2 3 4 5 6 
30. Your happiness 
in general? 
1 2 3 4 5 6 
31. Being satisfied 
with life? 
1 2 3 4 5 6 
32. Your personal 
appearance? 
1 2 3 4 5 6 
33. Are you to 
yourself? 
1 2 3 4 5 6 
 








Appendix O: Information sheet for second stage of the study 
[INSERT SERVICE LOGO]   
 
Psychological factors, pain and fatigue in cancer survivors 
Participant Information Sheet 
We would like to invite you to take part in a research study that is being conducted by Dawn 
Lindsay (Clinical Psychologist in Training, University of Bath). Before you decide, it is important 
for you to understand why the research is being done and what it will involve. Please take time 
to read the following information carefully and discuss it with others if you wish. Ask us if there 
is anything that is not clear or if you would like more information. Take time to decide whether 
or not you wish to take part. 
Why is this project being done? 
Many cancer survivors experience physical symptoms, including pain and fatigue, once they 
have completed treatment. We know that feeling low about these symptoms, fearing that 
cancer may return in the future and worrying about health in general, are common and very 
normal for people who have finished treatment. However, sometimes people can experience 
anxiety, fears and a low mood at a level that becomes quite disruptive and intrusive to their 
everyday lives. 
 
We would like to find out which psychological factors (e.g. feeling ‘defeated’ by physical 
symptoms or fearing that cancer may return in the future) have the biggest effect on mood, 
anxiety and quality of life. We would also like to explore whether what people think and feel is 
affected by the physical symptoms that they experience. 
This should help us to design more effective psychological therapies to support people to 
manage their emotional wellbeing better. 
 
Why have I been invited to take part? 
We would like to invite people who are aged 18 years or above and: 
• Have received a past diagnosis of cancer 
• Have completed primary cancer treatment 
• Do NOT have any existing co-morbid chronic physical health problems 
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What will I be asked to do if I take part? 
You will be invited to complete a set of brief questionnaires that ask about different aspects of  
your wellbeing, including your physical and mental health. The questionnaires should take 
approximately 35 minutes to complete. 
Once completed, please send the consent form and questionnaire pack back to the researcher 
in the pre-paid envelope.   
What are the benefits? 
Although there are no direct or immediate benefits to you completing this study, it is hoped 
and anticipated that the results of this study will help us to understand how the way in which 
people think and feel about their physical symptoms may lead to increased distress and 
reduced quality of life. This should help us to design and provide more effective and timely 
psychological help. 
On return of your completed questionnaire pack you will receive a £5 gift voucher as a token 
of appreciation. 
Will the information I give be kept confidential? 
Yes. In accordance with the Data Protection Act of 1998, all of the information you provide will 
be handled in strict confidence and will be anonymised with your name and personal 
information removed. The data collected will be stored securely in locked cabinets and password 
protected computer files and only the research team will have access to this. Data will be kept 
for 5 years after the close of the study and destroyed after.   
 
If the answers you provide in the questionnaires lead us to feel concerned about risk to your 
self or others, we may have to break confidentiality and discuss this with your Oncology team 
so that they can make contact with you and your GP to discuss your preferences and needs for 
additional support. We would discuss this with you first.  
 
We will analyse the data collected and hope to report our findings within academic/health 
related journals and present them at conferences. The findings will also contribute to Dawn 
Lindsay’s Doctorate in Clinical Psychology.  
 
You will not be identified in any reports or publications arising from the study. 
If you would like to receive a summary of the findings when the study is complete, then please 
indicate this at the end of the questionnaire pack. 
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What if I change my mind during the study? 
If you decide to take part and then later change your mind at any point before the close of the 
project, you can withdraw without giving your reasons and if you wish, your data will be 
destroyed. Taking part, or otherwise, in the project will not affect any current or future 
treatment that you may receive. 
Are there any risks? 
We consider there to be minimal risk to participating. However, it may be possible that 
completing the questionnaires relating to your experiences raises some emotional or 
distressing feelings. You may complete the questionnaires on your own or with the support of 
family/friends. You may also contact Dawn Lindsay (primary researcher) if you would like 
support to complete the questionnaires, or if you have any queries. 
If at any time you feel upset or distressed when completing the questionnaires, then please do 
not hesitate to contact one of the following sources of support: 
• Dawn Lindsay (contact details below) 
• Your Cancer Clinical Nurse Specialist or another member of your healthcare team 
Any of the above people will be able to talk through your concerns with you and discuss 
options for further support, according to your wishes. 
What if I have any further questions/concerns? 
If you have any questions or concerns, please contact Dawn Lindsay in the first instance.  
If you have any general questions about participating in a research study or if you require 
further advice or support, then you may contact your local Patient Advice and Liaison Service 
(PALS). 
University Hospitals Bristol PALS 
Telephone: 0117 342 1050 
Email: psct@uhbristol.nhs.uk 
Royal United Hospital, Bath PALS 
Telephone: 01225 825656 
Email: ruh-tr.PatientAdviceandLiaisonService@nhs.net 
Gloucestershire Hospitals PALS 
Telephone: 0800 019 3282  
Text: 07827 281 266 
Email: pals.gloucestershirehospitals@glos.nhs.uk 
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Salisbury NHS Foundation Trust PALS 
Telephone: 0800 374 208  
Email: customercare@salisbury.nhs.uk 
 
Who has approved the study? 
An independent ethics committee reviews all research in the NHS to ensure your safety, 
privacy, wellbeing and dignity. Approval for this study was given by the Department of 
Psychology’s Ethics Committee at the University of Bath and the Black Country National 
Research Ethics Service (NRES) Committee. 
What happens next? 
Please take some time to decide if you would like to participate in the study. If you wish to 
participate then please sign the consent form and complete the questionnaires. Once 
complete, please return the questionnaire pack and signed consent form to the researcher in 
the pre-paid envelope. Alternatively, you may return the documents to your local oncology 
clinic and they will be collected by the researcher. 
Contact details 
Services 
Please contact your named Cancer Clinical Nurse Specialist at your local clinic in the first 
instance, if you feel upset or distressed.  
Local clinic details: 
St Michael’s Hospital, Bristol    Bristol Haematology and Oncology 
Centre 
Main reception: 0117 342 5325    Main switchboard: 0117 923 0000 
 
Royal United Hospital, Bath 
Oncology outpatients: 01225 825097/825663  
 
Gloucestershire Royal Hospital    Cheltenham General Hospital 
Reception: 0300 422 2222    General Office Enquiries: 0300 422 
4027 
 
Salisbury District Hospital 
01722 336262 extension. 4382 
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Primary researcher      Research supervisor 
Dawn Lindsay      Professor Paul Salkovskis 
Clinical Psychologist in Training    University of Bath 
University of Bath     Email: p.m.salkovskis@bath.ac.uk 
10W, Department of Clinical Psychology      
Claverton Down, Bath 
BA2 7AY 
Email address: d.lindsay@bath.ac.uk 
Telephone: 01225 385506 
Mobile: 07922 168468 
 
 
Additional support services: 
Macmillan cancer support line  
Telephone: 0808 808 00 00 (Mon-Fri 9am-8pm) 
Email:  contactus@macmillan.org.uk 
www.macmillan.org.uk 
Tenovus, the cancer charity 
Telephone: 0808 808 10 10 (365 days a year, 8am-8pm) 
www.tenovus.org.uk 
Penny Brohn UK 
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Appendix P: Consent form for second part of study 
 
 
Psychological factors, pain and fatigue in cancer survivors 
Consent Form 
1. I confirm that I have read the information sheet dated  
20/11/2016 (Version 3) for the above project. I have had the  
opportunity to consider the information, ask questions and have  
had these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to  
withdraw at any time without giving any reason, without my medical  
care or legal rights being affected. 
 
3. I understand that the information that I provide will be made  
anonymous and kept confidential, except in the circumstances where 
information is provided that may place myself or others at risk. 
 




Name of participant (Print)  Signature of participant  
    
Date    
 
Please keep one signed copy of this consent form for your own records and return the 
other signed copy with your completed questionnaire pack in the envelope provided. 
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